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ABSTRACT 
Disease causes large economic losses in the swine industry, not only through the cost of 
medical treatment, but also due to reduced production performance of sick pigs. Expanding our 
knowledge of the genetic basis of diseases will allow more conscientious breeding programs to 
alleviate some of the economic impact. The overall objective of this thesis was to identify the 
molecular and quantitative genetic basis of two diseases in pigs, severe combined 
immunodeficiency (SCID) and porcine reproductive and respiratory syndrome (PRRS). SCID is 
a naturally occuring primary immunodeficiency in humans, horses, dogs, and, as we discovered, 
also in pigs. Immunological assays determined that these pigs had low/no B or T cells, but NK 
cells were present, resulting in T- B- NK+ SCID. Genetic mapping of the lesion and molecular 
characterization revealed two independent mutations in the Artemis gene that cause SCID in 
these pigs. Each of these mutations were associated with a distinct haplotype of single nucleotide 
polymorphisms (SNPs), both of which were traced back to the founder generation of this pig 
population, which was sourced from commercial pig populations in the midwestern United 
States. This suggests that the deleterious mutations repsonsible for causing SCID in these pigs 
may be present in the swine industry; although, likely at a low frequency. The presence of SCID 
in commercial swine operations may go undetected, but a PRRS outbreak certainly will not. 
Thirteen trials, each with ~200 piglets from commercial breeding programs, were experimentally 
infected with one of two PRRS virus (PRRSV) isolates. Phenotypes analyzed were viral load 
(VL) in blood during the first 21 days post infection (dpi) and weight gain (WG) from 0 to 42 
dpi. We utilized genotypes determined on this population using the Illumina Porcine SNP60 
panel to perform genome wide association studies (GWAS) and found several genomic regions 
associated with each trait. None of these genomic regions were associated in both PRRSV isolate 
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trials, except for the QTL on Sus Scrofa Chromosome (SSC) 4 that was previously identified, 
which is associated with VL in both isolates and with WG in the NVSL isolate. These results 
contradicted the previously estimated high genetic correlations of each trait between the two 
PRRSV isolates and lead us to believe that response to each PRRSV isolate is controlled by 
different loci, at least for loci with detectable associations with these traits. Gene ontology (GO) 
annotation information of genes in SNP-associated regions showed enrichment of immunology-
related GO terms in VL-associated regions and metabolism-related GO terms in WG-associated 
regions. We then used these data to assess the accuracy of genomic prediction across PRRSV 
isolates and across breeding companies. Incorporation of annotation information enabled the 
identification of subsets of SNPs that could be used for genomic prediction of response to 
PRRSV in pigs that have not been exposed to the virus. However, predictions based on these 
SNP subsets were not as accurate as predictions using SNPs across the whole genome. The work 
described in this thesis presents opportunities for disease reduction through genetic testing for 
SCID carrier status and genomic selection for response to PRRSV infection. Preventing the 
mating of SCID carriers will reduce losses in of nursery piglets, and genomic selection of pigs 
that are predicted to have more desirable response to PRRSV infection would lessen the impact 
of this disease.
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CHAPTER 1: GENERAL INTRODUCTION 
Introduction 
Disease is a topic of great concern in the swine industry, as diseased pigs have reduced 
production performance and require costly medical treatment. In addition to the economic 
impact, the welfare of diseased animals is of concern to farmers. The Pig Site 
(http://www.thepigsite.com/diseaseinfo/) lists over 140 diseases or health conditions that may 
affect pigs. Swine diseases caused by viruses include swine influenza (Nelson et al., 2015), 
African and classical swine fever (Grau et al., 2015), foot and mouth disease (Grau et al., 2015), 
porcine epidemic diarrhea virus (PEDV; Huang et al., 2013; Stevenson et al., 2013), porcine 
circovirus type 2 (PCV2) (Harding, 2004; Rose et al., 2012; Trible et al., 2012), and porcine 
reproductive and respiratory syndrome (PRRS; Lunney et al., 2010). Bacterial pathogens that 
often infect pigs include Eschericia coli (McLamb et al., 2013; Glass-Kaastra et al., 2014), 
Salmonella (Pires et al., 2014; Cortés et al., 2015), Streptococcus suis (Dee et al., 1993; Fittipaldi 
et al., 2011; Glass-Kaastra et al., 2014), and Mycoplasma hyopneumonia (Young et al., 1983; 
Bargen, 2004). Communicable diseases are of great concern in the swine industry, as 
transmission via direct pig-to-pig contact leads to quick spread within a farm, and various 
transmission routes, such as aerosol or mechanical transmission by vehicle or human traffic, 
cause spread from farm to farm (Ribbens et al., 2004; Cho and Dee, 2006; Alvarez-Ordóez et al., 
2013; Dvorak et al., 2013; Tobias et al., 2014; Hall and Neumann, 2015). 
The inherent susceptibility of pigs to these diseases may also play a role in the economic 
impact of disease in the swine industry. Piglets may be more susceptible to pathogens commonly 
found on farms due to an inability to mount an appropriate immune response. The genetic basis 
of susceptibility to pathogens may involve variation in many genes and have a complex 
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inheritance pattern (Reiner et al., 2002; Boddicker et al., 2012; Reiner et al., 2014; Ramis et al., 
2015) or may result from mutations in a single gene (Goetstouwers et al., 2014; Wang et al., 
2014). The latter scenario is the case for piglets affected with Severe Combined 
Immunodeficiency (SCID; Cino-Ozuna et al., 2012). These SCID piglets lack B and T cells 
(Ewen et al., 2014), which are indispensable to both the adaptive and innate immune systems. B 
and T cells play a role in regulation of the innate immune system through cytokine production 
(Zhao et al., 2009). These piglets fare well while nursing from the sow, but succumb to 
opportunistic infections once they have been weaned. In the swine industry, attributing deaths in 
the nursery barn to genetic disorders such as SCID is unlikely, as parentage information is 
typically not tracked past weaning. A solution to this possible problem is to avoid mating SCID 
carriers to one another, which can be achieved by genetic testing for the causative mutations 
described in this thesis. 
SCID is a primary immune deficiency that naturally occurs in humans (Cossu, 2010), 
horses (Wiler et al., 1995; Bernoco and Bailey, 1998; Perryman, 2004), dogs (Meek et al., 2001), 
and mice (Bosma et al., 1983). Recently, we discovered the first cases of naturally occuring 
SCID in pigs (Cino-Ozuna et al., 2012) during the necropsy of four piglets that died soon after 
arrival at Kansas State University as part of a PRRSV infection trial. These piglets were from a 
line of pigs selected for residual feed intake at Iowa State University (Cai et al., 2008). The 
inheritance of SCID in pigs followed a simple Mendelian recessive pattern, which agrees with 
the majority of SCID cases in humans (Cossu, 2010). Flow cytometry was used to quantify the 
numbers of B, T, and NK cells in circulating blood of these SCID piglets and showed that they 
were affected with T- B- NK+ SCID (Ewen et al., 2014). It was also shown that these SCID pigs 
were unable to reject cells from two human cancer lines after injection in the SCID piglets’ ears 
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(Basel et al., 2012). These piglets lack the ability to fight foreign cells or pathogens, such as 
viruses, bacteria, and even human cancer cells.  
SCID pigs provide a valuable model for biomedical research, and can be used to study 
many aspects of human immune function, disease, treatment methods, vaccination protocols, and 
transplantation, among others. In addition to studies investigating human immune function, 
SCID pigs also provide a model that would be useful in examining pig diseases. Understanding 
the host response to the PRRS virus (PRRSV) would benefit greatly from infection of SCID pigs, 
as there is much to learn about the contribution of B and T cells to clearance of the virus 
(Murtaugh et al., 2002; Mateu and Diaz, 2008; Darwich et al., 2010; Loving et al., 2015). 
Recently, a group at Kansas State University conducted a study in which SCID and non-SCID 
littermates were infected with the PRRSV, then followed for 21 dpi (Chen et al., 2015). This 
study showed that SCID piglets had lower virus levels in blood up to and including 11 dpi, at 
which time this relationship reversed and non-SCID piglets began clearing the PRRSV, while the 
SCID piglets were unable to control replication. The differences in amount of PRRSV between 
SCID and non-SCID pigs in this study can be attributed to the actions of B and T cells. Chen et 
al. (2015) hypothesized that cytokines secreted by T cells were responsible for both the 
decreased (IL-10; Patton et al., 2009; Cecere et al., 2012) and increased (IFN-γ; Rowland et al., 
2001) levels of PRRSV in the SCID pigs at early and later time points, respectively. Further 
studies are needed to examine the mechanisms responsible for the results found in this study. In 
particular, measuring the levels of IL-10 and IFN- γ would give information on the hypotheses in 
Chen et al. (2015). These valuable SCID pigs were used as a model to study the PRRSV, because 
this virus causes great economic losses to the swine industry (Holtkamp et al., 2013) and 
understanding the immunobiology of PRRSV infection may help to mitigate its impact.   
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The cost of PRRSV outbreaks to the swine industry can be categorized into three main 
groups: prevention, resolution of the disease, and biological effects on the diseased herd. 
Prevention efforts include strict biosecurity protocols to prevent introduction of the virus to a 
farm (Dee et al., 2003; Dee et al., 2004; Dee et al., 2010; Alonso et al., 2013) and vaccination 
against the PRRSV, which provides little protection, if any (Bourry et al., 2015; Kim et al., 2015; 
Lyoo, 2015; Renukaradhya et al., 2015; Rose et al., 2015). Methods used to resolve the PRRSV 
infection include veterinarian treatment through administration of antiviral medication (Liu et al., 
2015) or other compounds (Sun et al., 2014), or a complete depopulation and repopulation of the 
infected farm (Dee and Joo, 1994; Dee and Joo, 1997). PRRSV infected pigs have poorer growth 
rates than uninfected pigs (Mengeling et al., 1998; M.M. Li et al., 2015). All of these results of 
PRRSV outbreaks contribute to the economic impact of PRRS, which has been estimated to be 
over $664 million in the US each year (Holtkamp et al., 2013). Although these methods help to 
reduce the impact of PRRS, the combination of all have not been completely effective in 
eliminating the impact of PRRSV outbreaks. Therefore, there is value in additional tools that can 
be used to reduce the effects of PRRSV infection, such as genetic selection of pigs that are less 
affected by infection with the PRRSV (Lewis et al., 2007; Lunney et al., 2011; Rowland et al., 
2012). 
The Immune Response Annotation Group annotated 1,369 genes involved in the immune 
response of pigs (Dawson et al., 2013), each presenting an opportunity for genetic variation in 
immune response to pathogens. Genetic variability in susceptibility to several diseases has been 
previously described, including diseases caused by bacteria (Sellwood et al., 1975; Van Diemen 
et al., 2002) and viruses (Halbur et al., 1998; Reiner et al., 2002; Petry et al., 2005; Vincent et al., 
2005; Vincent et al., 2006; Ait-Ali et al., 2007; Nakajima et al., 2007; Petry et al., 2007; 
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Doeschl-Wilson et al., 2009). In light of these and other findings, the PRRS Host Genetics 
Consortium (PHGC) was established with the aim to study the genetic basis of piglet response to 
PRRS infection (Lunney et al., 2011). Genomic analysis of the first 8 trials of the PHGC project 
showed that there was a major quantitative trait locus (QTL) on Sus scrofa chromosome (SSC) 4 
that affected both the amount of PRRSV in the blood of infected piglets and the weight gain 
from 0 to 42 days post infection (dpi) (Boddicker et al., 2012; Boddicker et al., 2014a; Boddicker 
et al., 2014b). Nine PHGC trials were carried out using the NVSL 97-7985 (NVSL; Osorio et al., 
2002) PRRSV isolate. In order to assess the consistency of results with a more recent PRRSV 
isolate, KS2006-72109 (KS06) was used to infect an additional 5 trials of piglets. All of these 
data were available for determining the association of genetic variation in these pigs to VL and 
WG. 
Genome wide association studies (GWAS) employ statistical methods to identify regions 
of the genome that are associated with the trait of interest (Dean, 2003; Balding, 2006; Zeng et 
al., 2015). Bionformatic tools can then be used to determine if they contain candidate genes that 
have been shown to have a function related to the trait of interest. GWAS results of complex 
polygenic traits, such as response to infection with one of two isolates of the Porcine 
Reproductive and Respiratory Syndrome virus (PRRSV), may reveal one or two genomic 
regions with relatively large effects if such loci exist (Boddicker et al., 2012) with many other 
genomic regions having much smaller effects. In an effort to reduce the time required to identify 
candidate genes in these numerous genomic regions with small effects on this complex trait, 
genes located near moderately associated SNPs can be compiled into gene lists. These lists can 
then be assessed for overrepresenatation of gene ontology (GO) annotation terms to reveal 
functional processes or pathways that may be involved in the trait. In Chapter 4 of this thesis, we 
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identified genomic regions associated with VL and WG after infection with one of two PRRSV 
isolates, then perfomed GO term enrichment analyses on these GWAS results. 
Another genomic analysis technique employed in this thesis is genomic prediction, which 
involves the use of only genotypes of genetic markers that have been observed in both the 
training and validation populations to predict the genetic value of animals in the validation 
population for a phenotype of interest (Meuwissen et al., 2001). Genomic prediction estimates an 
animal’s genetic value without that animal having an observed phenotype for that trait. The 
accuracy of genomic prediction is typically quite high when the animals in the population for 
which phenotypes are being predicted (validation) are closely related to the animals in the 
population used to estimate the effects of each SNP (training; Habier et al., 2007; Goddard, 
2008; Hayes et al., 2009; Daetwyler et al., 2013). Genomic prediction accuracy is also affected 
by the similarity of phenotypes observed versus those that are predicted; slightly different 
conditions in the training versus the validation population could alter genomic prediction 
accuracy, for example running speed on flat ground versus an inclined plane or weight gained 
after infection with one virus isolate versus another isolate. In these examples, the observed 
phenotypes are the same, running speed or weight gain after virus infection, but the conditions 
are slightly altered, flat versus incline or infection with different virus isolates. The data used in 
this study allowed us to assess both of these scenarios; we assessed differences in accuracy of 
genomic prediction across genetic backgrounds and PRRSV isolates. Furthermore, we examined 
the contribution of different subsets of SNPs based on GWAS or GO annotation enrichment 
results, only SNPs near the SSC 4 QTL, or the whole genome (Chapter 5).  
The work presented in this thesis is based on the following hypotheses: 1) A Mendelian 
recessive mutation in a single gene causes the spontaneous SCID phenotype in pigs from a 
		
7	
selection line at Iowa State University; 2) Gene ontology (GO) annotation information can be 
used to aid identification of genomic regions that are associated with viral and weight gain traits 
in pigs infected with one of two PRRSV isolates; 3) Genomic prediction of VL and WG in 
response to PRRSV infection will be most accurate when the same virus isolates are used to 
infect training and validation populations, and genomic prediction across PRRSV isolate will be 
more accurate with increased genetic relationships between training and validation populations; 
and 4) Genomic prediction of VL and WG in response to PRRSV infection will be moderately 
accurate when the PRRSV isolate used to infect the training population is different from that of 
the validation population, and SNP subsets based on association information or gene ontology 
information will increase the accuracy of genomic prediction across PRRSV isolates. The 
objectives of this thesis were to test these hypotheses as follows: 
1) Perform genetic mapping, targeted gene sequencing, and functional validation to identify 
the causative mutation of SCID in pigs.  
2) Identify genomic regions associated with response to infection with one of two PRRSV 
isolates using genome-wide association analyses.  
3) Assess the enrichment of gene ontology annotation terms in genes near regions shown to 
be associated with PRRSV response by the genome-wide association analyses. 
4) Evaluate the accuracy of genomic prediction across PRRSV isolates, across genetic lines, 
and using SNP subsets based on association information or gene ontology information.  
Thesis Organization 
Three manuscripts were prepared for publication in scientific journals and are included as 
Chapters in this thesis. I, Emily Waide, was the major contributor and writer of each of the three 
manuscripts, and Drs. Jack Dekkers and Christopher Tuggle supervised the research presented. A 
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review of literature relevant to this research can be found in Chapter 2. The mutations discovered 
to cause the only known naturally occuring cases of SCID in pigs are described in Chapter 3. An 
application for a U.S. patent has been published pertaining to these two mutations and other 
work concerning the SCID pig discovery, Publication No. US-2015-0216147. The results of 
genome wide association studies of piglets infected with one of two isolates of the PRRSV are 
described in Chapter 4. Genomic prediction of response to experimental PRRSV infection using 
various training and validation populations as well as different SNP subsets is detailed in Chapter 
5. Chapter 6 includes general conclusions of this research, as well as the applicability of the 
findings to the swine industry. 
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CHAPTER 2: LITERATURE REVIEW 
Genetics of Disease 
Genetic control of diseases in animals ranges from the effect of one gene to the actions of 
hundreds or even thousands of genes. Disorders that segregate in a Mendelian recessive manner 
are often caused by mutations in one gene, and the associated phenotype may be categorical; the 
animal is affected or unaffected by the disease. Single gene mutations have also been shown to 
have major effects on susceptibility to one of several diseases; for example, a mutation in FUT1 
is responsible for postweaning diarrhea edema disease (Wang et al., 2012) and MX1 (Pastoret et 
al., 2012) and RIG-I (Barber et al., 2010) play important roles in susceptibility to the influenza 
virus in pigs and ducks, respectively. On the other hand, complex immunological traits are 
affected by genetic variants in many genes; for example, many genomic regions are involved in 
antibody response to vaccination for Bovine Respiratory Syncytial Virus (Glass et al., 2012), the 
top 20 SNPs associated with Johne’s disease in cattle were located on 8 different chromosomes 
(Zare et al., 2014), and a major QTL was found to be involved in viral load and weight gain 
following infection with the Porcine Reproductive and Respiratory Syndrome virus but with 
many additional regions showing small effects (Boddicker et al., 2012; Boddicker et al., 2014a; 
Boddicker et al., 2014b). The aims of this thesis were as follows: 1) discover the mutations that 
cause the Mendelian recessive spontaneous SCID that was discovered in pigs (Cino-Ozuna et al., 
2012), 2) identify genomic regions associated with response to one of two isolates of PRRSV, 3) 
evaluate the overrepresentation of gene ontology terms of genes in regions associated with 
response to one of two PRRSV isolates, and 4) assess the accuracy of genomic prediction of 
response to PRRSV infection with different isolates or genetic backgrounds in training and 
validation populations when using the whole genome or smaller subsets of SNPs. The remainder 
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of Chapter 2 of this thesis is a review of scientific literature that give background information on 
the diseases that were investigated in this research and the tools that were used to address the 
objectives provided above.  
Porcine Reproductive and Respiratory Syndrome 
Porcine Reproductive and Respiratory Syndrome (PRRS) is caused by an enveloped 
single-stranded positive sense RNA arterivirus (Wensvoort et al., 1991; Conzelmann et al., 
1993). The primary cell type infected by the PRRS virus (PRRSV) in vitro is the alveolar 
macrophage (Duan et al, 1997). PRRSV infection causes abortions, stillborn and mummified 
piglets, and those piglets that are born alive are weak (Keffaber, 1989). The repiratory symptoms 
of PRRSV infection cause increased morbidity and mortality in young pigs and leaves these 
nursery-aged piglets more susceptible to secondary respiratory infections (Zimmerman et al., 
1997). Research on the pathogenesis of PRRSV may provide knowledge on methods that can be 
used to reduce the economic impact of PRRSV infection in the swine industry (Holtkamp et al., 
2013). 
Immune response to PRRS. The PRRSV must overcome several hurdles after entering 
its host before it is able to replicate and go on to infect its next target. An initial challenge to the 
virus is finding a host cell that will permit the virus to enter. Porcine alveolar macrophages are 
widely thought to be the predominant cell type infected with PRRS virus (Duan et al., 1997); 
however, the virus has been shown to proliferate in other cell types or lines, such as monkey 
kidney cells in vitro (Calvert et al., 2007). The permissiveness of cells to entry of the PRRS virus 
is affected by the expression of cell surface receptors and cytokine activity (Darwich et al., 
2010). Once inside the cell, the virus must hijack the replication machinery of the host to use for 
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its own multiplication. In order to successfully replicate, while avoiding detection by the host 
immune system, the virus will need to alter the host’s expression of cytokines, such as 
interferons (Bautista and Molitor, 1997). Changes in expression of other cytokines, including IL-
1, IL-6, IL-8, IL-10, and TNF-α, have also been detected during PRRS infection studies 
(Darwich et al., 2010). Antibodies to PRRS virus antigens have been detected as early as 5 days 
post infection (Yoon et al., 1995), while neutralizing antibodies are not present until several 
weeks after infection (Murtaugh et al., 2002; Molina et al., 2008). This early production of non-
neutralizing antibodies is actually thought to exacerbate PRRSV infection, as it may increase 
internalization of an antibody coated PRRSV particle by macrophages (Yoon et al., 1996; Gu et 
al., 2015). The exact mechanisms of PRRSV pathogenesis are unclear and confusing at best 
(Mateu and Diaz, 2008; Darwich et al., 2010; Loving et al., 2015), which makes development of 
methods to control the disease extremely difficult. In addition, the PRRSV is a rapidly mutating 
virus (Fang et al., 2007; Murtaugh et al., 2010; Shi et al., 2010; Mu et al., 2013), which provides 
added difficulty in prevention, especially in creation of an effective vaccine (Hu and Zhang, 
2014; Li et al., 2014; Park et al., 2014; Renukaradhya et al., 2015).   
Transmission of PRRSV. Many excretions from infected pigs have been shown to 
contain PRRS virus particles, which increases the incidence of spread (Zimmerman et al., 1997). 
The ability of the virus to persist in infected pigs for long periods of time has been implicated in 
transmission of the PRRSV (Wills et al., 2003). Several methods have been attempted in order to 
eliminate PRRS from commercial populations, including removal of animals following positive 
diagnosis, depopulation of entire herds (Dee and Joo, 1994; Dee and Joo, 1997), and postponing 
introduction of new animals into a herd that has broken with the virus (Corzo et al., 2010). These 
practices may be effective in temporarily eliminating the PRRS virus but are costly and require 
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intense management practices. The most successful strategy to control PRRS virus infections in 
the swine industry will include a combination of proper management, improved biosecurity on 
each farm, as well as during transportation, effective vaccination and veterinary care, and genetic 
improvement of pigs for resistance to the PRRS virus. 
Genetic control of response to PRRS. Host immune response to PRRSV infection 
involves both the innate and the adaptive parts of the immune system. With this, there are many 
opportunities for genetic control of the response (Lewis et al., 2007). Breed differences have 
been noted in lung lesions, rectal temperatures, and viremia during PRRSV infections (Halbur et 
al., 1998; Petry et al., 2005); Petry et al. (2005) also noted within breed differences of these 
response to PRRSV infection phenotypes. Antibody titers, lung lesion scores, and viral tissue 
distribution after infection with highly pathogenic PRRSV were markedly different between wild 
and domestic pigs (Do et al., 2015). Do et al. (2015) found that infection with highly pathogenic 
PRRSV in wild pigs caused higher mortality, hemorrhagic lesions in internal organs, anti-
PRRSV IgG antibody titers, and lung lesion scores at 7 dpi (lower at 10 dpi), and a wider viral 
tissue distribution compared to domestic pigs. Several estimates of heritabilities for response to 
PRRSV infection have been published. Lewis et al. (2009) showed that the heritability of 
reproductive traits of sows was increased during PRRSV outbreak compared to normal health 
conditions; heritability of mummified piglets was 0.10 and heritability of matings per conception 
was 0.46 during a PRRSV outbreak. The majority of reproductive traits investigated by Serão et 
al. (2014) also had higher heritabilities during PRRSV infection compared to before the PRRSV 
outbreak. This increased heritability after PRRSV infection was also seen in the survivability of 
nursery age piglets, with an estimated heritability of 0.26 (Vukasinovic and Clutter, 2010). The 
heritability of PRRS viremia measured as a presence or absence of virus binary trait was shown 
		
20	
to be very low, 0.10 (Biffani et al., 2010). On the other hand, the first 8 trials of NVSL data have 
been previously analyzed, and heritabilities were estimated to be 0.44 for VL and 0.29 for WG 
for these quantitative traits (Boddicker et al., 2014a). For response to the KS06 PRRSV isolate, 
the estimates of heritability were higher, 0.65 for VL and 0.44 for WG (Hess et al., 2014).  
To date, few studies have employed the use of genotyping platforms, such as SNP chips, 
to investigate host genetics in response to PRRSV. In one of these, two major QTL were shown 
to affect the amount of PRRSV-specific antibodies in commercial sows (Serão et al., 2014). The 
PRRS Host Genetics Consortium (PHGC; Lunney et al., 2011) was established with the intention 
of exploring the genetic basis of host response to PRRSV. In total, 15 trials of ~200 commercial 
nursery age piglets each were experimentally infected with the PRRSV, then followed for 42 
days post infection (dpi). In 10 of these trials, pigs were infected with the NVSL 97-7985 
(NVSL) virus isolate (Osorio et al., 2002), which is more virulent than the KS2006-72109 
(KS06) isolate, which was used to inoculate pigs in the remaining 5 trials. Blood samples were 
taken at 0, 4, 7, 11, and 14 dpi, then weekly until the completion of the trial at 42 dpi. Individual 
body weights were observed weekly throughout the trial. Two of the phenotypes that were 
observed during each of these trials were viral load (VL), calculated as the area under the curve 
of log-viremia up to and including 21 dpi, and weight gain (WG), calculated as the difference 
between body weight at 42 and 0 dpi. Each pig was genotyped using the Illumina Porcine SNP60 
Beadchip (Ramos et al., 2009), enabling investigation of specific genomic regions associated 
with response to PRRSV infection.  
Boddicker et al. (2012) discovered several genomic regions associated with response to 
infection with the NVSL PRRSV isolate in the first 3 PHGC trials, including a major QTL on 
Sus scrofa chromosome (SSC) 4, in which the favorable allele was associated with decreased VL 
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and increased WG. VL was shown to have a heritability of 0.39, with the SSC 4 QTL explaining 
approximately 15% of the genetic variation in the initial 5 trials of the PHGC study (Boddicker 
et al., 2012; Boddicker et al., 2014a). These results were expanded to include the first 8 trials of 
NVSL infected pigs (Boddicker et al., 2014b). Several additional genomic regions were shown to 
have smaller effects on each trait, but the focus of these papers was the SSC 4 QTL effect. It is 
important to further investigate the effects of this and other QTL in the KS06 trials, to determine 
if there are QTL controlling response to more than one PRRSV isolate. PRRSV is a rapidly 
mutating virus, and pigs are unlikely to be naturally exposed to the same isolate in multiple years 
(Fang et al., 2007; Kimman et al., 2009; Mu et al., 2013). Ideally, identified QTL would improve 
response to multiple PRRSV isolates; furthermore, these QTL would ideally have a positive 
effect on response to other pathogens. A review on genetic control of mice to Leishmania 
discussed co-localization of QTL that are involved in susceptibility to Leishmania and QTL that 
influence susceptibility to other pathogens, including bacteria, parasites, and viruses (Lipoldova 
and Demant, 2006). High genetic correlations of response traits between the two PRRSV isolates 
used in this study have been reported; 0.95 for VL and 0.78 for WG (Hess et al., 2015). 
Furthermore, Hess et al. (2015) showed that the SSC 4 QTL was associated with VL in both 
isolates, but WG in only the NVSL isolate. Although this QTL has a large effect on the 
phenotypes, over 80% of the genetic variance is not explained by this region. In this thesis, we 
aim to identify additional regions associated with response to PRRSV infection.  
Although PRRS is an economically devastating disease that has plagued the swine 
industry for over two and a half decades (Benfield et al., 1992), host immune response to 
PRRSV infection is poorly understood (Loving et al., 2015). Interferon-gamma (IFN-γ) is a 
cytokine that plays an important role in immune responses to viruses (Novelli and Casanova, 
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2004; Carrero, 2013), and is secreted by T cells, NK cells, macrophages, and neurons (Meier et 
al., 2003; Sun et al., 2012; Li et al., 2014). PRRS-specific IFN-γ response has been shown to be 
delayed (Meier et al., 2003; Díaz et al., 2005; Díaz et al., 2006), erratic (Mateu and Diaz, 2008; 
Dotti et al., 2013), or even nonexistent (Dotti et al., 2011; Dotti et al., 2013). Antibody 
production occurs within the first two weeks after PRRSV infection (Yoon et al., 1995), while 
neutralizing antibodies are not observed until later in the infection (Nelson et al., 1994; Lopez 
and Osorio, 2004). The role of neutralizing antibodies in clearance of the PRRSV is debatable, 
though, as several studies have reported the presence of PRRSV alongside neutralizing 
antibodies in pigs (Murtaugh et al., 2002; Wills et al., 2003). Furthermore, antibodies may also 
act to exacerbate PRRSV infections through antibody-dependent enhancement of infectivity of 
the virus (Yoon et al., 1996; Gu et al., 2015). Infection of animals that lack an important 
component of the immune system may help to answer some of the questions that remain about 
immune response to PRRSV infection. This is challenging, though, as the PRRSV has only been 
shown to naturally infect pigs (Albina, 1997), and, until recently (Cino-Ozuna et al., 2012; 
Suzuki et al., 2012; Watanabe et al., 2013; Huang et al., 2014; Ito et al., 2014; Lee et al., 2014), 
immunodeficient pigs had not been available for use as research models. 
The recent identification of pigs without functional adaptive immune systems (Cino-
Ozuna et al., 2012) provided a unique model to study the pathogenesis of the PRRSV. These pigs 
were affected with severe combined immunodeficiency (SCID) and lacked both B and T cells, 
while NK cells were present in circulating blood (Ewen et al., 2014). Infection of SCID piglets 
and their non-SCID littermates gave insight into the role of the adaptive immune system in 
response to PRRSV infection (Chen et al., 2015). This study showed that up to and including 11 
dpi, SCID piglets had lower levels of viremia in circulating blood compared to non-SCID 
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littermates. This was hypothesized to be due to a decreased number of macrophages present for 
infection in the SCID pigs. Although there is not expected to be any difference in the raw 
numbers of macrophages in SCID pigs, the lack of an adaptive immune system may reduce the 
cytokine signals that affect macrophages. In particular, IL-10, which is a cytokine produced by B 
and T cells, macrophages, and dendritic cells, may act to increase infectivity of macrophages and 
lead to increased numbers of permissive macrophages for PRRSV infection (Couper et al., 2008; 
Patton et al., 2009; Cecere et al., 2012). At 21 dpi, this relationship between PRRSV levels in 
SCID and non-SCID pigs reversed; non-SCID piglets began clearing the virus as expected, while 
viremia in the SCID pigs continued to increase (Chen et al., 2015). While T cells were blamed 
for the increased PRRSV levels in non-SCID pigs at 11 dpi, they were credited for reducing 
viremia by 21 dpi through production of IFN-γ protecting macrophages from infection (Rowland 
et al., 2001). This study took advantage of pigs lacking B and T cells to study the pathogenesis of 
the PRRSV, but the utility of SCID pigs extends past pig-specific pathogens into biomedical 
research to further studies of human immune function.  
Severe Combined Immunodeficiency 
Severe Combined Immunodeficiency (SCID) is a primary immunodeficiency that has 
been documented as naturally occuring in humans (Cossu, 2010), horses (Wiler et al., 1995; 
Bernoco and Bailey, 1998; Perryman, 2004), dogs (Meek et al., 2001), mice (Bosma et al., 
1983), and recently in pigs (Cino-Ozuna et al., 2012). Genetic modification techniques have also 
been utilized to introduce the disease into mice, creating a widely used biomedical model . SCID 
is a large group of diseases, which are subdivided by the presence/functionality of B, T, and NK 
cells (Cossu, 2010; van der Burg and Gennery, 2011). Further divisions of these subgroups can  
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be made based on the genetic lesion that causes the disease (Cossu, 2010). Cossu (2010) 
describes the following general classifications of typical SCID and their inheritance patterns: 
Table 2.1. General classifications of typical SCID, as described in Cossu et al. (2010).  
Cellular phenotype of selected SCID 
(with + or - indicating presence or 
absence of cell types, respectively) 
Inheritance pattern Number of genes with 
known mutations 
T- B- NK+ Autosomal recessive 6 
T- B+ NK+ Autosomal recessive 10 
Autosomal dominant >37 
T- B- NK- Autosomal recessive 3 
T- B+ NK- Autosomal recessive 2 
X-linked 1 
In general, SCID infants appear normal at birth but quickly fail to thrive in the post-natal 
months. In humans, maternal antibody transfer occurs in utero by placental passage (Chucri et 
al., 2010). This is not the case with pigs (Chucri et al., 2010), but piglets acquire maternal 
antibodies through suckling of colostrum. Therefore, SCID piglets are not likely to show ill 
effects of the disease until maternal antibodies decay to a critical level, often occuring after they 
are weaned from the sow. At weaning, which occurs around 2 or 3 weeks of age, piglets at 
commercial farms are typically moved from the farrowing house, where they were born, to a 
nursery barn, where they are generally mixed in pens with non-littermates. This increased 
density of piglets increases the likelihood of becoming infected with transmissible diseases 
(Vicca et al., 2002). Normal piglets are generally able to mount an appropriate immune response 
to combat the disease, whereas the SCID piglets discovered by Cino-Ozuna et al. (2012) can not 
and succumb to the infection. We could assume that production of any SCID piglets in the swine 
industry would be caused by recessive mutations, as autosomal dominant inheritance would 
require one parent to be SCID affected. The loss of piglets from SCID carrier-by-carrier matings  
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would not be desirable in the swine industry; however SCID pigs could be a valuable commodity 
in biomedical research settings.  
SCID mice have been used extensively in biomedical research (Pearson et al., 2008); for 
example, aiding in human vaccine development (Koo et al., 2009), studies of human hepatitis 
virus infections (Chayama et al., 2011), human immunodeficiency virus infection (Denton and 
García), autoimmune diseases (Morel, 2004), and human hematopoietic stem cell transplantation 
(Tanner et al., 2014). Although mice provide a smaller vehicle to study human immune function, 
the fact remains that the immune systems of mice are more dissimilar to the human than pig 
immune systems (Mestas and Hughes, 2004).  
After many years of dedicated work towards creating a SCID pig, transgenic technology 
aided in the development of several SCID pig models, a RAG1 knockout pig (Ito et al., 2014), a 
RAG1/2 knockout pig (Huang et al., 2014; Lee et al., 2014) and two Il2rg knockout pigs (Suzuki 
et al., 2012; Watanabe et al., 2013). We (Cino-Ozuna et al., 2012) discovered naturally occuring 
SCID in a line of pigs selected for residual feed intake at Iowa State University (Cai et al., 2008). 
These pigs were shown to lack both B and T cells, but have NK cells (Ewen et al., 2014). The 
third Chapter of this thesis discusses the work that we did to discover the mutation causing this 
immunodeficiency in pigs. 
Genome Wide Association Studies 
Genome wide association studies (GWAS) are methods that assess the statistical 
association of genetic markers with phenotypes (Dean, 2003; Balding, 2006; Zeng et al., 2015). 
The overall goal of GWAS is to identify specific genomic regions that have an effect on the trait 
of interest. To perform GWAS, animals with both phenotypes and genotypes are required. 
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Genotypes may be microsatellites, SNPs, or sequence based, and the nature of phenotypes may 
be categorical (for example, affected vs. unaffected, or white vs. brown vs. black) or quantitative, 
numerically continuous, measurements (for example, weight or height). The sample size required 
for sufficient power of detection in GWAS depends on the genetic architecture of the phenotype 
of interest, LD between DNA markers, and the population structure of the sample (Laurie et al., 
2010; Hong and Park, 2012). In light of the various phenotypes and species of interest in 
scientific research, many methods have been developed to perform GWAS (Dean, 2003; 
Balding, 2006; Zeng et al., 2015). 
Prior to the current SNP chip era, where platforms are available to genotype individuals 
for thousands to hundreds of thousands of SNPs, QTL mapping was performed using a limited 
number of genetic markers across the genome. Highly polymorphic microsattelite markers were 
used extensively for QTL mapping experiments. The first example of QTL mapping in pigs 
utilized a wild boar x Large White cross (Andersson et al., 1994). Many QTL mapping studies 
followed, resulting in the identification of just under 14,000 QTL for over 650 traits in pigs, 
which have been gathered and are presented on the Animal Genome website 
(http://www.animalgenome.org/cgi-bin/QTLdb/SS/index). These QTL are generally not finely 
mapped, often spanning half of a chromosome (Georges et al., 1995; Goddard and Hayes, 2009), 
and are likely to provide little to no information outside of the specific breed crosses in which 
they were identified (Dekkers, 2012). Furthermore, these microsatellites are very expensive and 
difficult to genotype, and the small number of genotyped individuals reduced the power of QTL 
detection (Weller et al., 1990). Currently, the most common practice in agriculture is to use 
single nucleotide polymorphism (SNP) chips, which provide genotypes for thousands or 
hundreds of thousands of genetic loci covering the entire genome of the target species. As 
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described by Ramos et al. (2009), the biallelic SNPs on these widely used chips are chosen based 
on the amount of information the SNPs provide; SNPs should be easily genotyped, providing 
clear genotype results, SNPs should segregate in multiple populations, the frequency of the 
minor allele should not be too low, and other criteria. These criteria often exclude causative 
mutations from SNP chips. In order to identify causative mutations, GWAS is first used to 
identify genomic regions that are associated with the trait of interest. Once chromosomal 
locations that are associated with the trait of interest have been identified, bioinformatic analyses 
may be done to determine if there are annotated genes in these regions that may play a role in 
altering the phenotype of interest. For pigs, this can be done by searching for the associated 
chromosomal location in the most recent Sus scrofa genome assembly using Ensembl 
(http://www.ensembl.org/Sus_scrofa/Info/Index?db=core). Finally, if desired, targeted 
sequencing of candidate genes in the associated chromosomal location can be performed to 
determine the specific causative mutation. 
Several methods can be used to identify regions of the genome that are associated with a 
trait of interest, including Bayesian variable selection (Meuwissen et al., 2001; Fernando and 
Garrick, 2013; Garrick and Fernando, 2013), in which all markers are simultaneously fitted as 
random effects, and single SNP methods (Balding, 2006), in which the genotype at each locus is 
fitted as a fixed effect one at a time. Both of these methods rely on linkage disequilibrium, which 
is the non-random assortment of alleles at loci, between observable markers and the causative 
mutations that cause phenotypic differences (Lande and Thompson, 1990; Devlin and Risch, 
1995). Due to LD between SNPs on the chip, GWAS often shows a block of linked SNPs to be 
associated with the phenotype of interest; therefore, it may be advisable to assess the association 
of genomic regions with the trait of interest as opposed to each individual SNP. In Chapter 4 of 
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this thesis, we performed GWAS using two methods, single SNP and Bayesian GWAS, which 
are discussed further below.  
Single SNP GWAS method. Single SNP association methods, as implemented in 
ASReml4 (Gilmour et al., 2014), test the association of SNPs with the phenotype one at a time 
by fitting them as fixed effects in a linear mixed model, such as the one below:  
𝒚 = 𝑿𝒃+ 𝒁!𝒈𝒊 +𝑾𝒓+ 𝑽𝒖+ 𝒆 
where y = vector of phenotypic observations, X = design matrix associating phenotypes with 
fixed effects, b = vector of fixed effects, Zi = matrix of SNP genotypes for SNP i, for the AA, 
AB, and BB genotypes, respectively, gi = vector of fixed genotype class effects for SNP i, W = 
incidence matrix associating phenotypes with a random effect (for example, the pen to which an 
animal was randomly assigned to in a study), r = vector of random effects, V = incidence matrix 
associating phenotypes with random animal polygenic effects, u = vector of random animal 
polygenic effects with variance-covariance matrix based on the pedigree relationship matrix, and 
e = vector of residual errors assumed to be i.i.d. ~N(0,𝜎!!).  SNP genotypes are fitted as class 
effects in this model and results may be presented as the –log10(p-value) of the combined 
additive and dominance effects at each SNP. P-values are measures of strength of association 
between the SNP and the phenotype of interest, and range from 0 to 1, with smaller p-values 
reflecting stronger association with the phenotype. The -log10 of the p-value is calculated for use 
in Manhattan plots so that SNPs with stronger associations (smaller p-values), have higher peaks 
due to larger -log10(p-value) values. The animal polygenic effect, u, is used to account for 
correlations between observations due to genetic relationships that are picked up by the provided 
pedigree (Gilmour et al., 2014).  
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In the single-SNP method, each test is carried out as if it were an independent test and, 
thus, it is important to perform multiple testing correction to results. The following table shows 
the possible outcomes when testing multiple null hypotheses (Benjamini and Hochberg, 1995), 
with a total number of tests equal to n. 
Table 2.2. Possible outcomes when testing multiple null hypotheses, as described by 
Benjamini and Hochberg (1995). 
Hypothesis Accept Null Reject Null Total 
True Null U V n0 
False Null T S n - n0 
Total n - R R n 
A type I error occurs when we reject the null hypothesis (in single SNP GWAS, this means that 
we declare that the SNP has a significant effect on the phenotype of interest), but the null 
hypothesis is true (in single SNP GWAS, this means that the SNP does NOT have an effect on 
the phenotype with which the SNP was associated). In general, we determine 5% or a proportion 
of 0.05 false positives to be acceptable. This means that V/n0 = 0.05, which is also called α.  
The problem with high dimensional data is that we are performing tens of thousands of 
tests, which leads to a very large number of false positives when we are controlling only at the 
single test level, as described above. In order to reduce the total number of false positives, we 
must correct the p-value of each test using a mutliple testing correction method. Several methods 
can be utilized to correct p-values for multiple testing. Bonferroni correction is the simplest 
method of controlling the family-wise error rate (FWER; Bonferroni, 1935). FWER is the 
probability of at least one false positive result when all n null hypotheses are true (Sham and 
Purcell, 2014). The following formula is used to calculate the statistical significance threshold at 
a Bonferroni corrected p-value of 0.05: 
𝑇! =  0.05𝑛  
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where TB = the Bonferroni corrected significance threshold and n = the number of tests 
performed. For example, to calculate a significance threshold at a Bonferroni corrected p-value 
of 0.05 when 1,000 tests have been performed, TB = 0.05/1,000 = 0.00005. In this example, any 
p-value less than 0.00005 would be considered to be a statistically significantly association 
between the dependent and independent variables. Alternatively, each p-value could be corrected 
by multiplying the p-value by the number of tests performed. For example, a raw p-value of 
0.00005 when 1,000 tests were performed can be Bonferroni corrected as follows: 0.00005 x 
1,000 = 0.05. Traditional Bonferroni correction, is considered stringent, as it sets a significance 
threshold based on the total number of tests, assumed to be independent of one another, without 
consideration of correlations between tests (Sham and Purcell, 2014); in the case of single SNP 
GWAS, this can be caused by LD between SNPs. Bonferroni correction for multiple testing can 
be modified to take correlations between tests through the use of Principal Components Analysis 
(PCA; Gao et al., 2008). 
As described by Gao et al. (2008), when performing single SNP GWAS on genotype data 
from a large number of SNPs located near one another, a test of association of one SNP with the 
phenotype of interest is not independent of that for a closely linked SNP. These two SNPs are in 
LD with one another, resulting in the association of one SNP with the phenotype to be correlated 
with that of the other SNP. In this case, traditional Bonferroni correction, as described above, 
overcorrects the significance threshold by assuming no correlation between the tests (Sham and 
Purcell, 2014). In Chapter 4 of this thesis, we performed PCA on SNP genotypes directly to 
determine the number of effective loci, or the number of independent tests, as described by Gao 
et al. (2008). In our PCA of SNP genotypes, we calculated the number of effective loci as the 
number of principal components required to explain 99.5% of the genetic variance (Chapter 4). 
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This number of effective loci was then used to determine the multiple test corrected significance 
threshold at a Bonferroni p-value equal to 0.05.   
While single SNP GWAS methods require correction of results for multiple testing, other 
methods, such as Bayesian variable selection, do not. Bayesian methods applied to GWAS are 
described in the following. 
Bayesian variable selection. Bayesian methods are useful when performing GWAS, 
especially on datasets containing a greater number of marker genotypes than the number of 
animals with phenotypic information, as explained in Meuwissen et al. (2001), Fernando and 
Garrick (2013), and Garrick and Fernando (2013). The following is an example model that can 
be used to perform Bayesian GWAS: 
𝒚 = 𝑿𝒃+ 𝒛𝒊𝛼!𝛿!!!!! +  𝒆 
where y = vector of phenotypic observations, X = incidence matrix relating phenotypes to fixed 
effects, b = vector of fixed effects, zi = vector of genotype covariates for SNP i, αi = allele 
substitution effect for SNP i, δi = indicator for whether the effect of SNP i is included (δi = 1) or 
excluded from (δi = 0) the model for a given iteration of the Monte Carlo Markov Chain, and e = 
vector of residual errors.  
In the Bayesian GWAS mixed model shown above, all SNPs are simultaneously fitted as 
random effects in an iterative manner. Bayesian methods incorporate information from two 
sources, the prior information and the data itself. The user may specify a number of intial 
iterations that will be thrown out, called the burn-in period (Fernando and Garrick, 2008). 
Following this burn-in, iterations sample from the posterior distribution of the previous 
iterations. If a marker is fitted in the Bayesian model and explains a larger proportion of the 
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genetic variance than other markers that were fitted, that SNP will be more likely to be included 
in the model in the following iterations. An important parameter that is specified for Bayesian 
GWAS methods is π, which is equal to the proportion of SNPs that are expected to have no 
effect on the phenotype. Bayesian variable selection in GWAS assumes that a SNP either has an 
effect equal to 0, with probability equal to π, or has an effect that is sampled from a normal 
distribution, with probability equal to 1-π (Fernando and Garrick, 2013). If we set π=0.99, we are 
informing the Bayesian model that we expect only 1% of the SNPs in the genome to be 
associated with the phenotype. With this example, if our data includes genotypes for 50,000 
SNPs, each iteration of Bayesian variable selection will fit approximately 500 SNPs in the 
model.  
As discussed above, often SNPs located close to one another are in high LD. Therefore, 
in Bayesian methods, if two SNPs in high LD with one another are also in high LD with a 
causative muation, only one of the markers may be fitted into the model in each iteration. In light 
of this, it is important to consider the association of all SNPs within a chromosomal segment or 
window (Hayes et al., 2010; Sahana et al., 2010; Fernando and Garrick, 2013). This window-
based approach is implemented in GenSel (Fernando and Garrick, 2008) by summing the effects 
of all SNPs within a 1 Megabase (Mb) window.  
Several important differences between the single SNP and Bayesian GWAS methods 
used in this thesis are described in the following. First, in single SNP GWAS, the association of 
one SNP has no effect on the statistical association of another SNP, as association of each SNP is 
estimated in individual tests. In Bayesian GWAS models, the proportion of SNPs associated with 
the trait of interest is assumed known and is equal to (1-π), where the value of π is given by the 
user. This is related to the second difference, in that there is no prior assumption on the number 
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of SNPs that have an effect on the phenotype in single SNP methods, as there is in Bayesian 
GWAS. Third, the software in which single SNP GWAS was implemented in this thesis, 
ASReml4 (Gilmour et al., 2014), allows for additional random effects to be fitted in the model, 
whereas the Bayesian GWAS software used, GenSel (Fernando and Garrick, 2008), only allows 
for fixed effects to be fitted in the model beyond the random effects of SNPs.  
Functional Analysis of GWAS Results 
Complex traits are controlled by the action and interaction of many gene products and, 
therefore, may be altered by mutations in one of any of these genes. In other words, these traits 
are polygenic, and the action of many genes result in the observed phenotype. GWAS methods 
test the effects of genetic loci as independently acting components, which is often not ideal for 
identifying loci with small effects. This problem is compounded by the thresholds considered to 
be statistically significant when testing effects of over 50,000 SNPs. These small effects could be 
discovered through browsing each region with moderate associations in the genome (such as the 
Ensembl search described above) to identify candidate genes, but this would be very time 
consuming, as there could be hundreds of such regions. Another approach would be to create 
lists of genes located near moderately associated SNPs in these regions through tools such as 
BioMart (www.biomart.org), then perform gene ontology (GO) annotation enrichment analyses 
of the lists. Many genes are annotated with GO terms that describe their function or activity in 
certain processes, functions, or pathways (The Gene Ontology Consortium, 2001). This type of 
functional analysis narrows the candidate gene list to those contained in biologically relevant GO 
terms.  
Several studies have used functional analysis of GWAS results to add information to 
GWAS results. Serão et al. (2013) identified several GO terms that were enriched in genes near 
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SNPs involved in feed efficiency in cattle. This study also identified several genes along the 
MAPK pathway that were near associated SNPs. Another study found that genes in several 
metabolic-related GO terms were near SNPs associated with feed efficiency in Nelore cattle, a 
Bos indicus breed (Oliveira et al., 2014). This approach was also used to identify GO terms 
enriched in genes near SNPs shown to be associated with average daily gain in pigs (Fontanesi et 
al., 2014). These functional analyses of GWAS results give information about the biological 
function of genes near associated SNPs.  
Functional analyses of GWAS results add valuable information to complex traits, such as 
those mentioned above, or for investigation of genomic regions associated with immune 
response. These traits are very polygenic, meaning that there are many genes that have generally 
small effects on the overall phenotype measured. Exploring overrepresentation of GO terms for 
genes in regions shown to be associated with the complex trait of interest may reveal biological 
pathways or processes that are known to have an effect on the phenotype. For example, we found 
that USP18 was one of the 1,390 genes within 250 kb of SNPs associated with VL in the KS06 
data with P<0.003 (Chapter 4). It may not be immediately clear how the USP18 gene, which 
encodes an enzyme responsible for cleavage of ubiquitin from proteins, may be involved in 
response to viral infection (B. Li et al., 2015). When we look at enriched GO terms, we see that 
USP18 is annotated with the immune response GO term. Further investigation of this gene shows 
that it plays an important role in interferon signaling (Francois-Newton et al., 2012). Mounting 
an immune response involves a complicated network of gene products that interact with one 
another. Therefore, GO term enrichment, pathway analysis, or other similar methods can provide 
additional information to genomic analysis results. These functional analyses also greatly reduce 
the amount of time required for bioinformatic analyses of GWAS results, particularly for 
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complex traits with many small effects, as this would result in a large number of SNPs that have 
moderate associations with the phenotype of interest. Creating lists of genes located near these 
moderately associated SNPs and performing GO annotation enrichment analyses is less time 
intensive compared to browsing the genome for candidate genes in each region with moderately 
associated SNP. 
Genomic Prediction and Genomic Selection 
The overall goal of animal breeding is the production of animals with superior 
performance for economically valuable traits. Genetic progress, or the increase in the genetic 
value of animals from one generation to the next, was the focus of animal breeding programs 
long before breeders had the ability to observe genetic markers. Prior to genotyping capabilities, 
superior animals were selected to produce the next generation based on phenotypic observations 
of the traits used as selection criteria. Phenotypic selection of a heritable trait leads to genetic 
improvement, but requires phenotypes for each trait used as selection criteria on selection 
candidates or close relatives of those candidates. For traits that are only expressed in one sex or 
later in life, or those that involve response to disease, obtaining phenotypic observations may 
take a very long time (increasing the generation interval), be very costly, or may be impossible 
altogether. Genetic progress for these types of traits would benefit greatly from the ability to 
observe and select upon genetic markers, without having phenotypic observations on selection 
candidates or their relatives, through genomic selection techniques. Genomic selection practices 
require the prediction of total genetic merit of an individual using only genotypic information for 
the selection candidate, which is known as genomic prediction (Meuwissen et al., 2001).  
The first era of genetic selection in animals used blood group markers as a phenotypic 
indicator of the inheritance of the percentage of fat in milk (Neimann-Sorensen and Robertson, 
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1961; Rendel, 1961). The simple inheritance pattern of blood groups gave limited insight into the 
polygenic inheritance pattern of fat percentage and would only be useful for traits with QTL in 
specific chromosomal locations. Marker assisted selection (MAS) was the second era of direct 
selection on DNA markers (Smith and Simpson, 1986; Lande and Thompson, 1990). MAS relied 
on relatively few DNA markers associated with QTL with large effects, and were generally 
based on tests developed using data from specific breed crosses (Andersson, 2001).  
The theory of genomic selection was introduced by Meuwissen, Hayes, and Goddard 
(2001), interestingly before dense genome-wide genotyping technologies were even available. 
The invention of high throughput genotyping arrays, known as SNP chips, gives animal breeders 
an opportunity to realize large scale, genomic prediction of the genetic merit of selection 
candidates. This technology increases the rate of genetic gain acheivable in herds by impacting 
two components of the breeder’s equation described by Falconer and Mackay (1996). The 
breeder’s equation is used to predict the rate of genetic gain in the trait being selected upon, as 
shown below: 
∆𝐺 =  𝑖𝑟𝜎!𝐿  
where ΔG is the rate of genetic change per unit of time, i is the intensity of selection, r is the 
accuracy of selection, σA is the additive genetic standard deviation in the pool of selection 
candidates, and L is the generation interval, or the average age of a parent when their offspring 
are born. Genomic selection can increase the rate of genetic change (ΔG) in several ways: 1) 
increasing the accuracy of selection, 2) decreasing the generation interval, and 3) increasing the 
genetic standard deviation. Selection accuracy can be defined as the correlation between the 
estimated breeding value and the true breeding value of each selection candidate. Addition of 
molecular breeding values through genotypic information provides information on Mendelian 
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segregation of alleles among full-siblings, which can not be calculated using only pedigree for 
breeding value estimation. Generation interval reduction may have a greater contribution to 
increasing the rate of genetic progress in some species, such as dairy cattle, where young bulls 
with high genomic values are selected before extensive progeny data is available (Schaeffer, 
2006). In pigs, the contribution of generation interval reduction may be little to none, as the 
generation interval is already quite small (Wellmann et al., 2013). The use of genomic 
information allows distinction between the genetic value of full-siblings, reducing within-family 
selection (Lillehammer et al., 2011), which in turn may lead to reduced inbreeding and less of a 
decrease in the genetic variation available for selection. 
To predict the genetic merit of a selection candidate using only the candidate’s genotypic 
information, the phenotype for that particular animal is not necessary, but phenotypes must be 
collected on animals in the training population, or close relatives of those animals in the training 
population. The training population contains animals for which both phenotypic and genotypic 
information is available. SNPs for which genotypic information is available on the training 
population must be the same SNPs for which genotypic information is observed on animals in 
the validation population, or the selection candidates. Phenotypes and genotypes for animals in 
the training population are used to estimate SNP effects that may then be used to predict the 
genetic value of animals in the validation population.  
The basis of prediction of an animal’s genetic merit is a mixed linear model (Henderson, 
1975), such as the one that follows: 𝒚 = 𝑿𝒃+𝑾𝒓+ 𝒖+ 𝒆 
where y = vector of phenotypic observations, X = design matrix associating phenotypes with 
fixed effects, b = vector of fixed effects, W = incidence matrix associating phenotypes with 
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random effects, r = vector of random effects (for example, the pen to which an animal was 
randomly assigned in a study), u = vector of random animal polygenic effects with variance-
covariance matrix based on the pedigree relationship matrix, and e = vector of residual errors. In 
this equation, the genetic value of an animal for the trait observed in y is predicted using only 
pedigree information and is given in u; these values are the best linear unbiased predictions 
(BLUP). If the aim is to predict the genetic merit of an individual that does not have phenotypic 
information for the trait being selected upon, this individual should be in the pedigree and should 
have relatives with phenotypic observations for this trait. EBVs for all animals in the pedigree, 
including those without phenotypes for the trait being selected upon, are predicted in BLUP.  
In the case of MAS, the linear mixed model given above can be expanded upon, as 
follows: 𝒚 = 𝑿𝒃+ 𝒁𝒈+𝑾𝒓+ 𝒖+ 𝒆 
where Z is a matrix of genotypes at the marker and g is a vector of effects for each allele for the 
given marker. This equation can also be used when incorporating multiple markers in the 
prediction equation.  
Bayesian models may also be used in genomic prediction (Fernando and Garrick, 2008); 
the general Bayesian model used for genomic training is the same model provided for Bayesian 
GWAS methods above, with the genomic EBV (GEBV) calculated with the following equation: 
𝐺𝐸𝐵𝑉! =  𝒛𝒋𝛼!!!!!  
where the GEBV for individual i is equal to the sum of zj = vector of genotype covariates for SNP 
j and 𝛼j = allele substitution effect for SNP j across all k SNPs. Meuwissen et al. (2001) used 
simulations to show that Bayesian methods predicted GEBV with higher accuracy than a least 
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squares model, and the least squares model was unable to estimate effects of a large number of 
markers.  
A prime example of the application of genomic selection can be found in Wolc et al. 
(2015). This study described simulations and real data for 16 traits comparing genomic selection 
of layer chickens to traditional pedigree-based selection. Simulations showed that genomic 
selection would increase the selection response and decrease the amount of inbreeding compared 
to pedigree-based selection. Experimental results showed that on average, the genomic selection 
line significantly outperformed the pedigree-based selection line. Furthermore, this study 
demonstrated that retraining the allele effect estimates increased the accuracy of genomic 
prediction in future generations.  
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CHAPTER 3. NOT ALL SCID PIGS ARE CREATED EQUALLY: TWO 
INDEPENDENT MUTATIONS IN THE ARTEMIS GENE CAUSE SEVERE 
COMBINED IMMUNE DEFICIENCY (SCID) IN PIGS1 
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Abstract 
Mutations in over 30 genes are known to result in impairment of the adaptive immune 
system, causing a group of disorders collectively known as severe combined immunodeficiency 
(SCID). SCID disorders are split into groups based on their presence and/or functionality of B, T, 
and NK cells. Piglets from a line of Yorkshire pigs at Iowa State University were shown to be 
affected by T- B- NK+ SCID, representing the first example of naturally occurring SCID in pigs. 
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phenotype. Flow cytometry analysis of thymocytes showed an increased frequency of immature 
T cells in SCID pigs. Fibroblasts from these pigs were more sensitive to ionizing radiation than 
non-SCID piglets, eliminating the RAG1 and RAG2 genes. Genetic and molecular analyses 
showed two mutations were present in the Artemis gene, which in homozygous or compound 
heterozygous state cause the immunodeficient phenotype. Rescue of SCID fibroblast 
radiosensitivity by human Artemis protein demonstrated that the identified Artemis mutations are 
the direct cause of this cellular phenotype. The work presented here reveals two mutations in the 
Artemis gene that cause T- B- NK+ SCID in pigs. The SCID pig can be an important biomedical 
model, but these mutations would be undesirable in commercial pig populations. The identified 
mutations and associated genetic tests can be used to address both of these issues.  
 
Introduction 
Severe Combined Immunodeficiency (SCID) is a diverse group of primary 
immunodeficiencies that involve impaired development or function of both B and T cells 
(Notarangelo, 2010). Phenotypes causing SCID can be classified based on the presence or 
absence of B, T, and Natural Killer (NK) cells and further categorized by the genetic defect that 
causes the disease. Mutations in genes necessary for V(D)J recombination at the T cell receptor 
(TCR) or Immunoglobulin (IG) clusters, which are required for receptor maturation and T and B 
cell survival, respectively, lead to T- B- NK+ SCID (Cossu, 2010). T- B- NK+ SCID defects can 
be split into two groups based on sensitivity of affected cells to ionizing radiation. Lesions in the 
RAG1 and RAG2 genes result in immunodeficient animals that are resistant to radiation (Schwarz 
et al., 1996). Cells with defects in DNA-PKcs, DNA ligase IV, Cernunnos, or Artemis are 
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radiosensitive, as they are unable to repair damage to DNA caused by ionizing radiation (De 
Villartay, 2009). 
SCID animals are valuable biomedical models and have been used to study many aspects 
of human immune function, disease progression, as well as vaccine and drug development and 
testing. SCID mice, in particular, have been widely used as a vehicle to study the human immune 
system and play important roles in pre-clinical studies of the stability and function of human 
stem cells and their differentiated counterparts as potential therapies (Blum and Benvenisty, 
2008; Cunningham et al., 2012). In order to improve SCID mice as biomedical models, genetic 
engineering has been utilized to overcome some of the differences between the immune 
environment of mice and humans (Shultz et al., 2012). Much progress has been made in creating 
immunodeficient mice models used in biomedical research (Garcia and Freitas, 2012; Shultz et 
al., 2012) through selection of appropriate mice strains and conditioning regimens (Brehm and 
Shultz, 2012). However, regardless of these advances, the translatability of rodent immunology 
and inflammatory studies to humans is imperfect (Mestas and Hughes, 2004; Seok et al., 2013) 
and other models may be beneficial (Meurens et al., 2012; Plews et al., 2013). 
Anatomical, genetic, and immunological similarities underpin the usefulness of swine as 
a large animal model for humans (Meurens et al., 2012; Prather et al., 2013). Recently, 
transgenic methods have been used to create SCID pigs, including mutations in the X-linked 
IL2RG gene (Suzuki et al., 2012; Watanabe et al., 2013) and mutations in RAG1 or in both RAG1 
and RAG2 (Huang et al., 2014; Lee et al., 2014). Recently, our group (Cino-Ozuna et al., 2012) 
reported the first identification of a naturally occurring form of SCID in a line of purebred 
Yorkshire pigs that had been selected for increased feed efficiency at Iowa State University (Cai 
et al., 2008). Necropsy of four piglets that died abnormally early in a viral challenge study 
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showed they lacked functional adaptive immune systems. In subsequent work, we (Basel et al., 
2012) demonstrated that these immunodeficient pigs failed to reject human cancer cells, and 
Ewen et al. (2014) reported minimal circulating B and T cells but normal amounts of NK cells in 
a preliminary analysis of these SCID pigs. We present in this paper the first report of the 
characterization of the genetic lesions that cause the SCID phenotype in this pig population. 
Quantitative real-time PCR (qRT-PCR) and flow cytometry assays confirmed that the SCID pigs 
lack B and T cells, but do have NK cells; we also demonstrate T cell maturation defects in the 
thymus. Irradiation of fibroblasts from these SCID pigs and normal controls showed that the 
genetic defect is in the group of genes involved in DNA damage repair. Genetic mapping, 
phasing of genetic markers, and targeted sequencing revealed two independent mutations in the 
Artemis gene that cause SCID in this line of pigs. We confirmed that mutations in Artemis are 
responsible for the radiosensitivity of fibroblasts by rescuing this phenotype with expression of 
human Artemis in fibroblasts derived from the SCID pigs. These Artemis deficient pigs provide a 
large animal model to study various aspects of human disease and immune function. 	
Materials and Methods 
All animal experiments were performed under a protocol approved by the Iowa State 
University Institutional Animal Care and Use Committee (Ames, Iowa). 
Flow cytometry to determine cellular phenotype 
Thymic tissues were collected into ice-cold Minimal Essential Media, supplemented with 
HEPES, and penicillin/streptomycin. Tissues were minced into 2x2 cm2 pieces and treated with 
100 U/ml collagenase (collagenase I; Life Technologies, Grand Island, New York) in HBSS 
(+calcium and magnesium; Life Technologies) for 30 min at 37°C, with gentle agitation. Cells 
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were washed in PBS, counted, and 1,000,000 cells were stained using the following fluorescently 
conjugated antibodies: Alexa Fluor647 conjugated anti-pig CD8a (clone 76-2-11; BD 
Biosciences, San Diego, California), FITC conjugated anti-pig CD4 (clone 74-12-4; BD 
Biosciences), PE-conjugated anti-pig γδ (clone MAC320; BD Biosciences), or the appropriate 
isotype controls (BD Biosciences), or a with FITC-conjugated mouse anti-pig CD3ε (clone 
PPT3; Southern Biotech, Birmingham, Alabama). Cells were washed and resuspended in 400 µL 
0.2% BSA/PBS solution prior to acquisition on an EC800 flow cytometer (Sony Biotechnology, 
Champaign, Illinois). Data was analyzed using FCS Express 4 software (DeNovo Software, Los 
Angeles, California). 
For samples used in the homozygous h12 and h16 comparison, an aliquot of 100 µL of 
whole blood, collected in ACD, was transferred to a 12x75 mm polystyrene tube. Fc receptors 
were blocked with 10 µL of normal mouse serum (Equitech-Bio, Inc, Kerrville, Texas). Directly-
conjugated antibodies to CD3ε (FITC conjugated, clone PPT3; Southern Biotech, Birmingham, 
Alabama), CD16 (PE-conjugated, clone G7; Serotec, Raleigh, North Carolina), and CD21 (APC-
conjugated, clone B-ly4; BD Biosciences) were added and incubated for 30 minutes. Red blood 
cells were lysed using Multi-species RBC Lysis Buffer (eBiosciences, San Diego, California), 
and then washed twice in PBS-1% BSA (Fraction V bovine serum albumin; GE Healthcare Life 
Sciences). Cells were acquired on a Sony EC800 cytometer, equipped with counts/µL 
capabilities, and those detected within the lymphocyte gate were analyzed for the expression of 
CD3ε, CD21, or CD16 lineage-specific markers.  
Radiosensitivity testing of fibroblasts from SCID and non-SCID piglets 
Tissue processing and fibroblast collection was performed similarly as described by Ross 
et al. (2010). Ear snip tissue of 20 young piglets from five litters from carrier-by-carrier matings 
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was collected into PBS with Gentamycin and stored at 4°C until processing, three to 24 hours. 
Tissue was then soaked in 100% ethanol for 2-3 minutes, washed twice with PBS, then 
transferred to a dry dish and minced. Trypsin was added to the minced tissue and incubated at 
37°C for 30 minutes. Trypsin was deactivated with cell culture medium, containing low glucose 
DMEM, 15% Fetal Bovine Serum (FBS), and Gentamycin, then centrifuged for 10 minutes at 
600 x g. Cell culture media was removed from tissue and replaced with fresh media and cultured 
in the same medium to allow fibroblasts to migrate from tissue pieces. Fibroblasts were passaged 
to purify the culture, then stored in freezing media made up of FBS with 10% DMSO in liquid 
nitrogen. Frozen cultures were thawed and cultured in cell culture medium for approximately 7 
days prior to further analysis.  
Radiosensitivity assay. For irradiation, 150,000 fibroblast cells were suspended in 15 
mL fresh cell culture medium with four tubes per biological replicate. Samples were irradiated 
using a gamma irradiation machine (Mary Greeley Medical Center, Ames, Iowa) at 0, 2, 4, or 8 
gamma rays (Gy).  Each sample was then plated in triplicate at a density of 1,000 cells per plate 
and cultured for two weeks, with one media change 7 days post irradiation. After 14 days of 
culture, plates were washed with PBS, stained with methyl blue, and the number of individual 
colonies with a diameter greater than 2 mm determined by visual inspection were 
counted(Darroudi et al., 2007).  
Statistical analysis. The average number of colonies of three replicates for each animal 
and radiation dose was used as observations. Percentage survival for each animal was calculated 
by dividing the average number of colonies at each radiation dose (2, 4, and 8 Gy) by the average 
number of colonies at 0 Gy irradiation for that animal. Survival percentage was analyzed using 
Proc Mixed in SAS 9.3 (SAS, Inc.; Cary, North Carolina), with the fixed effects of SCID status, 
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radiation dose, and their interaction. Litter and animal within litter were fitted as random effects. 
Different error variances were allowed for each radiation dose.  
Data from irradiation of fibroblasts from pigs homozygous for each haplotype, and from 
compound heterozygous and normal pigs were also analyzed as described above, with the 
additional fixed effects of haplotype within SCID status and the interaction of haplotype and 
radiation dose.  
Genome wide association analysis 
Subjects. Genomic DNA from 20 SCID affected pigs, 50 unaffected littermates, their six 
parents, and 96 ancestors from the previous seven generations of the experimental residual feed 
intake (RFI) selection line at Iowa State University (Cai et al., 2008) (ISU) was isolated from tail 
or ear tissue using the Qiagen DNeasy Blood and Tissue Kit (Hilden, Germany). DNA samples 
were sent to GeneSeek Inc. (Lincoln, Nebraska) and genotyped using the Illumina Porcine 
SNP60 Beadchip (Ramos et al., 2009). SCID status was determined by plotting lymphocyte 
against white blood cell numbers obtained from complete blood cell analysis of whole blood 
from each piglet (data not shown).  
Statistical analysis. Initial attempts to map the genomic region harboring the causative 
mutation using runs of homozygosity (Drögemüller et al., 2011) in the affected piglets were 
unsuccessful. Associations of SNPs with the binary phenotype of affected versus unaffected 
SCID status were then analyzed with the dfam, disease within family, option of Plink (Purcell et 
al., 2007) to determine the genomic region most strongly associated with the categorical disease 
phenotype. The dfam option examines differential transmission of alleles from parents to 
affected versus unaffected offspring. This analysis assumes homogeneity of the associated allele 
within each family, but not between families.  
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Haplotype analysis. Following the results from the association study, genotypes of 
subjects used for the GWAS for 21 SNPs located in a 1-Mb region surrounding Artemis from the 
SNP60 panel were separated into haplotypes using PHASE 2.1.1(Stephens et al., 2001). This 
revealed two haplotypes that segregated with SCID status when present in a homozygous or 
compound heterozygous state. Carrier status of these haplotypes was added to the pedigree of the 
six parents of the SCID piglets, which showed that both could be traced back to the founders of 
the experimental population (Figure 3.5). 
Candidate gene sequencing 
Total RNA was extracted from either ear tissue or fibroblasts cultured from ear tissue 
using the TriZol extraction method (Gibco BRL, Life Technologies, New York). mRNA was 
reverse transcribed using SuperScript VILO (Invitrogen, Carlsbad, California). To examine the 
entire Artemis coding sequence for variation, the full coding region of the Artemis cDNA was 
PCR amplified using primers in the first and last exon: forward 5’-
GGATCCGTGTTCGCCAACGCT-3’ and reverse 5’-
GCGGCCGCAGAGCTGCCTTTTAGGTTAT-3’, using an annealing temperature of 60°C and 
an elongation time of 2 minutes and 30 seconds. Artemis cDNA PCR products were cloned into a 
TOPO vector and grown in E. coli bacteria on LB plates with Ampicillin. Individual colonies 
were then picked into LB-Ampicillin media and PCR amplified to ensure that each colony 
contained a vector with Artemis cDNA. Positive PCR products were cleaned using Exo-Sap and 
sent to the ISU DNA Facility for sequencing. 
To examine the genomic region for sequence variation, primers were designed to amplify 
targeted exons of Artemis and portions of each surrounding intron. The genomic region 
containing exons 7 and 8 was PCR amplified using primers: forward 5’-
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CTCAGTGGGTTAGGGACCTG-3’ and reverse 5’-GCCATCTGATAGGGTTTCCA-3’, using 
an annealing temperature of 54°C and an elongation time of 60 seconds. The genomic region 
containing exons 10 and 11 was PCR amplified using primers: forward 5’-
GCTAAAGTCCAGGCCAGTTG-3’ and reverse 5’-CAAGAGTCCCCACCAGTCTT-3’, using 
an annealing temperature of 56°C and an elongation time of 60 seconds. PCR products were 
cleaned using Exo-Sap and sent to the ISU DNA Facility for sequencing. Sequences for each 
haplotype were compared to those of normal littermates and to the reference sequence obtained 
from Sus scrofa build 10.2. 
Rescue of radiosensitive phenotype 
Fibroblasts for h12/h16 compound heterozygous SCID (n=2) and normal animals (n=3) 
from 3 litters were cultured in the same manner as described above. Fibroblasts were transfected 
with either 5 µg of the human Artemis plasmid (Certo et al., 2012; pExodus CMV.Artemis, 
which was procured through deposition to Addgene  [plasmid #40211] by Andrew Scharenberg), 
with 3.45 µg of the empty pExodus vector construct (also deposited by A. Scharenberg. 
Addgene; plasmid #39991), or shocked with no plasmid added. Cells were electroporated using 
electroporation media and conditions described by Ross et al. (2010). Briefly, 1,000,000 cells in 
200 µL were electroporated using three, 1 ms square-wave pulses of 300 volts in a 2 mm gap 
cuvette using a BTX ECM 2001 electroporator.  Transfected cells were incubated overnight in 
cell culture media. One day after transfection, fibroblasts were subjected to 4 Gy radiation and 
plated in triplicate as described above. Cells were cultured for 14 days, with one media change 
seven days post irradiation, stained with methyl blue, and colonies determined by visual 
inspection and counted.  
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Statistical Analysis. The average number of colonies of three replicates for each animal 
and plasmid was used as observations. Data were analyzed using Proc Mixed in SAS 9.3 (SAS, 
Inc.; Cary, North Carolina), including the fixed effects of SCID status, plasmid, and their 
interaction. Litter and animal within litter were fitted as random effects. Different error variances 
were allowed for data from normal versus SCID animals. 
 
Results 
SCID phenotype segregates as an autosomal recessive trait in Yorkshire pig population 
Weaned piglets of the eighth generation of a line of purebred Yorkshires selected for 
increased feed efficiency (residual feed intake; RFI) at Iowa State University (ISU; Cai et al., 
2008) were sent to Kansas State University (KSU) to undergo experimental infection with the 
Porcine Reproductive and Respiratory Syndrome virus to evaluate their ability to respond to an 
infectious disease stressor (Dunkelberger et al., 2015). Necropsy of four of these piglets that died 
soon after arrival at KSU showed that they had very low numbers of circulating B and T cells, 
and their lymph nodes and thymus were small (Cino-Ozuna et al., 2012). Pedigree analysis of the 
four litters that these piglets were from showed that the six parents of these four litters were 
related. To explore the genetic basis of this phenotype, matings between these six parents were 
repeated to produce a total of 13 litters (data not shown), each of which produced at least one 
affected piglet, as diagnosed by numbers of white blood cells and lymphocytes based on 
complete blood cell (CBC) counts of whole blood; plots of lymphocyte to white blood cell 
counts within litter distinguished suspected SCID piglets from non-SCID littermates (data not 
shown). A total of 176 piglets were born, 12 of which died before their SCID status could be 
determined. Of the remaining 164 piglets, 31 (19%) were confirmed to have SCID based on very 
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low lymphocyte counts as measured by standard CBC or flow cytometry. This frequency was 
lower (p=0.07) than the expected 25% if the immunodeficiency phenotype was caused by an 
autosomal recessive mutation. However, it is possible that a portion of the 12 pigs with unknown 
SCID phenotype in these litters were actually SCID, thus the SCID phenotype may be under-
reported in this population. Based on these results, we hypothesized that the immunodeficiency 
phenotype was caused by an autosomal recessive mutation. 
T- B- NK+ SCID pigs are defective in thymocyte maturation  
Flow cytometry analysis, recently published by Ewen et al. (2014), demonstrated that 
concentrations of circulating leukocytes in peripheral blood of normal and affected pigs were 
similar among granulocytes, monocytes, and NK cell populations; however, B and T cell 
populations were significantly reduced in SCID piglets. Consistent findings were produced when 
quantitative real-time PCR (qRT-PCR) was used to measure the relative expression of B, T, and 
NK cell marker genes in whole blood of SCID and non-SCID piglets; non-SCID piglets were 
shown to have significantly higher levels of B and T cell marker gene expression compared to 
SCID littermates (p<0.01; data not shown).  
To help ascertain the mechanism underlying the marked T cell paucity in the SCID pigs, 
thymocytes were prepared from thymic tissues and stained with CD3ε, CD8a, CD4, and γδ 
lineage markers to monitor thymocyte development in these animals. Flow cytometric analysis 
revealed that the frequency of immature CD4- CD8a- double negative thymocytes was 
significantly greater in the SCID pigs, 82.5% (±2.94%), compared to their non-SCID littermates, 
30.4% (±1.8%; p=0.001; Figure 3.1), indicating an arrest of differentiation at or prior to TCR 
rearrangement (Šinkora and Butler, 2009). Furthermore, the frequencies of CD4+ CD8a+ double 
positive and CD4+ and CD8+ single positive cells, which are usually observed following TCR 
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rearrangement (Sinkora et al., 2000; Sinkora et al., 2007), were also significantly reduced in 
thymocytes derived from SCID piglets (p<0.01). These cells were almost exclusively CD3ε 
negative, as CD3+ cells are approximately10-fold reduced in abundance in SCID thymocytes 
compared to those in non-SCID (Figure 3.1C). Aberrant thymocyte development was not 
restricted to αβ-TCR-bearing cells, as γδ+ thymocytes were also significantly decreased in SCID 
affected pigs compared to non-SCID pigs (p=0.0054; Figure 3.1). These findings from flow 
cytometry and qRT-PCR of lymphocyte marker expression indicated that the SCID phenotype 
may be caused by a lesion early in the lymphocyte developmental pathway, as both B and T cells 
were absent or low in number, but late enough that NK cells were unaffected, resulting in T- B- 
NK+ SCID. 
SCID fibroblasts are sensitive to ionizing radiation 
Human SCID patients with a T- B- NK+ phenotype have defects in genes in the somatic 
recombination pathway required for TCR and IG maturation. This involves two groups of genes; 
the first group includes RAG1 and RAG2, whose proteins catalyze the first step of TCR and IG 
maturation, creating a double-strand DNA break (DSDB) in pre-T and pre-B cells(Oettinger et 
al., 1990). The second group of genes repairs these breaks in the process of forming functional 
TCR and IG receptors (Xu, 2006). Defects in RAG1 and RAG2 affect somatic DNA 
recombination, which occurs only in B and T lymphocytes. However, the ubiquitously expressed 
genes in the second group are involved in the non-homologous end joining (NHEJ) DNA 
damage repair pathway, which is important in all cells (Bassing et al., 2002). Cells with lesions 
in DNA damage repair genes show increased sensitivity to ionizing radiation (Dvorak and 
Cowan, 2010). To determine if the genetic defect was in the first or second group of genes, we 
tested the ability of fibroblasts from SCID and normal pigs to repair DSDB caused by ionizing 
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radiation. Fibroblasts cultured from skin tissue of SCID and non-SCID littermates from five 
litters were gamma-irradiated. Fibroblast survival was significantly decreased for cells from the 
SCID pigs compared to cells from normal littermates at all radiation doses tested (p<0.0001; 
Figure 3.2). Even at the lowest dose of radiation, 2 gamma-rays (Gy), the proportion of 
fibroblasts that survived and developed colonies was significantly lower for those derived from 
SCID pigs, 0.28 ± 0.03, compared to those of normal pigs, 0.73 ± 0.03 (p<0.0001). This 
radiosensitivity in fibroblasts suggested that the mutation causing SCID in these pigs was in one 
of the ubiquitously expressed genes involved in NHEJ repair of DSDB.  
Genetic mapping of the locus mutated in SCID pigs 
Genotypes for over 60,000 single nucleotide polymorphisms (SNP) represented on the 
Illumina Porcine SNP60 panel (Ramos et al., 2009), covering the entire porcine genome, were 
obtained on the six carrier parents, 20 SCID affected piglets, 50 unaffected littermates of the 
SCID piglets, and 96 ancestors of these animals. A genome wide association study was 
performed to identify the region harboring the causative mutation. We identified a 5.6 Mb region 
on Sus scrofa chromosome 10 that was differentially transmitted (p=2.7 x 10-7 for SNP with 
strongest association) to SCID affected versus unaffected piglets (Figure 3.3). This region was 
found to contain the porcine Artemis gene, which, when mutated in humans (Moshous et al., 
2001) or mice (Rooney et al., 2002), causes a T- B- NK+ immunodeficiency phenotype. Lesions 
in Artemis have also been shown to cause increased sensitivity to ionizing radiation (Li et al., 
2002).  
To confirm the suspected autosomal recessive manner of transmission, a haplotype 
analysis was performed using 21 SNPs from the SNP60 panel in the 1-Mb region surrounding 
Artemis. Results showed two distinct haplotypes (h12 and h16), which when present in a 
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compound heterozygous or homozygous recessive state, were associated with the SCID 
phenotype. Both of these SNP haplotypes could be traced back to the founder generation of the 
RFI selection line (Cai et al., 2008), which was sourced from commercial Yorkshire populations 
in the Midwest region of the USA (Figure 3.4).  
We obtained SNP genotypes from animals from two sources to evaluate the segregation 
of SCID haplotypes in commercial pigs. The National Swine Registry (NSR) provided us with 
SNP60 data on 985 Yorkshire pigs, and a swine breeding company provided genotypes of over 
15,000 pigs from 3 of their breeding lines. Results from phasing of the genotypes of 55 SNPs 
located in the 2 Mb surrounding the Artemis gene into haplotypes are presented in Appendix A. 
Results showed that all analyzed datasets except for one line from the breeding company 
contained animals carrying haplotypes identical to the SCID affected animals from the ISU 
population. There were 6 animals in the NSR data that were homozygous for SCID haplotypes, 
which would indicate that these animals were SCID affected; this is not possible, though, as each 
of these animals were used for breeding purposes and SCID animals are not able to survive to 
breeding age. Overall, these results show that it is possible that the mutations in Artemis that 
cause SCID may be segregating in commercial pigs, but if they are, they are present at a low 
frequency.  
Candidate gene sequencing identifies independent mutations in Artemis 
To identify the causal mutation, the coding portion of the Artemis cDNA from fibroblast 
mRNA was sequenced for affected piglets and normal littermates (Figure 3.5). Selected exons 
and flanking portions of introns were also amplified and sequenced from genomic DNA. 
Multiple examples of alternative splicing events were seen in cDNA of both SCID and normal 
pigs (Supplemental Figure 3.1). The most abundant transcript observed in cDNA from normal 
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pigs contained all exons present in the human Artemis cDNA, but is missing the second exon of 
an Artemis porcine cDNA sequence isolated from alveolar macrophages that was reported by 
others  (NM_001258445.1). This exon was not present in any of the Artemis transcripts 
sequenced in this study, although it exists in the pig genome (Sus scrofa 10.2) between exon 1 
and what we refer to as exon 2 and may represent a bona fide exon. However, based on BLAST 
analysis of sequences that are present in dbEST (17 February 2015), cDNAs with the top six 
alignments did not contain this exon. In addition, this exon did not align to any portion of human 
Artemis cDNA sequences (NM_001033855.2). Both genome-guided transcriptome assembly and 
de novo transcriptome assembly using whole blood RNAseq data from 31 pigs in an unrelated 
project was found to contain only one Artemis transcript, which did not contain this exon (H. Liu 
and C.K. Tuggle, unpublished data). Based on these findings, we believe the swine reference 
transcript that contains this extra exon (NM_001258445.1) is a minor transcript. For clarity and 
consistency with the human literature, we denoted this extra exon as exon 1A and considered the 
second exon that is present in the transcripts observed in our study as exon 2. Translation of the 
longest transcript we sequenced from non-SCID pigs would produce a protein containing 712 
amino acids, with 81% sequence identity to the human encoded Artemis protein. 
Haplotype 16 has a lesion causing a predicted splice defect. The majority of cDNAs 
sequenced from normal pigs contained exons 1-14. The most complete transcript sequenced from 
cDNA from the h16 SCID haplotype contained all these exons except for exon 8, resulting in the 
loss of 141 nucleotides (Supplemental Figure 3.1). In fact, none of the cDNA sequences obtained 
from h16 chromosomes contained exon 8. Genomic sequencing of exon 8 and a portion of the 
surrounding introns revealed a splice donor site mutation in intron 8 (g.51578763 GàA; Figure 
3.5b). This GàA mutation was only seen in the h16 genomic sequence, as a G nucleotide at this 
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position was seen in both the h12 and normal sequences; to distinguish h16 from h12 transcripts 
in compound heterozygous animals, we used a synonymous point mutation in exon 13 that we 
identified to be present only in h16 transcripts (position g.51587796). This GàA nucleotide 
conversion disrupts the signals required to correctly splice exon 8 to exon 9, which explains the 
observed lack of exon 8 in cDNAs expressed from h16 haplotype chromosomes. An Artemis 
transcript with no exon 8 would retain the normal reading frame but would be expected to 
produce a protein missing 47 amino acids of the predicted full length 712-amino acid Artemis 
protein.  
Haplotype 12 has a nonsense point mutation and a predicted severely truncated protein. 
Multiple examples of alternative splicing, including aberrant splicing within exons and one 
intron, were observed for transcripts from chromosomes that carried the h12 haplotype 
(Supplemental Figure 3.1). All transcripts sequenced from homozygous h12 animals were found 
to lack the 137 base pair long exon 10, which would cause a frameshift that results in a stop 
codon shortly after the missing exon. The predicted protein translated from transcripts missing 
exon 10 would be severely truncated; at 277 amino acids long, it would be < 50% of normal 
length. To investigate the cause of this lack of exon 10 in all h12 transcripts, exons 10 and 11 
and portions of the surrounding introns were amplified from genomic DNA of homozygous h12 
animals. Signal sequences required for splicing of exon 10 were identical to those seen in the 
sequence of normal pigs, as well as in the reference sequence (Sscrofa 10.2, 
www.ensembl.org/Sus_scrofa/Info/Index).  However, sequence analysis of the exon 10 genomic 
region in homozygous h12 pigs identified a GàA nonsense point mutation at g.51584489 that 
changes the Tryptophan amino acid codon at position 267 to a stop codon (Figure 3.5C). Our 
interpretation of these data is that any transcript that contained exon 10 was not stable enough for 
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cDNA analysis to detect. Further, while not identified as part of any cDNA from homozygous 
h12 pigs, the predicted translation of this presumably unstable transcript containing exon 10 with 
the g.51584489 GàA mutation would also produce a severely truncated protein of 266 amino 
acids.  
Animals homozygous for either mutation are not different in numbers of specific 
lymphocytes or in radiosensitivity  
The flow cytometry and radiosensitivity assays described earlier were performed on a 
combination of compound heterozygous and homozygous h12 or h16 SCID animals. To 
determine if homozygosity for either mutation would result in altered severity of phenotypes, 
flow cytometry of circulating blood and assays of fibroblast irradiation were performed. 
Peripheral blood from SCID piglets that were homozygous for either mutation or compound 
heterozygous had greatly decreased percentages of CD21+ and CD3+ cells compared to carrier 
littermates (p<0.01), but no differences were seen among pigs with different SCID genotypes 
(p>0.10; Supplemental Figure 3.2). Fibroblasts from each SCID genotype were equally sensitive 
to ionizing radiation at all radiation doses (p>0.10; Supplemental Figure 3.3), and fibroblasts 
from each SCID genotype were significantly more sensitive than fibroblasts from normal pigs at 
2 and 4 Gy (p<0.05) and tended to be more sensitive at 8 Gy (p=0.087; Supplemental Figure 
3.3).  
Transfection with human Artemis rescues radiosensitivity of fibroblasts 
To further confirm the role of Artemis in the observed SCID phenotype, we assessed the 
complementation of the radiosensitivity of SCID pig fibroblasts by expression of human Artemis. 
Fibroblasts cultured from compound heterozygous SCID (n=2) and normal (n=3) piglets from 
three litters were transfected with a human Artemis containing plasmid (pArt), with the empty 
		
67	
vector construct (pExo), or shocked without the addition of either plasmid. Cells were then 
subjected to 4 Gy radiation and survival measured. Addition of pArt increased the 
radioresistance of fibroblasts from SCID pigs (p=0.001), while cells from normal littermates 
were unaffected by the addition of pArt (p=0.11; Figure 3.6), and pExo had no effect on the 
radiosensitivity of fibroblasts of SCID or non-SCID genotypes. 
Discussion 
Through immunophenotyping, genetic mapping, cDNA and genomic DNA sequencing, 
fibroblast radiation sensitivity testing, and cDNA rescue of radiosensitivity phenotypes of 
fibroblasts, we provide substantial evidence that a novel T- B- NK+ immunodeficiency trait in 
pigs is caused by two independent mutations in the same gene that codes for a DNA repair 
enzyme, which is known to cause this type of SCID phenotype in human patients. We document 
that the identified mutations in the Artemis gene are necessary to observe a SCID phenotype in 
directed matings and are sufficient to cause the radiosensitivity phenotype observed in SCID 
fibroblasts from this population. 
Novel immunodeficiency phenotype in pigs is a recessive Mendelian trait that shows defects 
in thymocyte maturation consistent with flawed somatic recombination 
Cino Ozuno et al. (2012) reported the initial analysis of the first cases of naturally 
occurring SCID in pigs, which was serendipitously found within a line selected for a 
commercially relevant trait at ISU (Cai et al., 2008). In our expanded analysis of litters born 
within the pedigree of this line, a Mendelian and non-sex-linked segregation of SCID affected 
status in litters born to carrier-by-carrier matings was observed, indicating that the SCID 
phenotype was an autosomal recessive trait (Cossu, 2010). Findings from qRT-PCR of 
lymphocyte marker expression in whole blood showed that the SCID pigs had very low numbers 
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of B and T cells, while NK cells were present. These results suggested that the ability of B and T 
lymphocytes to recombine genetic material to form functional receptors was compromised in the 
SCID affected piglets. Flow cytometry of thymus tissue showed an increased population of CD4- 
CD8a- and γδ- T cells in SCID pigs compared to non-SCID littermates. This suggested an arrest 
in early thymocyte development and TCR rearrangement in the SCID pigs (Sinkora et al., 2007; 
Šinkora and Butler, 2009). The increased sensitivity to ionizing radiation in fibroblasts of SCID 
pigs further narrowed the list of candidate genes to be evaluated for mutations to those involved 
in the NHEJ DNA damage repair system.  
Two distinct mutations in the Artemis gene found in SCID pigs 
Genomic association analysis of the population segregating the SCID phenotype pointed 
to a region containing the Artemis gene, while SNP genotype phasing results indicated that there 
were two distinct haplotypes that each carried a mutation postulated to cause the SCID 
phenotype. Both of these haplotypes could be traced back to the founders of this population, 
which suggests that these deleterious mutations may be present in commercial Yorkshire pigs in 
the US. This is an important implication for the swine industry, as SCID piglets thrive while 
suckling from their dam, but succumb to opportunistic infections after weaning. Parentage 
information is generally not tracked into the nursery, at least in part due to cross fostering 
practices, the lack of permanent individual identification and the frequent use of mixed semen 
from more than one boar for artificial insemination. Therefore, although the death of several 
littermates represents a concentrated loss for that litter, this clue to a genetic defect is not likely 
to be recognized on commercial farms. In addition, if the frequency of the SCID mutations is 
low, carrier-by-carrier matings may be rare in industry practice.   
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Sequencing of Artemis cDNA from non-SCID and SCID pigs carrying each haplotype 
identified multiple examples of alternative splicing. The cause for absence of specific exons in 
sequences of each SCID haplotype was explored using targeted genomic sequencing. A point 
mutation at the splice donor site for intron 8 in the h16 genomic sequence explained the lack of 
exon 8 in all cDNA sequences from the h16 haplotype. A compendium of 48 different causative 
mutations in Artemis in human SCID patients has cataloged six splice site mutations, although 
none involve exon 8 (Pannicke et al., 2010).  Translation of the most complete h16 transcript 
would produce a protein of 665 amino acids, lacking a 47 amino acid long portion of the beta-
CASP region, which is required for Artemis function (Callebaut et al., 2002; Poinsignon et al., 
2004). Genomic deletions of Artemis exons 5 through 8 (Moshous et al., 2001) and exons 7 and 8 
(Li et al., 2002) have been shown to cause SCID in human patients. For h12, no cDNAs were 
identified that contained exon 10, but the most complete cDNAs from homozygous h12 cells 
contained all other exons that were present in the non-SCID cDNA sequence.  Because the lack 
of exon 10 causes a frameshift and the open reading frame stops in exon 11, the longest protein 
that is predicted to be encoded by the observed cDNAs from haplotype h12 is 277 amino acids 
long, containing only 39% of the normal protein. Interestingly, genomic sequence of the h12 
haplotype identified a nonsense point mutation in exon 10, which would result in a protein of 
only 266 amino acids if this exon 10 were present in mRNA. This severely truncated protein 
would lack over half of the total amino acid sequence, including a highly conserved part of the 
beta-CASP motif (Callebaut et al., 2002). Therefore, in both observed cDNAs and RNA 
transcripts predicted from genomic sequence, h12 can encode only a greatly shortened protein, 
with 277 or 266 amino acids, respectively. In humans, an 8 base pair insertion in exon 14 of 
Artemis that changed a cysteine to a stop codon at position 330 of the protein was also shown to 
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cause SCID (Tomashov-Matar et al., 2012). Pannicke et al. (2010) lists several small deletions 
causing SCID, the majority of which lead to a frameshift that introduces novel nonsense codons 
that cause truncations that are distal to exon 10, in exons 12, 13, and 14. This suggests that either 
version of the h12 haplotype protein is highly unlikely to be functional in DNA damage repair. 
We thus hypothesized that the h12 mutation may cause a more severe immunodeficient 
phenotype than the h16 mutation, in which only 47 internal amino acids are predicted to be lost. 
However, flow cytometry and fibroblast irradiation showed no phenotypic differences between 
SCID pigs that were homozygous for either mutation or compound heterozygous. While single 
missense mutations, as well as deletions of single amino acids without a frameshift, can lead to a 
SCID or Omenn syndrome phenotype in humans (Pannicke et al., 2010), examples exist for 
frameshift mutations producing a truncated protein with partial activity. For example, the 
D451fsX10 mutation is a large truncation of >200 amino acids that retains partial nuclease 
activity(Huang et al., 2009). In a mouse model, the hypomorphic D451fsX10 mutation is 
associated with aberrant DNA joining that causes chromosomal rearrangements (Jacobs et al., 
2011). Thus, underlying cellular differences in DNA repair activity between the h12 and h16 
encoded proteins may exist, and further studies should be conducted to determine the functional 
differences between these two mutations in pigs.  
Value of Artemis SCID pigs in preclinical testing  
Similarities between humans and pigs emphasize the value of the pig as a biomedical 
model (Meurens et al., 2012), and pigs as large animal models for many diseases are being 
created (Walters et al., 2012). Body, tissue and organ size make them physiologically very 
similar, allowing surgical and imaging techniques to translate well (Swindle, 2007). Size 
similarity also makes the pig a more suitable model for testing delivery of cells (i.e., heart) and 
		
71	
for measuring location/stability of transplanted cells under orthopedic stress (i.e., joint tissue). 
However, the use of pig models in regenerative medicine has been minimal, due to the heretofore 
lack of a porcine immuno-compromised model that could be used as a xenogenic transplant 
model. As recently demonstrated for human cancer cells, the SCID pigs we describe here cannot 
reject a xenograft (Basel et al., 2012). Immunodeficient porcine models have long been sought, 
as is evident by the recently reported transgenic SCID pigs with targeted IL2RG (Suzuki et al., 
2012; Watanabe et al., 2013) and RAG1 and/or RAG2 mutations (Huang et al., 2014; Lee et al., 
2014). Here, we have described two naturally occurring genetic defects in Artemis that cause 
SCID in pigs. These porcine models will be valuable in studies involving cellular and organ 
transplantation, human cancer progression and treatment, vaccine development, and many other 
immunological questions. Specifically, defects in Artemis (as well as all genes encoding proteins 
needed for VDJ recombination) have been shown to be associated with poor outcome of stem 
cell transplantation in humans (reviewed in Cossu et al., 2010). In the case of Artemis, affected 
patients have substantially higher risk of late toxicity following hematopoietic cell transplants 
(HCT) as compared to patients with RAG lesions (Schuetz et al., 2014). This was attributed to 
the use of alkylating agents in conditioning regimens. A separate study also found Artemis 
defects were associated with negative clinical events following HCT, which included graft vs. 
host disease and a range of infections (Neven et al., 2009). While Xiao et al. (2009) generated an 
Artemis deficient mouse model that replicates the phenotype observed in human Artemis 
deficient SCID patients, these Artemis deficient pigs provide an additional and perhaps more 
relevant preclinical model to test and improve clinical therapies used in treating these patients. 
Future studies will focus on defining optimal husbandry practices to increase the lifespan of 
SCID pigs so that such modeling can be performed.  
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Conclusions 
We provide evidence of two mutations in the Artemis gene that result in the only known cases of 
naturally occurring SCID in pigs. Artemis deficient SCID pigs provide a large animal biomedical 
model to investigate numerous aspects of immunology and cancer biology and would be 
valuable in efforts to improve therapies for human Artemis deficient SCID patients. 
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Figures 
   
Figure 3.1 Flow cytometry shows very few CD4+ CD8+ and γδ+ cells in SCID pig thymus. The 
number in each diagram is the percentage of each cell type in thymocyte populations of a SCID 
pig or a non-SCID carrier littermate (A and B). CD8a (x-axis) and CD4 (y-axis) (A) and γδ (B) 
are T cell surface markers. The least square means of percentages of each thymocyte 
subpopulation are shown in (C). Error bars represent the SE of the estimates. Bars with different 
letters (a and b) indicate statistically significant (p < 0.01) differences between SCID and non-
SCID cell number within the cellular subset.  
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Figure 3.2 Effect of ionizing radiation on fibroblasts from SCID and normal pigs. Fibroblasts 
from SCID piglets (n = 10) and normal littermates (n = 10) were exposed to increasing doses of 
gamma rays. Colonies (>2 mm) were stained and counted after 14 d. Survival proportion was 
calculated as the average number of surviving colonies for three replicates at each radiation dose 
divided by the number of colonies from nonirradiated cells for each animal. Error bars represent 
the SE of the least squares means. *p < 0.0001, difference between SCID and normal pigs within 
radiation dose.  
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Figure 3.3 Manhattan plot of the genome-wide association study for SCID status. Results show 
the -log10(p-value) of the association of ordered SNPs on S. scrofa chromosomes 1–18, X, Y, and 
unknown (U) with SCID status based on the dfam option in PLINK.  
 
 
  
		
80	
 
Figure 3.4 Pedigree of SCID ancestors showing carriers of mutated haplotypes based on the 
Illumina porcine SNP60 panel. Circles represent females and squares represent males. Green 
symbols are h16 haplotype carriers and pink symbols are h12 haplotype carriers, with lines of 
each color tracking the respective SCID haplotype through the pedigree to the founder 
generation. Beige symbols are pigs that were genotyped with the SNP60 panel and did not carry 
either SCID haplotype. White symbols in generations 0–7 represent nongenotyped individuals. 
Boxes in generation 8 give information on the numbers of SCID (Affected) and non-SCID 
(Unaffected) piglets and the number of piglets that died before their SCID phenotype was 
determined (Unknown) from each parent pair.  
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Figure 3.5 Two independent mutations were found in Artemis. (A) The coding region of the 
Artemis transcript is indicated by slanted lines and genotypes at mutated positions are shown for 
chromosomes that carry normal, h12, and h16 haplotypes. Mutant alleles that cause SCID are 
shown in black lettering. (B) Genomic sequence of the h16 haplotype shows a splice donor site 
mutation (g.51578763 G→A) responsible for the lack of exon 8 in all h16 transcripts. Capital 
letters denote exonic sequence whereas lowercase letters denote intronic sequence. (C) A 
nonsense point mutation (g.51584489 G→A) in exon 10 changes the tryptophan at position 267 
to a stop codon in the h12 haplotype.  
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Figure 3.6 Rescue of sensitivity to ionizing radiation. Fibroblasts from compound heterozygous 
SCID (n = 2) and normal (n = 3) littermates were transfected with human Artemis-expressing 
plasmid (5 mg, Artemis), with a molar equivalent of pExodus plasmid without the Artemis gene 
(3.45 mg, Empty Vector), or shocked without plasmid added. Fibroblasts were exposed to a 4 Gy 
radiation dose 24 h after transfection. Colonies (>2 mm) were counted after 14 d of growth. The 
average number of surviving colonies for three replicates for a given plasmid was divided by the 
number of colonies from shock only cells for each animal. Error bars represent the SE of the 
least squares means. Dots show individual observations. Bars with different letters (a and b) 
within affected status represent statistical differences between means with p < 0.01. 
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Supplemental Figure 3.1 cDNA structures for the Artemis gene from normal, h16, and h12 
haplotypes. Exons are represented by blocks, with exon number shown above the exons present 
in each transcript. Fractions show the number of sequences for that transcript over the total 
number of transcripts sequenced for that haplotype. For h12 transcripts, purple indicates that a 
portion of intron 4 was present in the transcript sequence. The red color shows splicing inside of 
exons, with the size of the red box indicating the amount of the exon present in the sequenced 
transcript. Dashed lines show the normal size of the improperly spliced exon for some 
transcripts.  	 	
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Supplemental Figure 3.2 Flow cytometry shows no differences between the lymphocyte counts 
of SCID pigs with different genotypes. There were no differences between the numbers of any 
lymphocytes seen among the SCID genotypes (p>0.10). SCID and carrier littermates had the 
same numbers of NK cells (CD16; p>0.10), but all SCID pigs had lower numbers of B (CD21) 
and T (CD3e) cells (p<0.01). Error bars represent the standard errors of the least square means. 
Bars with different letters (a and b) represent statistically significant differences between least 
square means within marker type.  	 	
a 
a a a a 
a 
b b b b 
b 
b 
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Supplemental Figure 3.3 Radiosensitivity of fibroblasts from all SCID affected genotypes and 
normal piglets. Fibroblasts from h12/h12, h16/h16, h12/h16, and normal animals (n=4 per 
genotype) were exposed to indicated doses of gamma-rays (Gy). Survival proportion was 
calculated as the average number of surviving colonies for three replicates at each radiation dose 
was divided by the number of colonies from non-irradiated cells for each animal. Error bars 
represent the standard error of the least squares means. * indicates statistically significant 
(p<0.05) difference between all SCID genotypes and normal pigs. 
  
*	
*	
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CHAPTER 4. GENOME WIDE ASSOCIATION OF PIGLET RESPONSE TO ONE OF 
TWO ISOLATES OF THE PORCINE REPRODUCTIVE AND RESPIRATORY 
SYNDROME VIRUS1 
 
A paper prepared for publication in Journal of Animal Science 
 
Emily H Waide2,3, Christopher K Tuggle2, and Jack CM Dekkers2,4 
 
Abstract 
Porcine Reproductive and Respiratory Syndrome (PRRS) is a devastating disease in the 
swine industry, and identification of host genetic factors that enable selection for improved 
performance during PRRS virus (PRRSV) infection would reduce the economic impact of this 
disease. We conducted genome-wide association study (GWAS) analyses of data from 13 trials 
of ~200 nursery age piglets that were experimentally infected with one of two isolates of the 
PRRSV (NVSL and KS06). Phenotypes analyzed were: viral load (VL) in blood during the first 
21days post infection (dpi) and weight gain (WG) from 0 to 42 dpi. We accounted for the 
previously identified SSC 4 QTL in our models to increase power to identify additional regions. 
Bayes-B and single SNP analyses identified the same regions on SSC 3 and 5 to be associated 																																																								1	This	project	was	supported	by	the	USDA	NIFA	PRRS	CAP	Award	2008-55620-19132,	the	National	Pork	Board,	and	the	NRSP-8	Swine	Genome	and	Bioinformatics	Coordination	projects,	and	the	PRRS	Host	Genetics	Consortium	consisting	of	USDA	ARS,	Kansas	State	Univ.,	Iowa	State	Univ.,	Michigan	State	Univ.,	Washington	State	Univ.,	Purdue	Univ.,	University	of	Nebraska-Lincoln,	PIC/Genus,	Newsham	Choice	Genetics,	Fast	Genetics,	Genetiporc,	Inc.,	Genesus,	Inc.,	PigGen	Canada,	Inc.,	IDEXX	Laboratories,	and	Tetracore,	Inc.	Nick	VL	Serão,	Martine	Schroyen,	Andrew	Hess,	Raymond	RR	Rowland,	Joan	K	Lunney,	and	Graham	Plastow	contributed	to	the	work	presented	in	this	chapter	and	are	expected	to	be	co-authors	when	this	manuscript	has	their	approval.		2	Department	of	Animal	Science,	Iowa	State	University,	Ames,	Iowa	3	Current	address:	The	Seeing	Eye,	Inc.,	Morristown,	New	Jersey	4	Correspondence:	239D	Kildee	Hall	(phone:	515-294-7509,	email:	jdekkers@iastate.edu)	
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with VL in the KS06 trials and on SSC 6 in the NVSL trials (P<5x10-6); for WG, regions on SSC 
5 and 17 were associated in the NVSL trials (P<3x10-5). No regions were identified with both 
methods for WG in the KS06 trials. Many regions identified by single SNP analyses were not 
identified using Bayes-B.  Except for the GBP5 region on SSC 4, which was associated with VL 
for both isolates (but only with WG for NVSL), identified regions did not overlap between the 
two PRRSV isolate datasets, which disagrees with the high genetic correlations of traits between 
isolates estimated from these data. We also identified genomic regions whose associations with 
VL or WG had interactions with either PRRSV isolate or genotype at the SSC 4 QTL. Gene 
ontology (GO) annotation terms for genes located near moderately associated SNPs (P<0.003) 
were enriched for multiple immunologically (VL) and metabolism (WG) related GO terms. The 
biological relevance of these regions suggests that, although use of single SNP analyses and a 
relaxed threshold may increase the number of false positives, it also increased the identification 
of true positives. Although only the SSC 4 QTL was associated with response to both PRRSV 
isolates, genes near associated SNPs were enriched for the same GO terms across PRRSV 
isolates, suggesting they were affected by similar biological processes. 
Introduction 
The PRRS Host Genetics Consortium (PHGC) investigates host genetic control of 
response to Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) infection (Lunney 
et al., 2011). Analysis of PHGC infection trials showed weight gain (WG) and viral load (VL) 
responses to the NVSL 97-7985 (NVSL; Osorio et al., 2002) PRRSV isolate were moderately 
heritable (~0.30) and controlled by a major QTL (Boddicker et al., 2012). One SNP in this QTL, 
WUR10000125 (WUR), captured 99.3% of the genetic variance explained and was validated 
using independent NVSL trials (Boddicker et al., 2014a; Boddicker et al., 2014b).  
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The diversity of PRRSV in the field emphasizes the importance of research involving 
multiple virus isolates (Murtaugh et al., 2010). To expand the findings from NVSL trials, the 
KS2006-72109 (KS06) isolate, which shares 89% ORF5 sequence similarity with NVSL, was 
used in additional infection trials. Hess et al. (2015) showed that the SSC 4 QTL had an effect on 
VL in both isolates but on WG in only the NVSL isolate. High genetic correlations for VL 
(0.86±0.19) and WG (0.86±0.27) between the two PRRSV isolates (Hess et al., 2015) led us to 
hypothesize that specific genomic regions control response to both PRRSV isolates. 
Genomic evaluation of complex traits, such as host response to PRRSV, may benefit 
from the inclusion of biological information, such as gene ontology (GO) annotation (Fortes et 
al., 2011; Serão et al., 2013). Thus, we aimed to use genome-wide association to find regions 
associated with response to PRRSV and to use functional analyses to support these findings. 
Genomic regions associated with response to both PRRSV isolates may prove useful in industry 
application and may also control response to other pathogens. Regions associated with response 
to only one PRRSV isolate may give insight into isolate-specific pathogenicity. Enrichment of 
relevant GO terms in genes near associated SNPs adds functional information to support 
statistical associations. 
Materials and Methods 
All experimental protocols used in this study were approved by the Kansas State 
University (KSU) Animal Care and Use Committee. 
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Study design 
Lunney et. al (2011) provided a detailed description of the study design employed in the 
PHGC trials used in this study. Briefly, a total of 15 trials of approximately 200 commercial 
crossbred piglets each were sent to KSU at weaning, given one week to acclimate, then 
innoculated intramuscularly and intranasally with 105 tissue culture infectious dose50 of either 
the NVSL 97-7985 (Osorio et al., 2002) or KS2006-72109 PRRSV isolate. In total, 2,289 
commercial crossbred piglets from 8 genetic backgrounds were used. A more detailed 
description of the populations used in each trial is in Table 4.1. Trial 9 involved pigs from the 
ISU RFI selection lines (Cai et al. 2008) and was excluded from these analyses. Trial 13 was also 
excluded because piglets from this trial had much lower and more variable viremia profiles 
compared to the other KS06 trials. 
For each trial, blood samples were collected at 0, 4, 7, 11, and 14 days post-infection 
(dpi) and then weekly until the completion of the trial at 42 dpi. Individual weights were 
observed weekly throughout the trials. At 42 dpi, piglets were euthanized and ear tissue was 
collected for genomic DNA extraction, which was sent to GeneSeek, Inc. (Lincoln, Nebraska, 
USA) and genotyped using the Illumina Porcine SNP60 Beadchip (Ramos et al., 2009). 
Genotypes with a gene call score lower than 0.5 were set to missing. After removal of SNPs with 
minor allele frequencies less than 0.01 across all trials and genotyping call rates less than 0.80, 
52,386 SNPs remained for analysis, with an overall genotype rate of 99.2%.   
Phenotypes 
The two phenotypes analyzed in this study were described by Boddicker et al. (2012). 
Briefly, the amount of PRRSV RNA in blood samples was quantified using quantitative PCR 
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and reported as the log10 of PRRSV RNA copies relative to a standard curve. Viral load (VL) 
was calculated as the area under the curve of viremia up to and including 21 dpi. Weight gain 
(WG) was calculated as the difference between body weight at 42 and 0 dpi. 
Genome wide association studies 
Associations of SNP genotypes with each trait were assessed using Bayesian variable 
selection and single SNP methods, as described in the following.  
Single SNP analyses. The following linear mixed model was used in ASReml 4 
(Gilmour et al., 2014) to associate SNP genotypes with phenotypes: 
𝒚 = 𝑿𝒃+ 𝒁!𝒈𝒊 +𝑾𝒑+ 𝑺𝒍+ 𝑽𝒖+ 𝒆 
where y = vector of phenotypic observations, X = design matrix associating phenotypes 
with fixed effects, b = vector of fixed effects of the interaction of parity and trial, covariates of 
initial age and weight, and genotype at the WUR SNP, Zi = design matrix associating phenotypes 
with class effects for SNP i, gi = vector of genotype class effects for SNP i, W = incidence matrix 
associating phenotypes with the interaction of pen and trial, p = vector of random effect of pen 
within trial,  S = incidence matrix associating phenotypes with litter effect, l = vector of random 
effects of litter, V = incidence matrix associating phenotypes with random animal polygenic 
effects, u = vector of random animal polygenic effects with variance-covariance matrix based on 
the pedigree relationship matrix, and e = vector of residual errors assumed to be i.i.d. ~N(0,𝜎!!). 
A one generation pedigree, including 4807 animals, was used. Results are presented as the –
log10(P) of the combined additive and dominance effects at each SNP. The interaction of 
genotype at each SNP with PRRSV isolate and with WUR genotype was also tested on the  
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combined dataset, using the same model described above but including virus isolate or its 
interaction with SNP genotype as additional fixed effects. 
Bayesian methods. All SNP genotypes were simultaneously fitted as random effects 
using the Bayes B method (Habier et al., 2011), as implemented in GenSel version 4.90 
(Fernando and Garrick, 2008). Missing genotypes were replaced with the mean genotype for that 
individual’s genetic background for that SNP. We used the following mixed model, a modified 
form of the model used in Zeng et al. (2013), to estimate associations of SNPs with each 
phenotype: 
𝒚 = 𝑿𝒃+ 𝒛𝒂𝒊𝑎!𝛿!"!!!! + 𝒛𝒅𝒊𝑑!𝛿!"!!!! +  𝒆 
where y and X are as described above, b = vector of fixed effects of sex, the interactions of pen 
and parity with trial, genotype at the WUR SNP, and covariates of initial age and weight, zai = 
vector of the additive genotype covariates coded as -10, 0, and 10 for the AA, AB, and BB 
genotypes, respectively, for SNP i, ai = additive effect for SNP i, δai = indicator for whether the 
additive effect of SNP i was included (δai = 1) or excluded from (δai = 0) the model for a given 
iteration of the Markov Chain Monte Carlo (MCMC), zdi = vector of the dominance genotype 
covariates coded as 10, 0, and 10 for the AA, AB, and BB genotypes, respectively, for SNP i, di 
= dominance effect for SNP i, δdi = indicator for whether the dominance effect of SNP i was 
included (δdi = 1) or excluded from (δdi = 0) the model for a given iteration of the MCMC, and e 
= vector of residual errors assumed to be i.i.d. ~N(0,𝜎!!). GenSel version 4.90 (Fernando and 
Garrick, 2008) does not allow for random effects other than SNPs to be fitted in the model, 
therefore litter was not included as an effect in the Bayes-B model. In order to increase power to 
identify genomic regions other than the SSC 4 QTL (Boddicker et al., 2012) with effects on 
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response to PRRSV infection, genotype at the WUR SNP was fitted as a fixed effect in our 
models and the WUR SNP and all SNPs within 2.5 Mb on either side of the WUR SNP were 
masked from the GWAS. The prior probability that a given SNP was excluded from the model 
(δai = 0 and δdi = 0) was set equal to π = 0.99, fitting approximately 1% or 524 additive effects 
and 524 dominance effects in each of 51,000 iterations of the MCMC, with the first 1,000 
iterations designated as burn in. Results are presented as the percent of genetic variance (GV) 
explained by sum of the additive and dominance effects of SNPs within non-overlapping 1-Mb 
windows (Wolc et al., 2012) of the genome based on Sus scrofa genome build 10.2 
(http://www.ensembl.org/Sus_scrofa/Info/Index?db=core). Windows explaining greater than 1% 
GV were further discussed. Alternative methods of evaluating Bayes-B results, such as the 
proportion of iterations in which a window explained greater than average % GV, identified the 
same associated regions.  
Principal Component Analysis (PCA) of genotypes to determine the number of 
independent tests. The number of independent single-SNP tests was based on the number of 
PCA needed to capture 99.5% of the genetic variance (Gao et al., 2008). Genotype data from 
each PRRSV isolate dataset were split between chromosomes, then further divided to create 
chromosomal segments containing a number of SNPs equal to half of the number of animals in 
the respective dataset. We then used R (R Core Team, 2015) to determine the number of PCA 
required to explain 99.5% of the variance of SNP genotypes in each chromosomal segment. The 
summed number of PCA across all chromosomes was considered to be the number of 
independent tests and used to designate Bonferroni corrected p-value thresholds to determine 
significance of associations in the single SNP analyses. PCA results by chromosome are in  
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Supplemental Table 4.1. An alternative genome-wide significance threshold was calculated 
based on a modified Bonferroni correction as !.!"! !"#$ = 0.0002 (Mantel, 1980).  
Further analysis of specific genomic regions. Genes located within 500, 250, or 100 kb 
of SNPs based on Sus scrofa genome build 10.2 
(http://www.ensembl.org/Sus_scrofa/Info/Index?db=core) with p-value (P) <0.001, P<0.003, or 
P<0.01, as determined by single SNP analyses, with the addition of the WUR region on SSC 4, 
were compiled into gene lists to perform functional analyses. Resulting gene lists were analyzed 
for enrichment of GO annotation terms using the GO Slim categories in the Panther software (Mi 
et al., 2013). Both the complete GO terms and a “Slim” set of terms in both the Biological 
Process (BP) and Molecular Function (MF) components of the GO were used for annotation 
enrichment analysis. The Slim approach uses a limited set of GO terms that provides a broad 
coverage of the GO annotation (Mi et al., 2013). Panther GO Slim is a selected subset of the 
complete gene ontologies, which give an overview of the ontologies and remove the very 
specific detailed terms. Overrepresentation of GO terms was tested using the binomial 
distribution function (Cho and Campbell, 2000). Lists of genes within 500, 250, or 100 kb of all 
52,386 SNPs used in the GWAS analyses were used as backgrounds for the selected SNP lists 
for each respective window size. Resulting p-values for the enrichment of genes within a GO 
term were Bonferroni corrected by multiplying the p-value for each term within a category by 
the total number of terms in the category (Sham and Purcell, 2014); 257 for biological process 
Slim, 223 for molecular function Slim, and 177 for pathways.  
The 10 most overrepresented GO terms for each gene list (500 kb surrounding SNPs with 
P<0.001, 500 kb surrounding SNPs with P<0.003, etc.) were compared to determine the 
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significance threshold and window size that resulted in gene lists that were most overrepresented 
for functionally relevant biological process slim (BPS) GO terms (Supplemental tables 4.2 to 
4.5). The top 10 enriched BPS GO terms in lists of genes within 250 kb of SNPs with P<0.003 
contained 5 (KS06 VL), 8 (NVSL VL), 6 (KS06 WG), and 6 (NVSL WG) terms that were 
considered biologically relevant or were found to be enriched in similar phenotypes analyzed in 
other studies (Oliveira et al., 2014; Li et al., 2015; Schroyen et al., 2015). Overrepresentation of 
GO terms in Panther GO Slim and Complete categories of biological process and molecular 
function and Panther pathways of genes within 250 kb of SNPs with P<0.003 was assessed using 
Panther (Mi et al., 2013).  
Results 
In total, 2,288 commercial crossbred piglets from 8 genetic backgrounds were infected 
with one of two PRRSV isolates. Piglets averaged 26.6 (±2.4) days of age and weighed 7.2 
(±1.4) kg at the time of infection. Of this total, 1,557 piglets were infected with NVSL, with an 
average weight of 7.3 (±1.4) kg and 26.6 (±2.6) days of age at inoculation. VL in the NVSL 
trials was on average 107.0 (±8.4) units and average WG was 14.9 (±5.0) kg. The 731 piglets 
infected with KS06 averaged 26.7 (±1.9) days of age and weighed an average 6.8 (±1.3) kg at the 
time of inoculation. VL in the KS06 trials was lower, at an average of 104.6 (±8.9) units, and 
WG was higher, at an average of 19.5 (±4.3) kg, in comparison to that of NVSL trials. A more 
detailed description of the populations used in each trial is in Table 4.1. 
Trait heritabilities 
Using Bayes-B, the 52,386 SNPs together explained 53% and 48% of the phenotypic 
variance for VL in the KS06 and NVSL data, respectively, and 37% and 39% of the phenotypic 
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variance for WG in these respective datasets. When genotype at the WUR SNP was fitted as a 
fixed effect and SNPs within 2.5 Mb on either side of the WUR SNP excluded from the analysis, 
marker based heritabilities decreased 2% on average. Excluding the SSC 4 QTL region, the top 
50, 22, 62, and 26 1-Mb windows explained 10% of the genetic variance in the KS06 VL, NVSL 
VL, KS06 WG, and NVSL WG datasets, respectively. The 1 Mb window containing the SSC 4 
QTL explained 8.2%, 14.4%, 0.05%, and 10.4% of the genetic variance when genotype at the 
WUR SNP was not fitted as a fixed effect but is included as a random effect in Bayes-B. Table 
4.2 shows heritability and litter effect estimates from ASReml analyses of WG and VL in the 
two isolate datasets. Pedigree based heritability estimates were moderate and slightly higher for 
VL than for WG for both PRRSV isolates. These were estimated with the model used for GWAS 
in this study. When genotype at the WUR SNP was removed from the model, heritability 
estimates increased slightly. Litter effects were around 0 for WG and for VL in the KS06 data, 
and were larger for VL in the NVSL data (Table 4.2).  
Genome wide association studies 
Principal components analysis (PCA) determined that the number of principal 
components required to explain 99.5% of the genetic variation was 20,492, 21,658, and 22,708 
for KS06, NVSL, and the combined datasets, respectively (Supplemental Table 4.1). The 
resulting 5% Bonferroni-corrected genome-wide statistical significance thresholds were 2.4x10-6, 
2.3 x10-6, and 2.2 x10-6 for the KS06, NVSL, and combined datasets, respectively.  
Manhattan plots of the Bayesian and single SNP GWAS results for VL are shown in 
Figure 4.1, and information on the top genomic regions identified by each method are in Table 
4.3. Genotype at the WUR SNP was fitted as a fixed effect in all models, which explains the 
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absence of peaks on SSC 4. To compare the identified regions from the two GWAS methods, we 
plotted the largest –log10(P) for each 1-Mb window from the single SNP analysis against the % 
GV explained by that window using the Bayesian method (Supplemental Figures 4.1 to 4.4). 
These comparison plots showed that several of the most significantly associated windows were 
identified by both methods but, overall, more regions were shown to be moderately associated 
based on the single-SNP method. 
For VL in the KS06 data, Bayes-B and single SNP analyses identified the 57 Mb window 
of SSC 3 (3_57) as the most strongly associated genomic region (apart from WUR), explaining 
1.2% GV in the Bayes-B analysis and having a p-value of 5x10-6 in the single SNP analysis. 
Windows 7_35 and 7_30 explained the second and third highest percentage of GV in Bayes-B, 
0.82 and 0.32%, respectively; these regions were also associated with VL in the KS06 data in 
single SNP analysis (P=9x10-6; Table 3). Single SNP analysis also identified associations in the 
9_80, 11_28, 12_26, 14_17, and 15_84 regions (P<2.2x10-5), although none of these reached 
genome-wide significance after Bonferroni correction; these regions explained between 0.03 and 
0.13% GV in the Bayes-B analysis. 
For VL in the NVSL data, the two most significantly associated regions, 6_79 and 6_80, 
were identified by both Bayes-B (1% GV; Figure 4.1A) and single SNP analysis (P<1.6x10-7; 
Figure 4.1B); other regions were not consistently identified by both GWAS methods. A third 
region on SSC 6 at Mb 67 was identified only in the single SNP analysis (P=1.6x10-7; Figure 
4.1B). Results from Bayesian analysis of VL in the NVSL data also showed a region on 1_292 
that explained 1.76% GV (Figure 4.1A). Single SNP analysis also identified a genomic region on 
SSC 1 at 247 Mb to be associated with VL in the NVSL data (P=2.5x10-7; Figure 4.1B), 45 Mb 
upstream of the Bayes-B identified region.  
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Figure 4.2 shows Manhattan plots of the Bayesian and single SNP GWAS for WG; 
information on the top regions is in Table 4.4. For WG in the KS06 data, there were no regions 
that were identified by both Bayes-B and single SNP analysis. In fact, Bayes-B results showed 
no regions that explained more than 1% GV (Figure 4.2A) and no SNP reached genome-wide 
significance in the single SNP results (Figure 4.2B). The two most significantly associated 
regions from single SNP analysis were 13_59 and 10_52 (P=1.5x10-5), which explained 0.4 and 
0.06% GV in the Bayes-B analysis, respectively. The region identified by Bayes-B as explaining 
the largest % GV, 0.86%, was at 7_113; this region was not found to be strongly associated in 
the single SNP results (P=0.02). 
For WG in the NVSL data, figure 4.2A shows that windows on 5_68 and 7_35 explained 
more than 1% GV in the Bayes-B analysis, but these regions were not strongly associated in the 
single SNP analysis (P>0.005; Figure 4.2B). The most significant single SNP association was at 
17_22 (P=6.5x10-6); this window explained 0.8% GV in the Bayes-B analysis. 5_71 was shown 
to be moderately associated with WG in the NVSL data based on both Bayes-B (0.55% GV) and 
single SNP methods (P=3.3x10-5).  
Interaction GWAS 
There was no overlap of significantly associated regions between the two PRRSV isolates 
analyzed in this study. Supplemental Figures 4.5 and 4.6 show the max -log10(P) from single 
SNP analysis for each 1-Mb window corrected for the number of SNPs in that window for VL 
and WG, respectively, in the NVSL data versus the KS06 data. For VL, the most significantly 
associated regions in the NVSL data had very weak associations in the KS06 data, and vice  
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versa. For WG, 9_80 was associated in both isolates, but did not reach genome-wide significance 
in either dataset.  
We used single SNP analysis to assess the interaction of SNP genotypes with PRRSV 
isolate and with genotype at the WUR SNP in the combined dataset (Figure 4.3A); information 
on regions with strongest interactions is in Table 5. Genomic regions with the most significant 
interaction effects between PRRSV isolate and SNP genotype on VL were at 14_16, 7_33, 7_39, 
and 12_32 (Figure 4.3A). The 12_32 and 14_16 regions were found to be associated with VL in 
the KS06 data (P=0.0001 and 0.24% GV; P=5x10-5 and 0.31% GV, respectively) but not in the 
NVSL data (P=0.01 and 0.11% GV; P=0.01 and 0.11% GV, respectively). None of these regions 
reached genome wide significance for interaction with PRRSV isolate after Bonferroni 
correction.  
Figure 4.3B shows the Manhattan plot for the interaction of genotype at each SNP with 
PRRSV isolate for WG. SSC 17_22 was shown to have a genome-wide significant interaction 
with PRRSV isolate for WG (P=1.6x10-6). This region had the most significant association with 
WG in the NVSL data (P=6.5x10-6 and 0.8% GV) but was not associated with WG in the KS06 
data (P=0.01 and 0.07% GV). Although not genome-wide significant, peaks for interactions of 
SNP genotype with PRRSV isolate were seen on 10_53, 11_43, and 11_52 (P>1x10-5). The 
10_52 region, one Mb upstream of the isolate interaction region, was associated with WG in the 
KS06 data (P=1.5x10-5 and 0.4% GV) but was not strongly associated with WG in the NVSL 
data (P=0.001 and 0.16% GV). Neither region on SSC 11 with strong isolate interaction effects 
was strongly associated with WG in either isolate dataset (P>0.01 and between 0.03 and 0.16% 
GV). 
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Figure 4.4A shows the Manhattan plot of the interaction of each SNP with WUR 
genotype for VL. There were 22 SNPs, in 13 different 1-Mb windows, that reached genome-
wide significance for their interaction with genotype at the WUR SNP for VL. These 13 regions 
were on 5 chromosomes, SSC 1_78, 156, and 171, SSC 4_1, 96, 97, 126, 131, and 132, SSC 
9_138, SSC 14_125 and 137, and SSC X_11. Interactions of SNPs with WUR genotype for WG 
were identified on 1_35, 6_28, 13_199, 18_42, and X_98 (P<8x10-5; Figure 4.4B). None of these 
reached genome-wide significance for their interaction with WUR genotype after Bonferroni 
correction.  
GO term enrichment 
Panther (Mi et al., 2013) was used to analyze the enrichment of GO terms in lists of 
genes within 500, 250, or 100 kb of SNPs associated with the trait in question with P less than 
0.0001, 0.003, or 0.01 based on single SNP analyses. Details for gene lists for each scenario are 
in Table 4.6. The ten most enriched GO terms from the Panther Biological Process Slim (BPS) 
category for each scenario were compared to determine the SNP significance threshold and 
window size for further analyses (Supplemental Tables 4.2 to 4.5). Based on the consistent 
enrichment of biologically relevant BPS terms (Supplemental Tables 4.2 to 4.5), all further 
analyses were performed using gene lists created genes within 250 kb of SNPs with P<0.003. 
Results of overrepresentation of Panther GO Slim terms for each gene list are presented in tables 
4.7 to 4.10. Results from enrichment testing using the complete GO categories are in 
Supplemental Tables 4.6 and 4.7 for VL and WG, respectively. 
The most enriched GO Slim terms for VL for each PRRSV isolate are in Table 4.7; the 
complete GO analysis is available in Supplemental Table 4.6. The 3 BPS and 1 Molecular 
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Function Slim (MFS) GO terms most enriched in the gene list for VL in the KS06 data were also 
shown to be enriched in the NVSL VL gene list. The consistently enriched BPS GO terms were 
natural killer cell activation, immune response, and B cell mediated immunity; the MFS GO term 
enriched in both PRRSV isolate gene lists was binding. An additional 7 BPS and 4 MFS GO 
terms were enriched in the NVSL VL gene list. 
The most enriched GO terms for WG are in Table 4.8, with the enriched Complete GO 
terms in Supplemental Table 4.7. After Bonferroni correction, there were no GO terms that were 
significantly enriched in the KS06 WG gene list. Several metabolic process terms were enriched 
in the NVSL WG gene list, although only nucleobase-containing compound metabolic process 
was significantly enriched after Bonferroni correction (P=1 x10-4). Genes involved in the 
molecular function of nucleic acid binding were also enriched in the NVSL WG list (P=1 x10-4). 
The CCKR signaling map pathway was also enriched in the NVSL WG gene list (P=9.5x10-4).  
 Genes near SNPs whose association with VL had an interaction with PRRSV isolate 
were enriched for several metabolic process BPS GO terms (Table 4.10), while genes near SNPs 
whose association with WG had an interaction with PRRSV isolate were enriched for several 
immune function related GO terms. There were no GO terms that were consistently enriched in 
gene lists based on SNPs with interaction effects with PRRSV isolate for VL and WG. 
There were over 1,700 SNPs whose association with VL had an interaction with genotype 
at the WUR SNP at –log10(P)>2.5 and there were 4,599 genes within 250 kb of these SNPs, 
which was approximately 4 times as large as the gene lists created with these criteria for VL and 
WG in each PRRSV isolate dataset (Table 4.6). We would not expect such a large number of 
genes to have differential effects on VL in animals with different genotypes at the WUR SNP, 
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and this large list likely contains many false positives. Furthermore, an extremely large gene list 
decreases power to detect GO term enrichment. Therefore, we increased the significance 
threshold of SNP association for the interaction with genotype at the WUR SNP for VL and 
created a list of genes within 250 kb of the 383 SNPs with -log10(P)>4, resulting in a similar 
number of genes (1,048) as the other lists analyzed in this study. This list was enriched for 
enzymatic GO terms (Table 4.11). For WG, genes near SNPs with interactions with WUR 
genotype at –log10(P)>2.5 were not enriched for any BPS or MF GO terms. 
Discussion 
We used Bayesian and single SNP GWAS methods to identify genomic regions 
associated with host response to experimental infection with two different isolates of PRRSV. 
Several genomic regions were found to be consistently associated with the disease traits across 
analysis methods, but single SNP analysis was better able to detect small effects than Bayes-B. 
This result is in part due to the fact that Bayes-B analysis was performed with a prior probability 
of association for each SNP equal to 0.01. Bayes-B analysis fitted all SNPs simultaneously as 
random effects, whereas single-SNP analysis fitted each SNP at a time as a fixed effect. The 
single SNP method that was employed in this study also allowed for other random effects, 
whereas the current version of GenSel, which was used for the Bayes-B analyses does not allow 
fitting of random effects, other than those of SNP effects. Neither Bayes-B nor single SNP 
analysis found regions that were associated with either trait in both PRRSV isolates. This result 
was unexpected, due to the high genetic correlations between isolates estimated by Hess et al. 
(2015). This discrepancy may be due to the genetic correlation resulting from many very small 
pleiotropic effects that are not detected by GWAS, as shown by the mass of small associations in 
Supplemental Figures 4.5 and 4.6.  
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Genotype at the WUR SNP was fitted as a fixed effect to account for the highly significant effect 
of the SSC 4 QTL. Very few SNPs in other genomic regions reached genome-wide significance 
in the single SNP analysis and the genetic variance explained by 1-Mb windows in the Bayesian 
analyses was very small; their association may be considered spurious if not for results from 
functional analysis of neighboring genes. Immune and weight gain related traits are very 
complex and involve actions and interactions of a large number of genetic loci. Creating gene 
lists from genes nearby SNP associated with each trait and performing gene ontology term 
enrichment of these lists provided further evidence of associations. 
Viral Load 
GWAS revealed regions on 3_57, 7_30, 7_35, 9_80, 11_28, 12_26, 14_17, and 15_84 to 
be associated with VL in the KS06 data; 1_247, 1_292, 3_68, 3_72, 3_128, 6_67, 6_69, 6_80, 
and 15_7 were associated with VL in the NVSL data (Table 4.3).  Immune related QTL were 
found in 19 of the top 21 regions identified for VL in either PRRSV isolate; selected regions are 
further described in the following. 
The region on 1_292 was the only genomic region previously identified by Boddicker et 
al. (2014b) as being associated with VL in the first 8 trials of NVSL infected piglets, apart from 
the WUR region. Boddicker et al. (2014b) identified 1_292 using the Bayes-B method, which is 
the same GWAS method that identified this QTL in this study; single-SNP GWAS did not show 
a strong association for this region. Genes in the 1_247 region include DOCK8, dedicator of 
cytokinesis 8, which, when mutated in humans, causes combined immunodeficiency (Engelhardt 
et al., 2009). DOCK8 deficiency in a mouse knockout model leads to a loss of circulating NKT 
cells (Crawford et al., 2013). DOCK8 was also identified as a member of a gene module whose 
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expression was correlated with viremia at 4 and 7 dpi (Schroyen et al., 2015). A QTL for white 
blood cell counts was located in the region on 1_247 (Wattrang et al., 2005; Cho et al., 2011). 
GNG11, located at 9_80, plays a role in cellular senescence and shows expression changes 
during cellular stress (Hossain et al., 2006). GNG11 was shown to have differential expression in 
response to PRRSV infection (Badaoui et al., 2013). The 9_80 region also contained a QTL for 
immunoglobulin G level (Okamura et al., 2012). STAMBP (AMSH), located at 3_72, interacts 
with STAM and other proteins involved in cytokine signaling (Tanaka et al., 1999). QTL for C3c 
concentration (Wimmers et al., 2009) and IFN-γ and IL-10 levels (Uddin et al., 2011) were 
found in the 3_72 region. The 11_28 region identified for KS06 VL using single SNP analyses 
contains a QTL for IFN-γ, IL-10, and TLR9 levels in blood after vaccination (Uddin et al., 2010; 
Uddin et al., 2011).  
Genomic regions associated with VL did not overlap between PRRSV isolates, but we 
did see that genes near associated SNPs were enriched for the same GO terms. This indicates that 
associated SNPs are in LD with variants involved in similar biological processes or functions 
across the PRRSV isolates. For both PRRSV isolates, genes near SNPs associated with VL were 
enriched for natural killer cell activation, immune response, and B cell mediated immunity BPS 
GO terms. Additional GO terms were identified as being overrepresented in gene lists from each 
PRRSV isolate, without overlap. The activity of NK cells, specifically via production of IFN-γ, 
are thought to play an important role in clearance of PRRSV and reduction of viral load (Wesley 
et al., 2006). Nineteen and 15 genes in the gene lists for VL in KS06 and NVSL, respectively, 
were involved in NK cell activation. A region on SSC 5_64-65 contained several genes in one or 
both VL lists; including LY49 (KLRA1), KLRD1, KLRF1, KLRG1, CLECL1, CLEC1A, CLEC1B, 
CLEC7A, and CLEC12A. LY49 encodes a receptor found on the NK cell that is involved in 
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response to viral infection (Brown et al., 2001), possibly via their role in apoptosis (Berry et al., 
2013). KLRD1, KLRF1, and KLRG1 are molecules expressed on the NK cell (Li and Mariuzza, 
2014) that have the ability to recognize non-self cells that do not express MHC I (Li et al., 2009). 
The CLEC gene family are C-type lectin receptors that are found on antigen presenting cells and 
act to recognize pathogens and promote cell-cell interactions for effective immune responses 
(McGreal et al., 2005; Kanazawa, 2007).   
VL gene lists also included SLAMF9, JAK3, FCAR, FCRL3, IKBK, PRKRA (PACT), 
PECAM1, and the GBP family genes, all annotated with the immune response GO term. The 
seven genes in the porcine GBP family are in the SSC 4 QTL region, which was previously 
shown to have an effect on VL (Boddicker et al., 2012). Recently, the putative causative 
mutation for the SSC4 QTL was identified in the GBP5 gene (Koltes et al., 2015). IKBK is a 
kinase that is part of the pathway responsible for initiation of the NF-κB signaling cascade, 
which serves as one of the host’s first responses after viral invasion (Amaya et al., 2014). IKBK 
was also shown to be differentially expressed in response to infection with the NVSL PRRSV 
isolate (Schroyen et al., 2015). PACT recognizes RNA viruses and acts with RIG-I to stimulate 
IFN production during an immune response against a virus (Kok et al., 2011; Kok and Jin, 2013). 
SLAMF9 is a member of the Signaling Lymphocyte Activation Molecule receptor family, which 
are NK cell receptors that affect T cell responses to viral infection (Waggoner and Kumar, 2012). 
SLAMF9 was shown to be differentially expressed in response to PRRSV infection in an 
independent dataset (Badaoui et al., 2013). PECAM1 mediates adhesion of leukocytes to other 
cells and permits movement of leukocytes through endothelial walls (Proust et al., 2014).  
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Weight Gain  
GWAS identified regions on 7_113, 10_52, 13_59, and 13_214 were found to be 
associated with WG in the KS06 data; 1_15, 5_68, 5_71, 7_35, 7_39, 10_46, and 17_22 were 
associated with WG in the NVSL data. Production related QTL, such as average daily again and 
weight gain, were found in 24 of the top 25 regions associated with WG in either PRRSV isolate.  
The MX1 gene is located in the 13_214 region and has been shown to be associated with 
the initial defense mechanisms employed by macrophages upon PRRSV infection (Chung et al., 
2004). Furthermore, variations in the MX1 promoter were associated with increased MX1 gene 
expression, which could be expected to result in heightened immune response to PRRSV and 
possibly more resistant pigs (Y. Li et al., 2015). The 1_15 region contains the VIP (vasoactive 
intestinal peptide) gene. The VIP pathway was shown to be associated with obesity in humans 
(Liu et al., 2010). GLO1, located in 7_39, was associated with body weight in mice (Wuschke et 
al., 2007). The 17_22 region contains an interesting candidate gene, MKKS, as MKKS null mice 
were shown to weigh more and consume a greater amount of food compared to wild-type 
littermates (Fath et al., 2005). In addition, certain MKKS haplotypes were associated with obesity 
and metabolic syndrome in a Greek human population (Rouskas et al., 2008). QTL for pig 
weaning weight (Guo et al., 2008) and live weight at slaughter (Pierzchala et al., 2003) have also 
been identified in this region on SSC17. Nagamine and others (2003) mapped several growth 
related QTL to SSC7.  
Similar to results for VL associations, no genomic regions were identified to be 
associated with WG for both PRRSV isolates; however, we did not see overlap of 
overrepresented GO terms across PRRSV isolates for WG. The WG phenotype analyzed in this 
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study is more accurately be described as WG after infection with the PRRSV; therefore, we 
could expect the severity of PRRSV infection to have a negative relationship with WG. Genes 
near SNPs associated with WG in the NVSL data were enriched for several metabolic process 
BPS, several binding related MFS GO terms, and the CCKR signaling map pathway. Genes in 
the metabolic process GO term included FOXO3, INPP5F, PRKCQ, LIPC, BMP7, HMGA1, and 
NLK. The gene FOXO3 has been shown to be involved in growth retardation of piglets born to 
sows fed low protein diets during their gestation and lactation (Jia et al., 2015). Different 
INPP5F genotypes were associated with ADG in purebred Yorkshire gilts (Zhou et al., 2009). In 
addition, INPP5F was shown to have differential expression during PRRSV infection in a meta-
analysis (Badaoui et al., 2013). PRKCQ has been shown to be associated with obesity in mice, 
through insulin resistance (Serra et al., 2003; Gao et al., 2007). LIPC is an enzyme that is 
important in energy homeostasis, and was shown to affect weight gain in mice (Chiu et al., 
2010). BMP7 affects brown adipose tissue development and plays a role in obesity (Tseng et al., 
2008; Townsend et al., 2012). HMGA1 was shown to be associated with body mass index in 
Hispanic women (Graff et al., 2013). NLK variants were shown to be associated with fat body 
mass (Pei et al., 2014). The CCKR (cholecystokinin receptor) pathway is activated in response to 
food consumption and act to regulate gastrointestinal secretions and motility (Wank, 1995).  
Boddicker et al. (2012, 2014a, 2014b) estimated moderately negative phenotypic and 
genetic correlations between WG and VL in the NVSL data; phenotypic correlation estimates 
ranged from -0.25 to -0.29 and genotypic correlation estimates ranged from -0.31 to -0.46. We, 
however, did not identify any associated genomic regions that overlapped between WG and VL 
for either PRRSV isolate; however, we did find that the NVSL gene lists for WG and VL were 
both enriched for the binding molecular function GO term. In addition, the KS06 WG gene list 
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was enriched for antigen processing and presentation of peptide or polysaccharide via MHC 
class II.  
Interaction GWAS 
Regions associated with VL on 14_16, 7_33, 7_39, 12_32, and 9_36 had the strongest 
interaction effect with PRRSV isolate; for association with WG, SNPs at 17_22, 10_52, 11_43, 
11_52, and 7_113 showed interaction effects with PRRSV isolate. Several of these regions were 
associated with these respective traits in GWAS results using data from only one PRRSV isolate.  
The most notable result from the interaction GWAS was the identification of 13 regions 
with genome-wide significant associations for the interaction with genotype at the WUR SNP for 
VL. Candidate genes in these regions included DEDD, SLAMF6 (NTBA), CD48, CD244 (2B4), 
and LY9 at SSC 4_96 and LY6H at SSC 4_1. The DEDD (death effector domain containing) gene 
is involved in apoptosis (Alcivar et al., 2003). SLAMF6 plays a role in the activation of NK and 
T cells (Flaig et al., 2004; Valdez et al., 2004). CD244 is a receptor of NK cells whose ligand is 
CD48, expressed on T cells; both of these molecules are involved in lymphocyte activity 
(Pacheco et al., 2013; Kis-Toth and Tsokos, 2014). LY9 is another member of the SLAM family 
involved in mediating innate T cell function (Sintes et al., 2013).  
We expected to see enrichment of genes in GO terms related to GBP family protein 
functions in the gene lists created from the interactions of SNP genotypes with genotype at the 
WUR SNP, which is in LD with a putative causative mutation in the GBP5 gene (Koltes et al., 
2015). Instead, results showed enrichment for blood coagulation, proteolysis, and several 
peptidase activity GO terms. The interferon-inducible GBP family genes are annotated instead 
with cytokine-signaling, interferon signaling, cellular response to interferon gamma, defense 
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response to virus, and metabolic process GO terms. Thus, it is not clear how genes involved in 
blood coagulation, proteolysis, and peptidase activity functions could have differential effects 
based on genotype at the WUR SNP. Furthermore, there were no genes in the VL or WG gene 
list for interaction with genotype at the WUR SNP that were known to have protein interactions 
with any member of the GBP protein family. 
We also assessed the enrichment of WUR interaction gene lists for genes shown to be DE 
based on genotype at the WUR SNP in RNA sequencing data collected on 18 pigs infected with 
the NVSL isolate (Koltes et al., 2015). Seventeen and 13 of the 516 genes that were DE by WUR 
genotype were within 250 kb of SNPs whose association with VL and WG, respectively, had an 
interaction with genotype at the WUR SNP at –log10(P)>4 (VL) or 2.5 (WG; data not shown). 
DE genes by WUR genotype in the RNA sequencing data were not overrepresented in either of 
our WUR interaction gene lists (P>0.05).  
Value of functional annotation of GWAS results 
Single SNP analyses revealed 0, 2, 0, and 0 mapped genomic regions that reached 
genome-wide significance for KS06 VL, NVSL VL, KS06 WG, and NVSL WG, respectively. 
Few candidate genes were identified by looking at genes located in regions surrounding the most 
significantly associated SNPs. Thus, we created gene lists using a relaxed significance threshold 
for SNPs and assessed the enrichment of genes assigned to GO annotation terms in these lists. 
Initially, we analyzed genes within 100, 250, or 500 kb of SNPs associated with the trait at 
thresholds of P<0.001, 0.003, or 0.01. We looked at the top 10 enriched BPS GO terms for each 
scenario and chose the middle stringency threshold (P<0.003) and medium sized window (250  
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kb) to use for further analysis based on consistency of enriched terms across combinations of 
variables and based on the biological relevance of the enriched GO terms.  
Several biologically relevant GO terms were shown to be enriched in our lists, which 
provided a larger set of candidate genes consisting of genes with the given GO term annotation 
within 250 kb of SNPs associated with the trait at P<0.003. Several of the genes identified 
through this method were differentially expressed in response to PRRSV infection in other 
studies. The use of annotation information provided greater insight into genomic regions that 
may play a role in piglet response to PRRSV. This method was especially useful in interpretation 
of the complicated immune response related traits analyzed here, for which many genes may 
have small effects on phenotype, which may be undetectable when considered individually but 
by grouping the effects of genes that play a role in the same biological function or pathway, 
larger effects on the phenotype may be detected. These results may be useful for creating subsets 
of SNPs to be used in genomic prediction or selection, in an effort to reduce noise of unrelated or 
unassociated SNPs, while keeping SNPs that have small effects on the phenotype.  
We also tested the enrichment of our lists for genes that were shown to be differentially 
expressed (DE) in the blood of pigs selected from three NVSL trials at 4 or 7 dpi compared to 0 
dpi by Schroyen et al. (2015). The Pigoligoarray (Steibel et al., 2009) was used to measure gene 
expression in the blood of 100 pigs that were selected based on their assignment to one of four 
phenotypic groups after infection with the NVSL isolate (high VL with high WG, high VL with 
low WG, low VL with high WG, and low VL with low WG). Schroyen et al. (2015) found that 
239 and 165 genes were differentially expressed (FDR=0.10) at 4 and 7 dpi, respectively, 
compared to 0 dpi (Supplemental tables 1 and 2 in Schroyen et al., 2015). We did not find a 
statistically significant overrepresentation of DE genes in any of our analyzed gene lists, but 
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several of the candidate genes that we identified (Table 4.9) were present in the DE list. 
Furthermore, there were genes in our gene lists that were members of gene modules whose 
overall expression was correlated with either VL or WG, as shown in Table 4.9 (Figure 3 in 
Schroyen et al., 2015).  
We also compared our gene lists to results from two meta-analyses of pig immune 
response: 1. Dawson et al. (2013) expanded the pig immunome annotation through analysis of 
data from 188 Affymetrix 24K microarray chips from several studies of in vivo or in vitro 
immune stimulation, 2. Badaoui et al. (2013) used 779 chips from 29 studies to identify genes, 
pathways, and biological functions involved in immune response of pigs. Several genes in the 
gene lists analyzed in the current study were also in the gene lists from Dawson et al. (2013) or 
Badaoui et al. (2013), though not more than expected at P=0.05. The gene lists analyzed in the 
current study contained 1 (VL) and 10 (WG) genes that were members of a cluster of 511 gene 
transcripts that were DE in response to immune stimuli and had enriched GO terms related to 
immune function (Supplemental Table 6 in Dawson et al., 2013). Two (VL) and 2 (WG) and 
genes in our lists were contained in the 139 DE genes for general immune response, and 1 (VL) 
and 17 (WG) genes in our lists were contained in the 537 DE genes for response to PRRSV 
infection (Supplemental file 10, Table S8 in Badaoui et al., 2013). 
Conclusions 
We found several genomic regions associated with response to experimental infection 
with one of two isolates of the PRRSV that were consistently identified using both single SNP 
and Bayesian GWAS methods. We did not find genomic regions that were significantly 
associated with piglet response for both PRRSV isolates; however, we did find that genes near 
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associated SNPs were enriched for the same GO terms for both PRRSV isolates. This indicates 
similar biological mechanisms are involved in the response to both PRRSV isolates.  
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Figures 
 
Figure 4.1 Genome wide association results for VL using single SNP and Bayes-B analyses. (A) 
Bayes-B results showing the percent of genetic variance explained by 1-Mb non-overlapping 
windows of SNPs across chromosomes for KS06 (top) and NVSL (bottom). (B) Single SNP 
analysis results showing the -log10(p-value) of ordered SNPs across chromosomes and for 
unmapped (U) SNPs for KS06 (top) and NVSL (bottom). Dashed lines indicate genome wide 
significance at a Bonferroni corrected p-value of 0.05.  
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Figure 4.2 Genome wide association results for WG using single SNP and Bayes-B analyses. 
(A) Bayes-B results showing the percent of genetic variance explained by 1-Mb non-overlapping 
windows of SNPs across chromosomes for KS06 (top) and NVSL (bottom). (B) Single SNP 
analysis results showing the -log10(p-value) of ordered SNPs across chromosomes and for 
unmapped (U) SNPs for KS06 (top) and NVSL (bottom). Dashed lines indicate genome wide 
significance at a Bonferroni corrected p-value of 0.05. 
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Figure 4.3 Manhattan plots of  –log10(P) of the main (top) and interaction (bottom) of SNP 
genotype with PRRSV isolate for VL (A) and WG (B) across chromosomes and unmapped (U) 
SNPs. Dashed lines indicate genome wide significance at a Bonferroni corrected P of 0.05. 
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Figure 4.4 Manhattan plots of  –log10(P) of the main (top) and interaction (bottom) of SNP 
genotype with genotype at the WUR SNP for VL (A) and WG (B) across chromosomes and 
unmapped (U) SNPs. Dashed lines indicate genome wide significance at a Bonferroni corrected 
P of 0.05. 
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Supplemental Figure 4.1 Comparison plot of the largest –log10(P) in each 1-Mb window based 
on the single-SNP analysis for KS06 Viral Load against the percent of genetic variance 
explained by that window from Bayes-B. 
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Supplemental Figure 4.2 Comparison plot of the largest –log10(P) in each 1-Mb window based 
on the single-SNP analysis for NVSL Viral Load against the percent of genetic variance 
explained by that window from Bayes-B.
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Supplemental Figure 4.3 Comparison plot of the largest –log10(P) in each 1-Mb window based 
on the single-SNP analysis for KS06 Weight Gain against the percent of genetic variance 
explained by that window from Bayes-B. 
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Supplemental Figure 4.4 Comparison plot of the largest –log10(P) in each 1-Mb window based 
on the single-SNP analysis for NVSL Weight Gain against the percent of genetic variance 
explained by that window from Bayes-B. 
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Table 4.3 Top 1-Megabase (Mb) genomic regions associated with Viral Load in the KS06 
and NVSL trials. 
  Single SNP GWAS Bayes-B GWAS   
Chr. Pos. 
(Mb) 
Largest 
 –log10(P) 
Rank Genetic 
Variance(%) 
Rank Candidate 
Genes 
QTL 
KS06       
3 57 5.3 1 1.2 1  WBC counts1 
7 30 5.3 1 0.32 3  Lymphocyte number2 
7 35 5.0 2 0.82 2  Lymphocyte number2 
3 53 5.0 2 0.03 25  WBC counts1 
14 17 5.0 3 0.09 19  C3c concentration3 
11 28 5.0 3 0.03 25  IFN-γ level, IL-10 
level, IL-2 level, TLR 
2 level, TLR 9 level4 
12 26 4.9 4 0.13 15  IL-10 level 
TLR 2 level 
TLR 9 level4 
15 84 4.7 5 0.06 22  CD4+/CD8+ leukocyte 
ratio2 
9 80 4.7 5 0.02 26 GNG11 Immunoglobulin G1 
14 16 4.3 8 0.31 4  C3c concentration3 
12 32 3.9 15 0.24 5 MMD IL-10 level 
TLR 2 level 
TLR 9 level4 
7 32 3.5 36 0.24 5  Lymphocyte number2 
NVSL       
6 79 7.6 1 1.0 3  IL-2 level4 
6 80 6.8 2 1.0 2  IL-2 level4 
6 67 6.8 2 0.3 34  IL-2 level4 
1 247 6.6 3 0.2 35 DOCK8  WBC counts6 
3 68 5.4 4 0.3 34  C3c concentration3 
IFN-γ level4 
IL-10 level4 
3 128 4.7 5 0.16 21   
1 292 1.9 428 1.76 1  C3c concentration3 
PRRSV susceptibility7 
3 72 3.1 32 0.65 4 STAMBP C3c concentration3 
IFN-γ level4 
IL-10 level4 
15 7 2.3 200 0.6 5   																																																								
1 Okamura et al., 2012; 2 Reiner et al., 2008; 3 Wimmers et al., 2009; 4 Uddin et al., 2011; 5 Lu et 
al., 2011; 6 Wattrang et al., 2005; Cho et al., 2011; 7 Boddicker et al., 2011 
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Table 4.4 Top	1-Megabase	(Mb)	genomic	regions	associated	with	Weight	Gain	in	the	
KS06	and	NVSL	trials. 
  Single SNP 
GWAS 
Bayes-B GWAS   
Chr. Pos. 
(Mb) 
Largest –
log10(P) 
Rank Genetic 
Variance (%) 
Rank Candidate 
Genes 
QTL 
KS06 
13 59 4.82 1 0.06 22  ADG1,2 
10 52 4.82 1 0.4 3  ADG2,3 
Body weight4,5,6 
FCR7 
4 6 4.80 2 0.09 19  ADG2,4,8 
Body weight4,5,9,10 
9 90 4.80 2 0.03 25  ADG11 
Body weight6 
15 140 4.61 3 0.04 24  ADG4,12,13 
12 46 4.61 3 0.11 17  Body weight4,14 
ADG2 
4 5 4.43 4 0.24 6  ADG2,4,8 
Body weight4,5,9 
FCR7 
9 88 4.43 4 0.03 25  ADG11 
Body weight6 
7 2 4.41 5 0.04 24  ADG8 
8 26 4.41 5 0.16 12  ADG2,15,16 
Body weight6,14,15 
7 113 1.77 572 0.86 1  ADG8 
Body weight19 
13 214 3.9 14 0.43 2 MX1 Body weight21 
13 6 2.43 150 0.28 4  ADG1,3 
11 23 3.41 28 0.25 5   
NVSL 
17 22 5.19 1 0.8 4 MKKS Body weight19,25 
7 39 4.89 2 0.17 20 GLO1 ADG4,8,12,16,17,20 
Body weight4,6,17,19,20,21 
1 15 4.89 2 0.04 33 VIP Body weight15,25 
ADG2,3 
9 90 4.72 3 0.33 10  Body weight6 
ADG11 9 73 4.72 3 0.04 33  
9 85 4.56 4 0.13 18  
9 84 4.56 4 0.19 24  
9 145 4.56 4 0.04 33  ADG27 
Body weight14,27 
10 46 4.56 4 0.03 34 ZEB1 ADG1,2,3 
Body weight4,5,6 
FCR7 
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Table	4.4	Continued		
5 71 4.48 5 0.55 5 ADIPOR2 Body weight14 
ADG2 
1 22 4.48 5 0.05 32  ADG2,3,12 
Body weight14,19 
5 68 2.28 273 1.19 1  ADG2 
Body weight14,26 
7 35 3.69 21 1.18 2  ADG4,8,12,16,20 
Body weight4,6,17,19,20 
3 138 4.16 9 0.84 3  Body weight19 
PRRSV susceptibility28 																																																								
1Knott et al., 1998; 2de Koning et al., 2001; 3Liu et al, 2007; 4Liu et al., 2008; 5Edwards et al., 
2008; 6Ai et al, 2012; 7Jiao et al, 2014; 8Paszek et al., 1999; 10Choi et al., 2011; 11Duthie et al., 
2008; 12Ruckert et al., 2010; 13Soma et al., 2011; 14Yoo et al., 2014; 15Beeckmann et al., 2003; 
16Evans et al., 2003; 17Bidanel et al., 2001; 18Quintanilla et al., 2002; 19Guo et al., 2008; 
20Sanchez et al., 2006; 21Yue et al., 2001; 22Munoz et al., 2009; 23Harmengnies et al., 2006; 
24Stratil et al., 2006; 25Pierzchala et al., 2003; 26Schneider et al., 2012; 27Cepica et al., 2003; 
28Boddicker et al., 2014b 
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Table 4.5 GWAS results for the interaction of SNP genotype and PRRSV isolate or 
genotype at the WUR SNP. 
Interaction Chr. Pos. (Mb) 
Largest 
–log10(P) 
GWAS 
Rank Candidate Genes 
Viral Load 
PRRSV 
isolate 
14 16 4.93 1  
7 33 4.82 2  
7 39 4.70 3  
12 32 4.58 4  
9 36 4.21 5  
WUR 
genotype 
4 126 8.29 1  
4 131 7.87 2  
14 125 6.93 3  
1 78 6.57 4  
14 137 6.06 5  
X 11 6.05 6  
4 132 5.95 7  
4 96 5.93 8 DEDD, SLAMF6, CD48, CD244, LY9 
1 171 5.81 9  
4 97 5.78 10  
4 1 5.76 11 LY6H 
9 138 5.71 12  
1 156 5.69 13  
Weight Gain 
PRRSV 
isolate 
17 22 5.80 1 MKKS 
10 53 4.93 2  
11 43 4.71 3  
11 52 4.65 4  
7 113 4.38 5  
WUR 
genotype 
13 199 4.88 1  
X 98 4.48 2  
18 42 4.25 3  
6 28 4.25 3  
1 35 4.09 4  
13 19 3.98 5  
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Table 4.6 Information for gene lists created from genes located within 100, 250, or 100 kb 
of SNPs associated with the trait at three –log10(P) thresholds (2, 2.5 and 3) for Viral Load 
and Weight Gain for the KS06 and NVLS isolates.  
 
PRRSV 
Isolate 
-log10(P) 
threshold 
n SNPs with –
log10(P) > 
threshold 
n non-overlapping 
regions 
n pig Ensembl IDs 
(n Ensembl IDs with 
GO annotation) 
500 250 100 500 250 100 
Viral Load 
KS06 
3 215 157 166 187 1576 (1284) 
844 
(706) 
401 
(332) 
2.5 456 305 347 393 3304 (2723) 
937 
(781) 
443 
(369) 
2 1053 567 686 849 6445 (5305) 
3828 
(3170) 
1184 
(1557) 
NVSL 
3 115 88 95 102 1014 (835) 
556 
(461) 
263 
(218) 
2.5 303 208 239 267 2418 (1991) 
1390 
(1140) 
660 
(553) 
2 810 467 566 667 5347 (4441) 
3166 
(2645) 
1542 
(1323) 
Weight Gain 
KS06 
3 116 93 98 106 931 (762) 
514 
(423) 
254 
(210) 
2.5 245 193 208 223 2048 (1686) 
1108 
(916) 
510 
(430) 
2 720 476 554 625 5269 (4306) 
3024 
(2466) 
1451 
(1194) 
NVSL 
3 169 118 127 137 1173 (942) 
592 
(486) 
287 
(238) 
2.5 378 259 282 311 2812 (2291) 
1510 
(1254) 
722 
(613) 
2 958 516 639 770 6075 (4908) 
3555 
(2895) 
1745 
(1439) 
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Table 4.7 Most Enriched GO Terms for the gene lists for Viral Load for the KS06 and 
NVSL isolates. 
 
Category GO Term n Genes in 
List 
Fold 
Enrichment 
P-value Bonferroni 
P-value 
KS06 
Biological 
Process 
Slim 
natural killer cell 
activation 
19 4.9 2.79 x 10-8 6.28 x 10-6 
immune response 37 1.97 1.11 x 10-4 0.025 
B cell mediated 
immunity 
15 2.64 7.91 x 10-4 0.18 
Molecular 
Function 
Slim 
binding 244 1.25 5.22 x 10-5 9.08 x 10-3 
NVSL 
Biological 
Process 
Slim 
 
regulation of 
vasoconstriction 
13 4.92 4.1 x 10-6 9.23 x 10-4 
immune response 51 1.86 2.99 x 10-5 6.73 x 10-3 
metabolic process 484 1.15 6.2 x 10-5 0.014 
lysosomal transport 11 4.27 7.85 x 10-5 0.0177 
primary metabolic 
process 
407 
1.17 9.57 x 10-5 0.0215 
endocytosis 35 1.93 2.44 x 10-4 0.0549 
receptor-mediated 
endocytosis 
23 
2.27 3.26 x 10-4 0.0734 
biological regulation 246 1.23 3.43 x 10-4 0.0772 
B cell mediated 
immunity 
20 
2.41 3.78 x 10-4 0.0851 
natural killer cell 
activation 
15 
2.65 7.68 x 10-4 0.173 
Molecular 
Function 
Slim 
serine-type 
endopeptidase 
inhibitor activity 
20 
4.89 1.30 x 10-8 2.26 x 10-6 
binding 356 1.25 1.36 x 10-6 2.37 x 10-4 
peptidase inhibitor 
activity 
28 
2.73 3.11 x 10-6 5.41 x 10-4 
enzyme inhibitor 
activity 
35 
2.24 1.37 x 10-5 2.38 x 10-3 
receptor binding 74 1.53 2.79 x 10-4 4.85 x 10-2 
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Table 4.8 Most Enriched GO Terms for the gene lists for Weight Gain for the KS06 and 
NVSL isolates. 
 
Category GO Term Fold 
Enrichment 
n Genes in 
List 
P-value Bonferroni 
P-value 
KS06 
Biological 
Process 
Slim 
antigen processing 
and presentation of 
peptide or 
polysaccharide 
antigen via MHC 
class II 
4.95 7 6.25 x 10-4 0.147 
NVSL 
Biological 
Process 
Slim 
nucleobase-
containing compound 
metabolic process 
1.25 238 1.38 x 10-4 0.031 
metabolic process 1.11 514 1.5 x 10-3 0.34 
Molecular 
Function 
Slim 
nucleic acid binding 1.28 200 1.6 x 10-4 0.028 
DNA binding 1.35 130 3.52 x 10-4 0.061 
binding 1.16 365 5.67 x 10-4 0.099 
Panther 
Pathway 
CCKR signaling map 2.29 19 9.52 x 10-4 0.15 
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Table 4.9 Selected candidate genes identified by GO term enrichment.  
 
Candidate Gene Evidence Reference 
KS06 Viral Load   
MYO5A, CFI, FCRL1, 
FCRL4, SLA-DQA1 
Members of gene modules 
correlated with VL 
Schroyen et al. (2015) 
TXNDC9, IKBKB Differentially expressed in blood Schroyen et al. (2015) 
SLAMF9 PRRS specific response Badaoui et al. (2013) 
GBP1 General immune response Badaoui et al. (2013) 
NVSL Viral Load   
CCRL1, CLEC1A, HP, 
SEMA6C, SEZ6L, 
TMEM176A, TMEM176B, 
CCRL1, CLEC1A 
Members of gene modules 
correlated with VL 
Schroyen et al. (2015) 
RHOC  Dawson et al. (2013) 
HSPB1 General immune response Badaoui et al. (2013) 
KS06 Weight Gain   
CDIPT, SLAMF9, NMT1 PRRS specific response Badaoui et al. (2013) 
NMT1, TAP1  Dawson et al. (2013) 
SBF1, TAP1 Differentially expressed Schroyen et al. (2015) 
NVSL Weight Gain   
SSU72, TOP2A General immune response Badaoui et al. (2013) 
TOP2A, CDA, CDK6, EPS15, 
FKBP3, IER3, INPP5F, 
NFIL3, PSMD12, RGS10, 
RHOQ, TAB2, TCEB3, 
WBSCR22 
PRRS Specific response Schroyen et al. (2015) 
ALPK2, CEBPB, CPSF3, 
NEK9, TFAP2A, TXNDC9, 
DDX6 
Differentially expressed Schroyen et al. (2015) 
EIF5B, UBE2V1, CITED2, 
LAPTM4A, LCN2, PLA2G4A 
Members of modules correlated 
with weight gain 
Schroyen et al. (2015) 
AIFM1, ATP11C, CNOT7, 
FUNDC1, HIST1H2BH, 
MOBKL3, MTRF1L, PLA2G6 
 Dawson et al. (2013) 
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Table 4.10 Most enriched GO terms for the interaction with PRRSV isolate for Viral Load 
and Weight Gain. 
 
Category GO Term Fold 
Enrichment 
n Genes in 
List 
P-value Bonferroni 
P-value 
Viral Load 
Biological 
Process 
Slim 
nucleobase-
containing compound 
metabolic process 1.32 260 1.47 x 10-6 3.31 x 10-4 
primary metabolic 
process 1.18 468 1.15 x 10-5 2.59 x 10-3 
metabolic process 1.15 552 1.82 x 10-5 4.10 x 10-3 
transcription from 
RNA polymerase II 
promoter 1.42 129 5.31 x 10-5 1.19 x 10-2 
transcription, DNA-
dependent 1.36 139 1.83 x 10-4 4.12 x 10-2 
regulation of 
transcription from 
RNA polymerase II 
promoter 1.43 98 3.13 x 10-4 7.04 x 10-2 
Molecular 
Function 
Slim 
nucleic acid binding 1.31 212 2.7 x 10-5 4.63 x 10-3 
nucleotide kinase 
activity 3.94 11 1.57 x 10-4 0.027 
sequence-specific 
DNA binding 
transcription factor 
activity 1.41 107 2.81 x 10-4 0.05 
Weight Gain 
Biological 
Process 
Slim 
antigen processing 
and presentation 
> 5 11 2.36 x 10-6 5.31 x 10-4 
pattern specification 
process 
3.02 19 2.94 x 10-5 6.62 x 10-3 
response to 
interferon-gamma 
> 5 8 7.24 x 10-5 0.016 
antigen processing 
and presentation of 
peptide or 
polysaccharide 
antigen via MHC 
class II 
> 5 7 1.41 x 10-4 0.032 
skeletal system 
development 
2.63 18 2.52 x 10-4 0.057 
DNA binding 1.35 130 3.52 x 10-4 0.061 
binding 1.16 365 5.67 x 10-4 0.099 
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Table 4.11 Most enriched GO terms for the interaction with genotype at the WUR SNP for 
Viral Load (VL). 
 
Category GO Term Fold 
Enrichment 
n Genes 
in List 
P-value Bonferroni 
P-value 
Viral Load 
Biological 
Process 
Slim 
blood coagulation 3.42 18 9.75 x 10-6 2.19 x 10-3 
proteolysis 1.73 45 3.45 x 10-4 0.078 
Molecular 
Function 
Slim 
serine-type 
endopeptidase 
inhibitor activity > 5 18 
3.17 x 10-9 
5.52 x 10-7 
peptidase inhibitor 
activity 3.45 26 9.34 x 10-8 1.63 x 10-5 
amylase activity > 5 6 2.53 x 10-6 4.4 x 10-4 
hydrolase activity, 
hydrolyzing O-
glycosyl compounds > 5 9 1.46 x 10-5 2.54 x 10-3 
enzyme inhibitor 
activity 2.45 28 2.15 x 10-5 3.74 x 10-3 
peptidase activity 1.9 41 9.9 x 10-5 0.017 
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Supplemental Table 4.1 Number of independent principal components for Sus scrofa 
chromosomes 1 through 18, X, and unknown (U) from Principal Components Analysis.  	
Chro- 
mosome # SNPs 
Dataset 
KS06 NVSL Combined 
1 6031 1990 1990 1986 
2 3201 1129 1258 1317 
3 2808 1120 1241 1283 
4 3360 1269 1317 1382 
5 2331 1028 1101 1125 
6 3481 1275 1330 1397 
7 3161 1295 1356 1430 
8 2715 1058 1096 1217 
9 3056 1212 1299 1365 
10 1725 846 887 976 
11 1851 815 835 934 
12 1578 748 801 875 
13 3908 1230 1327 1316 
14 3683 1191 1279 1284 
15 2770 1074 1163 1204 
16 1811 760 801 889 
17 1647 725 778 858 
18 1269 577 627 604 
X 1146 499 514 577 
U 854 651 658 689 
Total 52386 20,492 21,658 22,708 
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Supplemental Table 4.2 Top enriched Biological Process Slim GO terms for KS06 Viral 
Load. Green colored cells contain GO terms considered to be biologically relevant to VL after 
PRRSV infection. Bolded GO terms were found to be enriched in genes differentially expressed 
after PRRSV infection (Schroyen et al., 2015). Underlined GO terms were enriched in genes 
differentially expressed in porcine alveolar macrophages after co-infection with PRRSV and 
Mycoplasma hyopneumoniae (Li et al, 2015).  
Genes within given kb of SNPs 
with P < 0.001 
Genes within given kb of SNPs with P 
< 0.003 
Genes within given kb of SNPs 
with P < 0.01 
500 kb 250 kb 100 kb 500 kb 250 kb 100 kb 500 kb 250 kb 100 kb 
segment 
specificati
on 
segment 
specificati
on 
cell-cell 
signaling 
NK cell 
activation 
NK cell 
activation 
NK cell 
activation 
NK cell 
activatio
n 
antigen 
proc and 
pres 
antigen 
proc and 
pres 
ectoderm 
developme
nt 
NK cell 
activation 
NK cell 
activation 
B cell 
mediated 
immunity 
immune 
response 
immune 
response 
immune 
respons
e 
NK cell 
activation 
cation 
transport 
cellular aa 
metabolic 
process 
cell-cell 
signaling 
response 
to 
interferon-
gamma 
immune 
response 
B cell 
mediated 
immunity 
antigen proc 
and pres 
ion 
transpor
t 
primary 
metabolic 
process 
ion 
transport 
metabolic 
process  
reg of 
trans 
from RNA 
pol II 
promoter 
macropha
ge 
activation 
antigen proc 
and pres 
cellular aa 
catabolic 
process 
antigen proc 
and pres via 
MHC class II 
B cell 
mediate
d 
immunit
y 
immune 
response 
antigen 
proc and 
pres via 
MHC 
class II 
NK cell 
activation 
pattern 
specificati
on process 
induction 
of 
apoptosis 
immune 
system 
process 
mammary 
gland 
developme
nt 
reg of trans 
from RNA 
pol II 
promoter 
cation 
transpor
t 
metabolic 
process 
cell-cell 
signaling 
embryo 
developme
nt 
ectoderm 
developme
nt 
female 
gamete 
generation 
antigen proc 
and pres via 
MHC class II 
cellular aa 
metabolic 
process 
segment 
specification 
antigen 
proc and 
pres 
regulation 
of 
molecular 
function 
immune 
response 
immune 
response 
RNA 
metabolic 
process 
immune 
response 
macrophage 
activation 
trans 
from RNA 
pol II 
promoter 
spermatogene
sis 
metabol
ic 
process 
reg of 
catalytic 
activity 
cellular 
defense 
response 
pattern 
specificati
on process 
trans 
from RNA 
pol II 
promoter 
reg of 
trans 
from 
RNA pol 
II 
promoter 
cellular 
defense 
response 
muscle 
organ 
developme
nt 
cellular aa 
metabolic 
process 
primary 
metabol
ic 
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ion 
transport 
NK cell 
activation 
digestive 
tract 
mesoderm 
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digestive 
tract 
mesoderm 
dev 
segment 
specificati
on 
protein 
phosphorylati
on 
reg of 
trans 
from RNA 
pol II 
promoter 
lipid 
metabolic 
process 
reg of 
phospha
te 
metabol
ic 
process 
skeletal 
system 
developme
nt 
carbohydr
ate 
transport 
cell-cell 
signaling 
transcripti
on, DNA-
dependent 
digestive 
tract 
mesoderm 
dev 
ion transport 
transcripti
on, DNA-
dependent 
female 
gamete 
generation 
immune 
system 
process 
B cell 
mediated 
immunity 
synaptic 
transmissi
on 
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Supplemental Table 4.3 Top enriched Biological Process Slim GO terms for NVSL VL. 
Green colored cells contain GO terms considered to be biologically relevant to VL after PRRSV 
infection. Bolded GO terms were found to be enriched in genes differentially expressed after 
PRRSV infection (Schroyen et al., 2015). Underlined GO terms were enriched in genes 
differentially expressed in porcine alveolar macrophages after co-infection with PRRSV and 
Mycoplasma hyopneumoniae (Li et al, 2015). 
Genes within given kb of SNPs 
with P < 0.001 
Genes within given kb of SNPs 
with P < 0.003 
Genes within given kb of SNPs 
with P < 0.01 
500 kb 250 kb 100 kb 500 kb 250 kb 100 kb 500 kb 250 kb 100 kb 
NK cell 
activation 
reg of 
molecular 
function 
reg of seq-
specific 
DNA 
binding 
trans factor 
activity 
reg of 
vasoconstric
tion 
reg of 
vasoconstric
tion 
reg of 
vasoconstric
tion 
metabolic 
process 
metabolic 
process 
reg of 
vasoconstric
tion 
B cell 
mediated 
immunity 
NK cell 
activation 
response to 
external 
stimulus 
metabolic 
process 
immune 
response 
immune 
response 
reg of 
vasoconstric
tion 
primary 
metabolic 
process 
primary 
metabolic 
process 
reg of 
molecular 
function 
response to 
external 
stimulus 
reg of 
molecular 
function 
immune 
response 
metabolic 
process 
lysosomal 
transport 
primary 
metabolic 
process 
reg of 
vasoconstric
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metabolic 
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response to 
external 
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proteolysis blood coagulation 
receptor-
mediated 
endocytosis 
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transport 
digestive 
tract 
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devt 
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Proteo-lysis lysosomal transport 
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endocytosis 
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transport 
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protein 
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protein 
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Supplemental Table 4.4 Top enriched Biological Process Slim GO terms for KS06 Weight 
Gain. Green colored cells contain GO terms considered to be biologically relevant to WG after 
PRRSV infection. Bolded GO terms were found to be enriched in genes differentially expressed 
in blood after PRRSV infection (Schroyen et al., 2015). Underlined GO terms contain genes 
shown to be involved in feed efficiency traits in beef cattle (Oliveria et al., 2014).  
Genes within given kb of SNPs 
with P < 0.001 
Genes within given kb of SNPs 
with P < 0.003 
Genes within given kb of SNPs 
with P < 0.01 
500 kb 250 kb 100 kb 500 kb 250 kb 100 kb 500 kb 250 kb 100 kb 
cellular 
component 
morphogen
esis 
anterior/pos
terior axis 
specificatio
n 
nuclear 
transport 
antigen 
proc and 
pres 
antigen 
proc and 
pres via 
MHC class 
II 
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Supplemental Table 4.5 Top enriched Biological Process Slim GO terms for NVSL Weight 
Gain. Green colored cells contain GO terms considered to be biologically relevant to WG after 
PRRSV infection. Bolded GO terms were found to be enriched in genes differentially expressed 
in blood after PRRSV infection (Schroyen et al., 2015). Underlined GO terms contain genes 
shown to be involved in feed efficiency traits in beef cattle (Oliveria et al., 2014). 
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Supplemental Table 4.6 Most Enriched GO Terms in Panther Complete Categories for 
Viral Load. 	
PRRSV 
Isolate 
Category GO Term Fold 
Enrich-
ment 
n 
Genes 
in List 
P-value Bonfer-
roni  
P-value 
NVSL Biological 
Process 
Complete 
adenylate cyclase-
activating adrenergic 
receptor signaling 
pathway >5 9 6.83 x 10-7 7.96 x 10-3 
adrenergic receptor 
signaling pathway >5 10 8.5 x 10-7 9.91 x 10-3 
negative regulation of 
peptidase activity 2.94 27 1.22 x 10-6 1.42 x 10-2 
negative regulation of 
proteolysis 2.64 32 1.32 x 10-6 1.54 x 10-2 
negative regulation of 
cellular protein 
metabolic process 1.94 57 2.87 x 10-6 3.35 x 10-2 
negative regulation of 
protein metabolic 
process 1.88 59 5.28 x 10-6 6.15 x 10-2 
Molecular 
Function 
Complete 
peptidase inhibitor 
activity 3.59 
26 
4.60 x 10-8 1.48 x 10-4 
enzyme inhibitor 
activity 2.89 
34 
7.92 x 10-8 2.55 x 10-4 
peptidase regulator 
activity 3.2 
27 
2.43 x 10-7 7.82 x 10-4 
endopeptidase 
inhibitor activity 3.33 
22 
1.65 x 10-6 5.31 x 10-3 
endopeptidase 
regulator activity 3.24 
22 
2.57 x 10-6 8.27 x 10-3 
serine-type 
endopeptidase 
inhibitor activity 4.11 
15 
6.56 x 10-6 0.0211 
molecular function 
regulator 1.66 
71 
3.35 x 10-5 0.108 
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Supplemental Table 4.7 Most Enriched GO Terms in Panther Complete Categories for 
Weight Gain. 	
PRRSV 
Isolate 
Category GO Term Fold 
Enrichment 
n 
Genes 
in List 
P-value Bonferroni 
P-value 
KS06 Biological 
Process 
Complete 
negative regulation 
of retinoic acid 
receptor signaling 
pathway > 5 8 8.11E-07 9.45E-03 
regulation of 
retinoic acid 
receptor signaling 
pathway > 5 8 2.16E-06 2.52E-02 
NVSL Molecular 
Function 
Complete 
protein 
heterodimerization 2.5 42 
1.34 x 
10-4 4.31 x 10-4 
DNA binding 
1.52 131 
2.02 x 
10-6 6.5 x 103 
nucleic acid binding 
1.29 236 
2.38 x 
10-5 7.66 x 10-2 
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CHAPTER 5: GENOMIC PREDICTION OF PIGLET RESPONSE TO ONE OF TWO 
ISOLATES OF THE PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME 
VIRUS1 
Prepared for publication in Genetics, Selection, and Evolution 
 
Emily H Waide2,3, Christopher K Tuggle2, and Jack CM Dekkers2,4 
 
Abstract 
Background : Genomic prediction of the pig’s response to the Porcine Reproductive and 
Respiratory Syndrome (PRRS) virus (PRRSV) would be a useful tool in the swine industry. 
Increasing accuracy of genomic prediction through addition of biological information of SNPs is 
gaining interest in the genetics community. This study investigated the accuracy of genomic 
prediction using training and validation datasets from populations with different genetic 
backgrounds that were challenged with different PRRSV isolates, as well as the accuracy of 
these predictions using annotation-based subsets of SNPs.  
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Results : Genomic prediction accuracy averaged 0.36 for viral load (VL) and 0.23 for 
weight gain (WG) following experimental PRRSV challenge, which demonstrates that genomic 
selection could be used to improve response to PRRSV infection. Training on weight gain (WG) 
data during infection with a less virulent PRRSV, KS06, resulted in poor accuracy of prediction 
for WG during infection with a more virulent PRRSV, NVSL. Inclusion of SNPs that are in 
linkage disequilibrium with a major QTL on chromosome 4 was vital for accurate prediction of 
viral load (VL). Overall, neither SNPs that were significantly associated with either trait in single 
SNP genome-wide association analysis, nor SNPs near genes enriched for biologically relevant 
GO terms were able to predict the phenotypes with as high an accuracy as using SNPs across the 
whole genome.  Inclusion of data from related animals into the training population increased 
whole genome prediction accuracy by 33% for VL and by 37% for WG. Accuracy of prediction 
using only the SNPs in the major QTL was not changed with inclusion of related animals into the 
training population. 
Conclusions : Results show that genomic prediction of response to PRRSV infection is 
moderately accurate and, when using all SNPs in the genome, is not extremely sensitive to 
differences in virulence of the PRRSV in training and validation populations. Including related 
animals into the training population increases prediction of accuracy when using the whole 
genome or SNPs other than those in a major QTL. 
Introduction 
Improving phenotypic performance of livestock is the overall goal of animal breeding 
programs. For some economically important traits, phenotypes on selection candidates or close 
relatives are difficult to obtain due to high cost of phenotyping, strict biosecurity measures, or 
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age at which phenotypes are measurable. Genomic prediction provides an attractive alternative to 
select for these traits. Porcine Reproductive and Respiratory Syndrome (PRRS) is an 
economically devastating disease in the swine industry caused by a rapidly mutating virus 
(PRRSV; Fang et al., 2007). Genomic prediction for response to the Porcine Reproductive and 
Respiratory Syndrome (PPRS) virus (PRRSV) in pigs would be highly valuable to the swine 
industry, as most selection takes place in high health nucleus farms that are unlikely to face 
PRRSV outbreaks. Conducting experimental PRRSV infection trials requires the use of strictly 
regulated biocontainment facilities and is very expensive and labor intensive. Therefore, the 
ability to combine data from pigs with different genetic backgrounds which were infected with 
different PRRSV isolates to use as a training population for genomic prediction of response of 
unrelated piglets to other PRRSV isolates would be very beneficial.  
Genomic prediction involves the use of genotypes at single nucleotide polymorphisms 
(SNPs) across the genome to predict phenotypes that have not been observed in the selection 
candidates (Meuwissen et al., 2001). SNP chips contain thousands to hundreds of thousands of 
genetic markers that cover the whole genome of the species (Ramos et al., 2009). Recently, 
several studies (Morota et al., 2014; Do et al., 2015) have investigated the effect of addition of 
annotation information on the accuracy of genomic prediction by grouping SNPs based on their 
genic location - intronic, exonic, intergenic, etc. We aimed to expand on this concept by using 
the functional annotation information of genes near SNPs to create biological SNP subsets, 
which has been explored in few studies to date (Snelling et al., 2013; Maltecca, 2014). 
The data used in this study were from the PRRS Host Genetics Consortium (PHGC, 
Lunney et al., 2011) and included phenotypes on weight gain (WG) and viral load (VL) from 9 
trials of ~200 piglets that were infected with the NVSL 97-7985 (NVSL) PRRSV isolate (Osorio 
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et al., 2002) and from 4 similarly sized trials of piglets infected with the KS2006-72109 (KS06) 
isolate. Using data from the first 8 NVSL trials, Boddicker et al. (Boddicker et al., 2012; 
Boddicker et al., 2014a; Boddicker et al., 2014b)  discovered and validated a QTL on Sus scrofa 
chromosome (SSC) 4 for VL and WG and showed that a single SNP in this region, 
WUR10000125 (WUR), explained most of the genetic variance of the QTL. Furthermore, 
Boddicker et al. (2014a) showed that accuracy of genomic prediction across breeds within the 
NVSL data was maximized when only the SNPs within the 1 Mb window containing the WUR 
SNP were used. Our study expands these questions to prediction across PRRSV isolates. 
Genotype at the WUR SNP was shown to be associated with VL in both PRRSV isolates and 
with WG in the NVSL isolate (Hess et al., 2015). Genetic correlations for VL and WG between 
the two isolates were both estimated to be 0.86, which indicates that accurate genomic prediction 
across isolates is possible. Also, using field data, which likely contained multiple PRRSV 
isolates or strains of infection, Serão et al. (2014) showed that genomic prediction of PRRSV 
antibody response was moderately accurate. These findings are important to the swine industry, 
as PRRSV is a rapidly mutating virus (Fang et al., 2007; Kimman et al., 2009) and different 
strains are infecting industry populations and are likely to evolve from one outbreak to the next.  
Except for the SSC 4 QTL, which was associated with VL in both isolates and with WG 
in the NVSL isolate, genome-wide association studies (GWAS) in the data used in this study did 
not identify genomic regions that overlapped between the two PRRSV isolate datasets (Chapter 
4), despite the high genetic correlations that have been estimated for traits between isolates (Hess 
et al., 2015). However, although the most strongly associated regions were inconsistent between 
PRRSV isolates, we found that genes near these SNPs were enriched for several of the same GO 
terms. Thus, we hypothesized that selection of SNPs near genes involved in biological processes 
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relevant to the phenotype could improve the accuracy of genomic prediction by reducing the 
number of uninformative SNPs used for prediction (Chapter 4). 
Against this background, the objectives of this study were to assess the accuracy of 
genomic prediction for VL and WG in the following scenarios: 1) across PRRSV isolates and 
genetic sources, 2) using all SNPs, all SNPs other than those in the SSC 4 QTL region, or only 
SNPs in the 1 megabase (Mb) SSC 4 QTL region, and 3) using smaller subsets of SNPs chosen 
based on GWAS analyses and GO annotation.  
Materials and Methods 
All experimental protocols used in this study were approved by the Kansas State 
University (KSU) Animal Care and Use Committee. 
Study design and animal populations 
Lunney et. al  (2011) provided a detailed description of the study design employed in the 
PHGC trials used in this study. Briefly, a total of 13 trials of approximately 200 commercial 
crossbred piglets each were sent to Kansas State University at weaning, given one week to 
acclimate, then inoculated intramuscularly and intranasally with 105 tissue culture infectious 
dose of either the NVSL 97-7985 (NVSL) (Osorio et al., 2002) or KS2006-72109 (KS06) 
PRRSV isolate. Blood samples were collected at 0, 4, 7, 11, and 14 days post-infection (dpi) and 
then weekly until termination of the trial at 42 dpi. Individual weights were observed weekly 
throughout the trial. At 42 dpi, piglets were euthanized and ear tissue was collected for genomic 
DNA extraction, which was sent to GeneSeek, Inc. (Lincoln, Nebraska, USA) and genotyped 
using the Illumina Porcine SNP60 Beadchip (Ramos et al., 2009). Quality control of genotype 
data has been previously described (Waide et al., 2015). Briefly, after filtering genotypes with 
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GenCall Scores lower than 0.5, minor allele frequencies less than 0.01, and genotyping call rates 
less than 0.80, 52,386 SNP remained, with an overall genotype rate of 99.2%.  
In total, data on 2,288 commercial crossbred piglets from 8 genetic backgrounds were 
used. Piglets averaged 26.6 (±2.4) days of age and weighed 7.17 (±1.4) kg at the time of 
infection. Of this total, 1,557 piglets were infected with NVSL, with an average weight of 7.34 
(±1.4) kg and 26.6 (±2.6) days of age at inoculation. The remaining 731 piglets averaged 26.7 
(±1.9) days of age and weighed 6.80 (±1.29) kg on average at the time of inoculation with KS06. 
A more detailed description of the populations used in each trial is in Waide et al. (2015). Trial 9 
involved pigs from the ISU RFI selection lines (Cai et al. 2008) and were excluded from these 
analyses. Trial 13 was also excluded from these analyses because piglets from this trial had much 
lower and more variable viremia profiles compared to the other KS06 trials. Relationships 
between piglets used in each trial were investigated using principal component analysis (PCA) of 
genotypes for all SNPs using the R function prcomp (R Core Team, 2015). 
Phenotypes 
The two phenotypes analyzed in this study were described by Boddicker et al. (2012). 
Briefly, the amount of PRRSV RNA in blood samples was estimated using quantitative PCR and 
reported as the log10 of PRRSV RNA copies relative to a standard curve. Viral load (VL) was 
calculated as the area under the curve of viremia up to and including 21 dpi. Weight gain (WG) 
was calculated as the difference between body weight at 42 and 0 dpi. 
Genomic prediction analyses 
Bayesian variable selection, Bayes-B, was used to estimate additive and dominance 
effects for 52,386 SNPs for genomic prediction using the following equation: 
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𝒚 = 𝑿𝒃+ 𝒛𝒂𝒊𝑎!𝛿!"!!!! + 𝒛𝒅𝒊𝑑!𝛿!"!!!! +  𝒆 
where y = vector of phenotypic observations, X = incidence matrix relating phenotypes to fixed 
effects, b = vector of fixed effects of sex, the interactions of pen and parity with trial, genotype at 
the WUR SNP, and covariates of initial age and weight, zai = vector of the additive genotype 
covariates coded as -10, 0, and 10 for the AA, AB, and BB genotypes, respectively, for SNP i, ai 
= additive effect for SNP i, δai = indicator for whether the additive effect of SNP i was included 
(δai = 1) or excluded from (δai = 0) the model for a given iteration of the Markov Chain Monte 
Carlo (MCMC) chain, zdi = vector of the dominance genotype covariates coded as 10, 0, and 10 
for the AA, AB, and BB genotypes, respectively, for SNP i, di = dominance effect for SNP i, δdi 
= indicator for whether the dominance effect of SNP i was included (δdi = 1) or excluded from 
(δdi = 0) the model for a given iteration of the MCMC chain, and e = vector of residual errors. 
The prior probability that a given SNP was excluded from the model (δai = 0 and δdi = 0) was set 
equal to π = 0.99, fitting approximately 1% or 524 additive effects and 524 dominance effects in 
each of 51,000 iterations of the MCMC chain, with the first 1,000 iterations designated as burn 
in. We also performed these analyses with addition of genotype at the WUR SNP as a fixed 
effect and SNPs within 2.5 Mb on either side of the WUR SNP excluded from the analysis.  
Using the estimates obtained from the Bayes-B analysis, the genomic estimated 
genotypic value (GEGV) was obtained for each animal in the validation population using the 
following equation: 
𝐺𝐸𝐺𝑉! = 𝒛𝒂𝒊𝒋𝑎!!!!! + 𝒛𝒅𝒊𝒋𝑑!!!!!  
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where GEGVj = the genotypic value for individual j, zaij and zdij are as described above, 𝑎i = 
estimate of the additive effect for SNP i,  and 𝑑i = dominance effect for SNP i. To estimate the 
prediction accuracy of the SSC 4 QTL alone, we used the additive and dominance effects from 
the whole genome Bayes-B analysis of the training population for the 39 SNPs in the 1 Mb 
window that contains the WUR SNP to estimate GEGVs in the validation population. To 
estimate the predictive accuracy of the rest of the genome aside from the SSC 4 QTL (Genome-
WUR), genotype at the WUR SNP was fitted as a fixed effect in the model and all SNPs within 
2.5 Mb on either side of the WUR SNP were excluded from analysis.  
Training and validation datasets. Figure 5.2 shows examples of how the data were split 
into training and validation groups for the 5 main genomic prediction scenarios described in the 
following, followed by an example of each scenario. 1) Genomic prediction across PRRSV 
isolate (black arrows in Figure 5.1A): e.g., all data from the NVSL isolate used for training and 
all data from the KS06 isolate used for validation (NTàKV). 2) Genomic prediction across 
breeding company with both PRRSV isolates in training (red arrow in Figure 5.1A): e.g., trials 4-
15 from the NVSL isolate and trials 10, 12, and 14 from the KS06 isolate used for training and 
trials 1-3 from the NVSL isolate used for validation (NKTàNV). 3) Genomic prediction across 
breeding company within PRRSV isolate (small blue arrow in Figure 5.1B): e.g., trials 11, 12, 
and 14 from the KS06 isolate used for training and trial 10 from the KS06 isolate used for 
validation (KTàKV). 4) Genomic prediction across breeding company and PRRSV isolate (large 
blue arrow in Figure 5.1B): e.g., trials 11, 12, and 14 from the KS06 isolate used for training and 
trial 15 from the NVSL isolate used for validation (KTàNV). 5) Including breeding company 
across PRRSV isolate (purple arrow in Figure 5.1B): e.g., trials 1-8 and 15 from the NVSL 
isolate used for training and trial 14 from the KS06 isolate used for validation (NTàKV). 
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Accuracy of genomic prediction was calculated as the correlation between the GEGV and 
phenotypes adjusted for the fixed effects included in the genomic prediction model, divided by 
the square root of the heritability of the trait for the PRRSV isolate of infection in the validation 
population, as estimated by Hess et al. (2014). For example, when we trained on VL from one or 
more NVSL infection trials and validated on VL from one or more KS06 infection trials, 
genomic prediction accuracy was calculated as the correlation between the GEGV and adjusted 
phenotypes for VL in the KS06 trial(s) divided by the square root of heritability for VL in all of 
the KS06 data. Phenotypes were adjusted for estimates of fixed effects (sex and interactions of 
pen and parity with trial; genotype at the WUR SNP was included as a fixed effect in Genome-
WUR analyses only) within the validation population.  
SNP subset selection  
Genomic prediction between PRRSV isolates was also performed using subsets of SNPs selected 
based on results of GWAS and functional annotation information. To identify subsets of SNPs 
selected to have an effect on phenotype, single SNP GWAS were performed using ASReml 4 
(Gilmour et al., 2014) with the following linear mixed model: 𝒚 = 𝑿𝒃+ 𝒁!𝒈𝒊 +𝑾𝒑+ 𝑺𝒍+ 𝒖+ 𝒆 
where y, X, and b are as described above, Zi = matrix of genotypes coded as 0, 1, and 2 for the 
AA, AB, and BB genotypes, respectively, for SNP i, gi = vector of genotype class effects for 
SNP i, W = incidence matrix associating phenotypes with the interaction of pen and trial, p = 
vector of random interaction effects of pen and trial,  S = incidence matrix associating 
phenotypes with litter effects, l = vector of random effects of litter, u = vector of random animal 
polygenic effects with variance-covariance matrix based on the pedigree relationship matrix, and 
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e = vector of residual errors. A two generation pedigree of 4807 animals was used. Single SNP 
analyses were performed on data from each PRRSV isolate separately. 
SNPs with P<0.003 within PRRSV isolate, as determined by single SNP analyses 
described above, were used as the largest SNP subset of potentially informative SNPs for 
genomic prediction. In order to add functional annotation information to this subset selection, 
genes within 250 kb of SNPs associated with the trait at P<0.003 were compiled into gene lists to 
perform gene ontology (GO) term enrichment analyses using the Panther software (Mi et al., 
2013). We then created subsets of the list of SNPs with P<0.003 consisting of SNPs that were 
within 250 kb of genes in biologically relevant enriched GO terms; for example, SNPs with 
P<0.003 that were within 250 kb of genes in the natural killer cell activation GO term were 
grouped into a SNP subset. We added the WUR SNP to each of these lists.We also performed 
genomic prediction using all SNPs within 250 kb of all genes in biologically relevant enriched 
GO terms, regardless of the strength of association. 
In order to evaluate the accuracy of genomic prediction using these subsets, we estimated 
the effects of the SNPs in these lists using Bayes-A (i.e. Bayes-B with π=0). For these analyses, 
we trained on the PRRSV isolate with which the SNPs were associated in single SNP analysis 
and validated on the data from pigs infected with the other PRRSV isolate. 
Results 
The data used in this study consisted of 2,288 pigs from 8 breeding companies that were 
infected with one of two PRRSV isolates. Information on each trial is in Table 5.1. Principal 
components analysis (PCA) of SNP genotypes from all animals used in this study showed that 
pigs from each breeding company clustered together (Figure 5.1). The first principal component 
		
155	
(PC) explained 7.2% of the variance in genotypes and PC2 explained 6.4%. When we plotted 
PC1 against PC2, pigs generally clustered by breeding company. PC1 distinguished pigs in 
breeding company 1 from pigs in breeding company 7, and each were separated from pigs in the 
other breeding companies. PC2 separated pigs based on their actual breed make-up, with the 
progeny of Duroc sires bred to white crossbred dams clustered together and those without Duroc 
sires clustered together. This breed separation agrees with previous reports that show clustering 
of Large White (LW), Landrace (LR), and Pietrain pigs together and separate from Duroc pigs 
based on genomic data (Ramírez et al., 2015).  
Genomic prediction of Viral Load (VL) 
Prediction across PRRSV isolates. Although genomic regions associated with VL were 
not consistent across PRRSV isolate (Chapter 4), except for the SSC 4 QTL, we found that 
genomic prediction across PRRSV isolate (black arrows in Figure 5.2A) was moderately 
accurate. Accuracy of whole genome prediction training on the NVSL data and validating on the 
KS06 data (NTàKV) was 0.34, while training on the KS06 data predicted genomic estimated 
genotypic values (GEGVs) in the NVSL data (KTàNV) with an accuracy of 0.44 (Figure 5.3A). 
When we accounted for the WUR SNP in the analysis (Genome-WUR) – in other words, when 
we fitted genotype at the WUR SNP as a fixed effect and removed SNPs within 2.5 Mb on either 
side of the WUR SNP from the prediction –  these accuracies were reduced to 0.12 and 0.13, 
respectively (Figure 5.3A). Accuracy of prediction using only the 39 SNPs in the 1 Mb window 
containing the WUR SNP (WUR only) was less than that of the whole genome, but greater than 
the accuracy of Genome-WUR (Figure 5.3A). For the whole genome and WUR-only predictions,  
KTàNV was more accurate than NTàKV, but accuracy was equivalent between KTàNV and 
NTàKV when using Genome-WUR.  
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Effect of genetic relationships between training and validation. In order to determine 
the contribution of genetic relationships between animals in the training and validation datasets, 
the accuracy of genomic prediction across PRRSV isolates when validating on data from one 
breeding company was compared using two training scenarios: 1) excluding the validation 
breeding company from training (large blue arrow in Figure 5.2B) and 2) including the 
validation breeding company in training (purple arrow in Figure 5.2B). These analyses were only 
conducted for breeding companies that had data for both PRRSV isolates (5 trials of NVSL data 
and 3 trials of KS06 data; Figure 5.2). Including the validation breeding company in the training 
population increased accuracy of prediction most for the Genome-WUR prediction (Figure 5.3B; 
trial specific genomic prediction accuracies are in Figure 5.4). The average prediction accuracy 
for Genome-WUR when the validation breeding company was excluded from training was 0.01; 
this prediction accuracy increased to an average of 0.17 when the validation breeding company 
was included in training (Figure 5.3B). This could indicate that the Genome-WUR predictions 
are primarily based on genetic relationships instead of biological effects. The accuracy of 
genome-WUR prediction for one breeding company in the NVSL data (indicated by triangles in 
Figure 5.3B) was very low even with inclusion of related animals in the training population. If 
this accuracy is ignored, the average accuracy of KTàNV genome-WUR prediction increased 
from 0.19 to 0.26 when related animals are included in training. For WUR only prediction, 
inclusion of the validation breeding company increased accuracy by 48% for trial 15 but did not 
have an effect on prediction accuracy for other trials (Figure 5.4C). The favorable allele at the 
WUR SNP had a larger effect on VL for the NVSL isolate than for the KS06 isolate, and also has 
a larger effect on VL in trial 10 than in the other KS06 trials.  
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Prediction across breeding companies with both PRRSV isolates in training. Since 
the PRRSV mutates rapidly (Fang et al., 2007), it would be valuable to be able to use data from 
response to one PRRSV isolate to predict the ability of pigs to respond to another PRRSV 
isolate. Furthermore, collection of response to PRRSV infection is expensive and difficult. Thus, 
it would be beneficial to use all available data for genomic prediction, resulting in a training 
dataset consisting of pigs infected with one of several different PRRSV isolates. To assess the 
effect of PRRSV isolates in the training dataset, we compared genomic prediction across 
breeding company within PRRSV isolate (small blue arrow in Figure 5.2B), across PRRSV 
isolates (large blue arrow in Figure 5.2B), and using data from both PRRSV isolate infections in 
training (red arrow in Figure 5.2A). Results showed that whole genome prediction was 
moderately accurate within isolate, across isolate, and with both isolates in training (Figure 
5.3C). Training on VL in the KS06 data gave the only positive accuracy for KTàNV and 
KTàKV Genome-WUR prediction. On average, whole genome and WUR-only prediction were 
not sensitive to the PRRSV isolate used in training. The trial with zero WUR-only prediction in 
within isolate, across isolate, and both isolates in training scenarios (indicated by a gray 
diamond) was trial 8, which has been shown to have very low predictive accuracy using on the 
SSC 4 QTL (Boddicker et al., 2014b) and genotype at the WUR SNP was shown to not have an 
effect on VL in that trial (Hess et al., 2015).  
Prediction using SNP subsets. Results of single SNP GWAS were used to perform gene 
ontology (GO) annotation enrichment analyses, as previously described (Waide et al., 2015). The 
largest SNP subsets that were used for genomic prediction contained SNPs with associations of 
P<0.003 within trait and PRRSV isolate. SNP effects were estimated using data from the PRRSV 
isolate with which they were associated in single SNP analysis using Bayes-A. The resulting 
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SNP effect estimates were then used to predict GEGVs of pigs infected with the other PRRSV 
isolate. There were 930 and 616 SNPs associated with VL at P<0.003 in the KS06 and NVSL 
data, respectively. When we used only these SNPs for genomic prediction of VL across PRRSV 
isolates, accuracy decreased to 0.18 (from 0.44) for KTàNV and to 0.27 (from 0.34) for NTàKV 
(Figure 5.4). Genes near each of these SNP subsets were shown to be enriched for several 
immune function related GO terms (Chapter 4). However,when we used only the 108 (KS06) 
and 166 (NVSL) SNPs near genes in these immune related GO terms, prediction accuracy was 
0.19 for KTàNV and 0.24 for NTàKV (Figure 5.4).  
Genomic prediction of Weight Gain (WG) 
Prediction across PRRSV isolates. Accuracies for genomic prediction of WG across 
PRRSV isolates are in Figure 5.5A. Whole genome or Genome-WUR prediction was most 
accurate for NT_KV ; however, for KT_NV, WUR only prediction was over twice as accurate as 
whole genome and Genome-WUR prediction (Figure 5.6A). The SSC 4 QTL was shown to have 
a large effect on WG in the NVSL data (Boddicker et al., 2014a) but was not significantly 
associated with WG in the KS06 data (Hess et al., 2015). Bayes-B results showed that the 1 Mb 
window containing the WUR SNP explained 10.4% of genetic variance for WG in the NVSL 
data, but only 0.05% in the KS06 data (data not shown). GWAS of WG in the KS06 data 
detected no QTL with large effects but many very small effects spread out across the genome 
(Chapter 4). Furthermore, genes near SNPs moderately associated with WG in the KS06 were 
not enriched for metabolic GO terms, unlike those for WG in the NVSL data. The NVSL isolate 
is more virulent than the KS06 isolate; piglets infected with the KS06 isolate had lower viral load 
and higher weight gain than pigs infected with the NVSL isolate (Chapter 4). Additional KS06 
infection trials may be needed to accurately estimate SNP effects for WG.   
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Effect of genetic relationships between training and validation. Including the 
validation breeding company in training had no effect on the average accuracy of genomic 
prediction of WG for either PRRSV isolate or for any SNP subset, but these accuracies had large 
standard deviations (Figure 5.5B). Figure 5.5B shows the trial specific accuracies that were 
averaged to get each of these estimates. When training on WG in the KS06 trials and predicting 
trials 1-3 or trial 5 of the NVSL data, whole genome and Genome-WUR prediction yielded 
negative accuracies but the accuracy of WUR only prediction was positive.Whole genome or 
Genome-WUR prediction of WG in trial 15 of the NVSL data was moderately accurate, 0.28 and 
0.31, respectively, but WUR only prediction accuracy was low, 0.11 (Figure 5.5B). When SNP 
effects were trained on WG in the NVSL data, whole genome prediction most accurately 
predicted GEGV for WG in trials 10 and 11 of the KS06 data, whereas Genome-WUR most 
accurately predicted GEGV for WG in trial 14 of the KS06 data (Figure 5.5B). Across breed 
prediction of WG for KT_NV using the whole genome ranged from -0.39 to 0.46. Trials with low 
or negative accuracies using the whole genome tended to have higher accuracies when using the 
WUR region for prediction, while trials with high whole genome accuracy (Figure 5.5B) had 
lower WUR-only prediction accuracies (Figure 5.5B).  
Prediction across breeding companies with both PRRSV isolates in training. Figure 
5.5C shows the average accuracy for WG of whole genome, Genome-WUR, and WUR-only 
prediction within isolate, across isolates, and when training on both isolates. Including WG from 
both isolates in training increased the accuracy of whole genome and Genome-WUR prediction 
of WG in the KS06 data compared to within isolate prediction. Furthermore, although accuracies 
had large standard deviations, the average accuracy of prediction for WG in the KS06 data was 
more accurate when NVSL data were used for training compared to within-isolate prediction. 
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WUR-only prediction in the KS06 data had zero accuracy regardless of the PRRSV isolate used 
for training. This could be an effect of the size of the training population for within-isolate 
prediction of KS06. There also was no predictive ability of the whole genome or Genome-WUR 
for NVSL data when SNP effects were trained on WG in the KS06 isolate.  
Prediction using SNP subsets. Prediction accuracy of WG for KTàNV increased from 
0.10 when using the whole genome to 0.14 when using only the 496 SNPs with P<0.003 and 
decreased slightly to 0.08 when using the 134 SNPs near genes in metabolism-related GO terms 
(Figure 5.6). For NTàKV, the accuracy of prediction decreased from 0.34 when using the whole 
genome to 0.24 when using the 770 SNPs with P<0.003. Interestingly, when the 484 SNPs near 
genes in biologically relevant GO terms were used for prediction, accuracy increased slightly to 
0.29. Prediction accuracies for WG were lower for each scenario involving KTàNV, which may 
be caused by the decreased virulence of the KS06 PRRSV isolate, which had a diminished effect 
on WG, when compared to infection with the NVSL isolate.  
Discussion 
The results presented in this study show that even without overlap of genomic regions 
identified in GWAS, we can still obtain moderately accurate genomic predictions across two 
isolates of the PRRSV. Genomic prediction using the whole genome was more accurate that 
Genome-WUR or WUR-only prediction for all scenarios in both VL and WG, except for 
excluding related animals in training in KTàNV for WG which was most accurate using WUR-
only. For VL, the most accurate genomic prediction scenario involved using the whole genome 
to predict across PRRSV isolates when the validation breeding company was included in the  
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training data. For WG, the most accurate genomic prediction scenario involved whole genome 
prediction with both PRRSV isolates included in the training data.  
Overall, genomic prediction of WG was less accurate than genomic prediction of VL. 
This may be in part due to the differences in the effect of the SSC 4 QTL on WG in these two 
PRRSV isolates. Furthermore, weight gain or a related trait (such as feed efficiency or average 
daily gain) is a common trait selected upon in the commercial pig industry (Rauw et al., 1998), 
whereas VL after PRRSV infection is not selected upon. Although the WG measured in this 
study was in piglets infected with PRRSV, as opposed to healthy piglets, prediction of the trait 
may be affected by the selection in the industry. 
Genomic prediction across breeding companies 
Prediction within PRRSV isolate. Whole genome prediction of VL across breeding 
companies within PRRSV isolate was more accurate than WUR-only prediction, and WUR-only 
was more accurate than Genome-WUR prediction. There was very little to no predictive ability 
of Genome-WUR for VL within isolate, indicating that the effects of the SSC 4 QTL contributed 
most of the prediction accuracy in this scenario. Genome-WUR accuracy was moderately 
negative for NVSL trial 6, which may be due to the fact that the pigs in this trial were purebred 
Landrace while pigs in other trials were crossbred. Accuracy of within isolate prediction for VL 
in NVSL trial 8 was negative for all three SNP sets, which is not explained by PCA or the 
average VL in this trial. The negative accuracy of WUR-only prediction for trial 8 can be 
explained by the lack of effects of the WUR SNP on VL in this trial (Boddicker et al., 2014b).  
Accuracy of WG prediction within PRRSV isolate was more accurate for the NVSL trials 
compared to the KS06 trials. In NVSL trials, whole genome prediction accuracy was higher than 
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WUR-only, and WUR-only was more accurate than Genome-WUR prediction. In KS06 trials, 
whole genome and Genome-WUR prediction accuracies were equivalent and higher than WUR-
only prediction. WUR-only prediction was more accurate in NVSL trials compared to KS06 
trials, which is due to the lack of effect of the WUR SNP on WG in the KS06 isolate (Hess et al., 
2015). For KS06 trials 10, 11, and 12, WUR-only prediction accuracy was low (range 0.09-
0.13), yet positive. However, there was no accuracy of WUR-only prediction in KS06 trial 14, 
which can be explained by the fact that effects of the WUR SNP on WG in trial 14 are in the 
opposite direction (AA animals had numerically higher WG than AB animals) of the effects in 
other KS06 trials (Hess et al., 2015).  
Prediction including related animals in training. The most notable increase in 
prediction accuracy due to inclusion of related animals in training was for VL in NVSL trial 15. 
Including related animals in training increased whole genome prediction accuracy by 100%, 
Genome-WUR by 200%, and WUR-only by 50% for NVSL trial 15. Trial 15 is from breeding 
company 7, which is separated from all other breeding companies by PCA, which may explain 
these large increases in accuracy. However, prediction accuracy for WG in trial 15 did not show 
dramatic increases from inclusion of related animals in training. In fact, the largest increases in 
accuracy due to inclusion of related animals in training were for KS06 trial 10, which is from the 
same breeding company as NVSL trial 15. For WG in KS06 trial 10 inclusion of related animals 
in training led to increases in accuracies of whole genome prediction by 40% and Genome-WUR 
by 700%, while WUR-only prediction was equivalent between excluding and including related 
animals in training. 
On average, inclusion of the validation breeding company in the training population 
increased whole genome and Genome-WUR prediction accuracy for both VL and WG, as is 
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expected with increased relationships between the training and validation animals (Habier et al., 
2007; Goddard, 2008; Hayes et al., 2009; Daetwyler et al., 2013). Although other studies have 
found that genomic prediction has very low or no accuracy when training and validating across 
breeds (Hayes et al., 2009; Ibánẽz-Escriche et al., 2009; de Roos et al., 2009; Toosi et al., 2009; 
Daetwyler et al., 2012), we showed that there was predictive ability across genetic backgrounds 
in our data when using the whole genome. Although the training and validation populations used 
in this study were from different breeding companies, the commercial crossbred pigs were likely 
more genetically similar across breeding companies than the purebred Holstein and Jersey 
populations used by Hayes et al. (2009). Ibánẽz-Escriche et al. (2009), de Roos et al. (2009), and 
Toosi et al. (2009) examined the accuracy of genomic prediction across breeds using simulation, 
which requires many assumptions that are often violated in real data, such as that used in this 
study. Another likely explanation for differences in predictive ability across genetic backgrounds 
in our study was the large predictive contribution of the SSC 4 QTL. Inclusion of related animals 
in training increased accuracy of WUR-only predictions less than compared to whole genome, 
and increase in accuracy of whole genome prediction was less than compared to Genome-WUR 
prediction. Therefore, accuracy of genomic prediction across genetic backgrounds without 
related animals in training and validation may be higher when there is one or several QTL with 
large effects on the phenotype of interest compared to scenarios in which no major QTL affect 
the trait and effects are small and spread across the genome. 
Genomic prediction across PRRSV isolates. 
Prediction across breeding companies. Prediction accuracies of VL across isolates and 
breeding companies followed the same pattern as within isolate prediction across breeding 
companies, with whole genome prediction having the highest accuracy followed by WUR-only 
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and Genome-WUR having the least accurate prediction. For prediction of WG, accuracy patterns 
switched between the two isolates of within isolate prediction. For KTàNV, WUR-only 
prediction was more accurate than whole genome and Genome-WUR, while whole genome and 
Genome-WUR prediction accuracies were equivalent to one another. For NTàKV, whole 
genome prediction was slightly more accurate than Genome-WUR, and Genome-WUR accuracy 
was 200% higher than WUR-only prediction.  
Prediction within isolate, across isolate, and both isolates in training. For prediction 
of VL, average accuracies were the same for within isolate, across isolate, and both isolate in 
training for each PRRSV isolate in validation. For WG, on average, whole genome and Genome-
WUR predictions were most accurate when NVSL trials were included in training; NTàNV was 
more accurate than KTàNV, NTàKV was more accurate than KTàKV, and NKTàKV was more 
accurate than both NTàKV and KTàKV. This may be due to the absence of peaks seen in the 
GWAS for WG in the KS06 data (Chapter 4), which spreads very small effects out over many 
SNPs. For WUR-only prediction of WG, accuracies were similar among within isolate, across 
isolate, and both isolates in training for each validation isolate, with WUR-only prediction of 
WG in NVSL trials having higher accuracy compared to that of KS06 trials. Genotype at the 
WUR SNP was shown to be associated with WG in the NVSL data, but not in the KS06 data, 
which explains the increased accuracy for WUR-only prediction in NVSL trials. Effects of the 
WUR SNP are in the same direction in 3 of 4 KS06 trials as in the NVSL trials, therefore WUR-
only prediction accuracy of NTàNV and KTàNV are equivalent. 
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Genomic prediction using SNP subsets based on functional analyses 
When we used SNPs that were associated with VL in the NVSL data based on single 
SNP analysis, we found that NTàKV accuracy was 81% of that using all SNPs in the genome; 
when only SNPs near genes with GO terms shown to be enriched in associated regions were used 
for prediction, accuracy was 72% of whole genome accuracy. Using SNPs associated with VL in 
the KS06 data based on single SNP analysis or associated SNPs near enriched GO terms for 
KTàNV resulted in accuracies 40 and 44% of the whole genome accuracy for prediction of VL, 
respectively.  
Using only SNPs associated with WG in the KS06 data in single SNP analysis increased 
KTàNV prediction accuracy was 143% of accuracy using the whole genome, but was less 
accurate than WUR only prediction. Accuracy of KTàNV prediction for WG decreased to 81% 
of the accuracy of whole genome prediction when using only SNPs near GO enriched genes. For 
NTàKV, using SNPs associated with WG in the NVSL data or associated SNPs near enriched 
GO terms resulted in accuracies 72 and 86% of the whole genome accuracy, respectively. 
 Overall, prediction using SNPs near GO enriched genes was more accurate than using all 
SNPs with P<0.003, but both were still less accurate than the whole genome. The results from 
this study agreed with a study conducted by Lucot et al. (2015), in which it was shown that fewer 
windows most significantly associated with age at puberty were required to explain the 
phenotypic variance in training, but using all SNPs in the genome explained the largest 
proportion of phenotypic variance in validation. This study also showed that the accuracy of 
genomic prediction was maximized when the whole genome was used (Lucot et al., 2015). Do et 
al. (2015) performed genomic prediction of feed efficiency traits in pigs using SNP subsets based 
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on genic locations of SNPs, such as intergenic, intron, exon, etc. None of the SNP subsets had an 
effect on prediction accuracy, and were equivalent in all cases except for one category (missense 
SNPs) to a randomized set of SNPs (Do et al., 2015). In this study, we saw that SNP subsets 
based on association or GO term enrichment information gave lower accuracies than the whole 
genome. When we used all SNPs other than those in the association or GO term enriched 
categories used in this study, genomic prediction accuracy was the same as the accuracy of the 
whole genome, which would indicate that these SNP subsets did not contribute significantly to 
the prediction accuracy. However, when we randomly selected the same number of SNPs in each 
of the association or enriched GO term categories in this study and found that the randomly 
selected subsets had zero predictive accuracy.  
Addition of functional annotation of GWAS associations may increase the accuracy of 
genomic prediction through alternative methods, though, such as by assigning SNPs to subsets 
based on annotation of genes and allowing different π values for the subsets, such as is 
implemented in Bayes-R (Erbe et al., 2012). In this manner, the whole genome is used for 
prediction, with the probability of association for SNP subsets determined by possible biological 
relevance. Bayes-N is another Bayesian GWAS method in which a nested model is used, where 
association of groups of SNPs with the phenotype is analyzed first, then associations of SNPs 
within the associated groups are examined (Zeng, 2015).  
Comparison to previous studies 
Our results for within PRRSV isolate Genome-WUR prediction for VL in the NVSL data 
were similar to the results of Boddicker et al. (2014b) using data from trials 1 to 8; however our 
WUR only prediction accuracy was lower than Boddicker et al. (2014b) estimates. For trial 4, 
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Boddicker et al. (2014b) showed a negative accuracy when using SNPs across the genome 
except for the SSC 4 QTL (similar to our Genome-WUR scenario), whereas our analysis showed 
a moderately positive prediction accuracy. There are several possible reasons for these 
differences. Boddicker et al (2014b) used the Bayes-C method of GenSel (Fernando and Garrick, 
2008); we fitted the covariates of initial age and weight in a Bayes-B model, while these effects 
were not in their model. Third, our training dataset included an additional trial of data (trial 15). 
Boddicker et al. (2014b) predicted breeding values, while we estimated genotypic values using 
both additive and dominance effects for each SNP. Furthermore, Boddicker et al. (2014b) 
adjusted phenotypes in the validation population using estimates of fixed effects obtained from 
ASReml analysis on all 8 trials of NVSL data used in their study. The fixed effect estimates used 
to adjust validation phenotypes in this study were estimated using only the validation data. 
We used Bayes-B with π=0.99 for all analyses in this study. For the Genome-WUR 
analyses, it may have been more appropriate to utilize Bayes-C. Generally, Bayes-B would be a 
more appropriate method to analyze a trait in which there are one or several major QTL and 
remaining effects are small, as Bayes-B allows for each SNP to have locus-specific variance 
(Meuwissen et al., 2001). In contrast, with Bayes-C and Bayes-Cπ, all SNPs have a common 
variance (Habier et al., 2011). We repeated the across isolate Genome-WUR analyses using 
Bayes-C, but genomic prediction accuracies were the same for VL and declined by 18% for WG 
(data not shown). Bayes-B with π=0.99 provided more accurate estimates of GEGV compared to 
the Bayes-Cπ method for both VL and WG. Furthermore, accuracy obtained with Bayes-B when 
we set π equal to the estimates from Bayes-Cπ analysis were the same as using Bayes-B with 
π=0.99. For VL and WG in the KS06 data, Bayes-Cπ estimates of π were 0.99 for both the whole 
genome and Genome-WUR analyses. For VL and WG in the NVSL data, π was estimated to be 
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0.69 and 0.77 for the whole genome, respectively, and 0.56 and 0.42 for Genome-WUR, 
respectively.  
Our estimates of genotypic value include both additive and dominance effects, whereas 
genomic estimated breeding values (GEBV) are calculated based on only additive effects 
(Meuwissen et al., 2001). When we evaluated the whole genome accuracy of GEBV prediction 
across PRRSV isolates, average accuracy for VL was unchanged, but prediction accuracy for 
WG increased by 30%, from 0.34 to 0.4 for NTàKV and from 0.1 to 0.16 for KTàNV, compared 
to the additive and dominance combination model. 
Conclusions 
Genomic prediction of response to PRRSV isolate was moderately accurate on average, 
including genomic prediction across PRRSV isolates and across breeding companies. Overall, 
the Bayes-B method yielded the most accurate genomic predictions in this study. Whole genome 
prediction across PRRSV isolates and breeding companies was moderately accurate, but 
accuracy was greatly reduced when SNPs in the SSC 4 QTL were removed from the prediction. 
The previously identified QTL on SSC 4 (Boddicker et al., 2012) had a large effect on VL for 
both PRRSV isolates and on WG for the NVSL isolate (Hess et al., 2015), and therefore, had a 
large contribution to prediction accuracy. Greater relationships between training and validation 
populations had larger effects on genomic prediction accuracy for scenarios in which there were 
many QTL with small effects on the trait of interest. Especially for VL, inclusion of related 
animals in training yielded the largest increase in Genome-WUR prediction.  
We found that using the whole genome for prediction was most accurate. The use of 
SNPs shown to be associated with each trait in single SNP analysis decreased prediction 
		
169	
accuracy. Furthermore, SNPs near genes annotated with biologically relevant GO terms had less 
predictive ability compared to the whole genome.  
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Figures 
 
 
Figure 5.1 Principal components analysis of the SNP genotype data. Each point represents a 
single animal, with each color representing one of the 8 breeding companies used in this study. 
The breeding company numbers match those shown in Table 5.1. The breed makeup of the 
animals for each breeding company are shown in the same color. LR=Landrace, LW=Large 
White, and Y=Yorkshire. Breeds are presented as breed of sire x breed of dam. 
  
		
173	
 
Figure 5.2 Scenarios used for training and validation for genomic prediction. Pink, purple, 
and blue colored rectangles represent each of the 3 breeding companies with pigs in both NVSL 
and KS06 trials, with the trial number indicated inside the rectangle. Gray colored rectangles 
represent individual breeding companies with only one trial of PRRSV infected pigs. Arrows 
indicate direction of genomic prediction, with the tail originating from the trials used in training 
and the head pointing towards the trial(s) used for validation. (A) Genomic prediction across 
PRRSV isolates using all data indicated by black arrows; across breeding company using both 
PRRSV isolates in training indicated by red arrows. (B) Genomic prediction across PRRSV 
isolate including validation breeding company in training indicated by purple arrow; Genomic 
prediction across breeding company within PRRSV isolate and across breeding companies and 
isolate indicated by small and large blue arrows, respectively.   
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(A)  
(B)  
(C)   
 
Figure 5.3 Accuracy of genomic prediction across PRRSV isolates for Viral Load. 
Accuracy, presented as the average correlation between genomic estimated breeding values and 
adjusted phenotypes divided by the square root of heritability in the validation population, of 
genomic prediction for VL in the given scenario. (A) Accuracy of genomic prediction across 
PRRSV isolates for the whole genome, genome when we account for WUR genotype (Genome - 
WUR), and using only the SNPs in the 1 Mb window containing the WUR SNP (WUR only). 
(B) Average accuracy of genomic prediction across PRRSV isolates without validation breeding 
company in training (Excluding) and with validation breeding company in training (Including). 
(C) Average accuracy of prediction across breeding companies with indicated PRRSV isolate 
validation population when training within the same PRRSV isolate, across isolate, or using both 
isolates. Individual points represent the accuracy of prediction for one trial with breeding 
companies represented in both PRRSV isolates having the same black shape and gray diamonds 
representing the trials which were not replicated. 
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Figure 5.4 Genomic prediction accuracy for Viral Load using SNP subsets based on single-
SNP GWAS and functional analysis. Accuracy of genomic prediction using all SNPs (Whole 
Genome), those SNPs with P<0.003 from single-SNP analysis, or SNPs located near genes in 
enriched biologically relevant gene ontology terms (Gene Ontology).  
  
		
176	
 
(A)  
(B)  
(C)   
Figure 5.3 Accuracy of genomic prediction across PRRSV isolates for Weight Gain. 
Accuracy, presented as the average correlation between genomic estimated breeding values and 
adjusted phenotypes divided by the square root of heritability in the validation population, of 
genomic prediction for WG in the given scenario. (A) Accuracy of genomic prediction across 
PRRSV isolates for the whole genome, genome when we account for WUR genotype (Genome - 
WUR), and using only the SNPs in the 1 Mb window containing the WUR SNP (WUR only). 
(B) Average accuracy of genomic prediction across PRRSV isolates without validation breeding 
company in training (Excluding) and with validation breeding company in training (Including). 
(C) Average accuracy of prediction across breeding companies with indicated PRRSV isolate 
validation population when training within the same PRRSV isolate, across isolate, or using both 
isolates. Individual points represent the accuracy of prediction for one trial with breeding 
companies represented in both PRRSV isolates having the same black shape and gray diamonds 
representing the trials which were not replicated. 
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Figure 5.6 Genomic prediction accuracy for Weight Gain using SNP subsets based on 
single-SNP GWAS and functional analysis. Accuracy of genomic prediction using all SNPs 
(Whole Genome), those SNPs with P<0.003 from single-SNP analysis, or SNPs located near 
genes in enriched biologically relevant gene ontology terms (Gene Ontology). 	 	
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Tables 
Table	5.1	General	information	on	each	PRRSV	infection	trial.			
Trial(s) Breeding Company Breed 
Viral Load Weight Gain PRRSV 
Isolate n Average (s.d.) n 
Average 
(s.d.) 
1-3 1 LW1 x LR2 504 108.3 (8.1) 487 12.1 (4.4) 
NVSL 
4 2 Duroc x LW/LR 192 113.2 (6.3) 190 15.9 (4.0) 
5 3 Duroc x LR/LW 184 101.4 (7.2) 183 19.1 (2.9) 
6 4 LR x LR 123 109.6 (8.0) 106 14.8 (5.6) 
7 5 Pietrain x LW/LR 189 104.5 (6.2) 189 14.5 (3.2) 
8 6 Duroc x Y3/LR 188 107.9 (6.6) 182 10.2 (4.6) 
15 7 LR x LW 171 107.6 (10.9) 165 19.1 (4.0) 
NVSL - - 1551 107.0 (8.4) 1502 14.9 (5.0) 
10 7 LR x LW 174 93.9 (6.7) 179 19.1 (4.2) 
KS06 11 1 LW x LR 170 100.4 (6.4) 178 18.6 (4.4) 12 8 LR x LW 171 104.7 (6.3) 170 19.0 (4.1) 
14 3 Duroc x LR/LW 180 98.6 (7.7) 171 21.3 (4.1) 
KS06 - - 695 99.4 (7.8) 641 19.5 (4.3) 
Total - - 2246 104.6 (8.9) 2200 16.4 (5.2) - 1	Large	White	(LW);	2	Landrace	(LR);	3Yorkshire	(Y).	 	
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CHAPTER 6: GENERAL DISCUSSION 
Diseased pigs cause great economic losses in the swine industry. Inherited diseases, such 
as immunodeficiencies, are not generally a main focus of producers or animal breeders; however 
ignoring an issue will not resolve it. Death loss in the nursery phase is likely to be attributed to 
post-weaning multisystemic wasting syndrome (López-Soria et al., 2011) or other communicable 
diseases, while Mendelian segregating immune deficiencies have not been considered to date.  
Severe Combined Immunodeficient Pigs 
The first objective of this thesis was to discover the mutations that caused naturally 
occuring Severe Combined Immunodeficiency (SCID) in pigs from a selection line of pigs at 
Iowa State University. In Chapter 3 of this thesis, we describe the discovery of two novel 
mutations in the Artemis gene that cause SCID in these pigs. The SCID phenotype of these pigs 
also closely mimics humans with Artemis deficiency (also known as Radio-Sensitive SCID; 
Dvorak and Cowan, 2010), as fibroblasts from SCID pigs were shown to have increased 
sensitivity to ionizing radiation. We provided further evidence of mutations in Artemis as causing 
SCID in these pigs by rescuing this cellular phenotype by transfection of human Artemis cDNA 
containing plasmid into the SCID fibroblasts, which resulted in reduced radiosensitivity. We 
interpreted this results as indicating the human ARTEMIS protein expressed from the plasmid 
had rescued the lack of porcine ARTEMIS protein. These mutations were associated with two 
haplotypes based on SNPs on the commercially available Illumina Porcine SNP60 Beadchip 
(Ramos et al., 2009). Both of these haplotypes were traced back through the pedigree to the 
founders of the population in which SCID was discovered, which were sourced from commercial  
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pigs in the Midwestern United States. This indicates that these deleterious mutations may be 
segregating in the swine industry.  
SCID carrier status of commercial pigs 
To determine if commercial pigs carried the SCID haplotypes, we performed a haplotype 
analysis on a total of 17,324 breeding-age pigs from the National Swine Registry dataset, a 
commercial pig breeding company, and the RFI selection lines at ISU. The pigs from the 
National Swine Registry and the RFI selection lines at ISU were purebred Yorkshire pigs, while 
the pigs from the breeding company were from multiple lines with unknown breed composition. 
The results of these haplotype analyses are in Appendix A. Out of the total 14,974 commercial 
pigs for which SNP genotypes were available (those from the National Swine Registry and the 
breeding company), 359 pigs were shown to carry haplotypes identical to one of the SCID 
haplotypes identified in Chapter 3 of this thesis. Out of the 2,350 pigs from the RFI selection 
lines at ISU, 312 animals carried one of the identified SCID haplotypes. However, there were 14 
pigs that were either homozygous for one SCID haplotype or compound heterozygous, carrying 
one of each SCID haplotype, yet survived into adulthood, presumably displaying a normal 
immunosufficeint phenotype. These 14 pigs were from the low RFI line, which is the line in 
which the first 4 known SCID piglets were identified. These 14 pigs would be expected to be 
SCID affected, meaning that they would not have been able to survive past approximately 6 
weeks of age without sterile housing conditions. As these pigs were of breeding age (over 8 
months old), this shows that the SNP60 genotypes in this region do not fully track transmission 
of the causative mutations for SCID, and it is possible that the SCID SNP haplotypes, although 
they are closely associated with the SCID phenotype in the ISU population, do not track the 
causative mutations in all populations.  
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The true SCID mutation carrier status could be obtained by genotyping these suspected 
SCID carriers and those supposedly SCID affected pigs for the causative mutations at Artemis, as 
described in Chapter 3. Furthermore, genetic tests for the SCID causitive mutations can be used 
to avoid carrier-by-carrier matings. SCID carrier-by-carrier matings would result in litters in 
which one quarter of the piglets weaned would not survive the nursery phase. It is not absolutely 
necessary that SCID carriers are completely eliminated in the commercial pig industry. One 
option would be to ensure that all parents of one sex do not carry either SCID mutation. In this 
way, no matings would be able to produce SCID piglets; only, at most, SCID carriers could be 
produced, which have none of the health symptoms of SCID affected pigs. Since haplotypes 
based on the commercially available porcine SNP60 chip (Ramos et al., 2009) do not reliably 
track the SCID causative mutations, tests for these specific mutations need to be used to make 
sure there are no carrier-by-carrier matings. We have begun the development of such tests (see 
Appendix B).  
SCID pig as a biomedical model 
In commercial swine operations, SCID pigs would be undesirable, causing economic 
losses and increased piglet disease and suffering. On the other hand, this immunodeficient pig 
provides a very attractive model to the biomedical community. In fact, several groups have spent 
years attempting to create SCID pigs. This hard work paid off with the creation of transgenic 
SCID pigs, including RAG1 or RAG1/RAG2 knockouts (Huang et al., 2014; Lee et al., 2014) and 
others with mutations in the X-linked IL2RG gene (Suzuki et al., 2012; Watanabe et al., 2013). 
Pigs are anatomically, physiologically, and immunologically more similar to humans than mice 
(Mestas and Hughes, 2004; Meurens et al., 2012), and these SCID pig models provide an 
alternative to the widely used biomedical model, SCID mice. SCID pigs could be used in studies 
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investigating many aspects of human immune function, stem cell-based therapeutics and vaccine 
testing, etc.  
Studies are ongoing to develop this biomedical model, as several questions remain with 
regards to the use of Artemis deficient SCID pigs. We discovered two independent mutations in 
the Artemis gene that cause SCID in these pigs (Chapter 3). One mutation, in haplotype 16 (h16), 
is a splice site variant that results in Artemis transcripts lacking the 141 base pair exon 8. This 
transcript would maintain its reading frame, but would lack a portion of the beta-CASP region, 
which is required for proper Artemis function (Callebaut et al., 2002; Poinsignon et al., 2004). 
The other mutation, in h12, is a point mutation in exon 10, which changes a Tryptophan amino 
acid codon to a stop codon. Translation of a transcript with this mutation would be expected to 
produce a truncated protein missing 61% of the amino acids in the complete Artemis protein. 
There may be functional differences in these two mutated proteins, which remain to be fully 
investigated. Results presented in Chapter 3 have shown that there are no differences in the 
numbers of B or T cells or sensitivity of fibroblasts to ionizing radiation between animals or cells 
homozygous for either mutation. But, differences have been noted in fatal cancers of bone 
marrow rescued pigs with different combinations of these haplotypes, as described in the 
following.  
Allogenic bone marrow transfer rescues immunodeficient phenotype in pigs 
Allogenic bone marrow transfer (BMT) has been employed to rescue the 
immunodeficiency in a total of 9 piglets to date (Powell et al., In preparation). Five of these had 
to be euthanized at an early age due to severe graft versus host disease (GvHD). The remaining 4 
BMT-rescued piglets survived the initial months following BMT. They were housed in a non-
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sterile environment, indicating that these pigs were exposed to pathogens and were able to mount 
an immune repsonse to maintain their health. Two of these surviving piglets were shown to 
respond to vaccination, as well (Powell et al., In preparation). Three of these 4 BMT pigs 
succumbed to cancers at approximately 12 months of age. Interestingly, 2 of these pigs were 
homozygous for the h16 mutation and both developed immune related cancers, lymphoma and/or 
leukemia. The third BMT pig, who was a compound heterozygous h12/h16 SCID, developed 
nephroblastoma, which is a fairly common cancer affecting swine (Engström and Granerus, 
2009). As of October, 2015, the last BMT SCID pig has survived to 3 years and 5 months of age. 
This boar, Wayne, is a compound heterozygous h12/h16 SCID pig who was BMT-rescued. 
There could be many reasons for the differences in life span of SCID pigs; but, the current 
hypothesis is that the protein translated from the h16 mutant transcript may have some residual 
enzymatic activity, leading to abberant rearrangement of lymphocyte receptors. Hypomorphic 
Artemis mutations have been shown to result in oncogenic chromosomal rearrangements in mice 
(Jacobs et al., 2011). Also, clinical manifestations vary based on the specific mutations in 
Artemis deficient human SCID patients (Lee et al., 2013), including lymphoma arising from 
several types of mutations (Felgentreff et al., 2015). Further studies are required to determine the 
functional differences in vitro and in vivo between these two Artemis mutations.  
As described above, our group was able to rescue this immunodeficiency in pigs with 
allogenic BMT (giving a pig immune system to SCID pigs). One large question that remains is 
whether or not we will be able to successfully humanize the SCID pigs. Humanization involves 
transplantation of human immune cells into a non-human animal (Pearson et al., 2008), such as 
our SCID pigs. SCID mice have been widely used in biomedical reasearch (Mestas and Hughes, 
2004; De Villartay, 2009) and much research has been done to improve the SCID mouse model, 
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including combining mutations to increase the success rate of humanization (Shultz et al., 2007; 
Pearson et al., 2008; Tanner et al., 2014). The SCID pig described in this thesis and other 
publications (Cino-Ozuna et al., 2012; Ewen et al., 2014) was not able to reject human cancer 
cells (Basel et al., 2012), but a large question remains on whether or not human stem cells would 
survive in this model, resulting in a humanized SCID pig.  
SCID pigs as a model to study disease in swine 
SCID pigs are a valuable model in biomedical research due to the similarity of pigs and 
humans (Lunney, 2007; Kuzmuk and Schook, 2011; Meurens et al., 2012; Swindle et al., 2012), 
but these pigs would also be useful in studies of pig-specific diseases. The SCID pigs described 
in Chapter 3 lack both B and T cells (Ewen et al., 2014), two very important cellular components 
of the adaptive immune system, which could help answer questions about the pathogenesis of 
diseases in swine. The Porcine Reproductive and Respiratory Syndrome (PRRS) is one example 
of an economically important swine disease (Holtkamp et al., 2013) for which the viral 
pathogenesis is not well understood. Recently, a study was conducted to determine the 
differences in response to PRRS virus (PRRSV) infection between these SCID pigs and their 
non-SCID littermates (Chen et al., 2015). While the non-SCID piglets responded in a typical 
fashion to the PRRSV infection, reaching peak viremia around 11 days post infection (dpi), then 
decreasing the levels of virus in the blood until the end of the study, PRRSV viremia of the SCID 
pigs showed a different profile. Up to and including 11 dpi, the SCID pigs had lower levels of 
PRRSV in their circulating blood compared to non-SCID littermates. Subsequently, this 
relationship reversed because SCID pigs were unable to control PRRSV replication; while the 
non-SCID pig immune system was combatting and clearing the PRRSV, the PRRSV levels in 
SCID pigs continued increasing. T cell function may play a role in the low PRRSV levels during 
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the first 11 dpi, as well as the high PRRSV levels after 11 dpi. These results led Chen et al. 
(2015) to speculate that IL-10, a cytokine produced by suppressor T cells, could be responsible 
for increasing the permissivity of macrophages available to be infected by the PRRSV (Patton et 
al., 2009; Cecere et al., 2012), in turn allowing for more viral replication at the early time point 
in non-SCID pigs. Later in the PRRSV infection period, T helper cells produce another cytokine, 
IFN-γ, which acts to protect macrophages from infection by the PRRSV (Rowland et al., 2001). 
While no cytokine measurements are available to support this hypothesis, Chen et al. (2015) used 
these immunodeficient pigs and their non-SCID littermates to examine the immune response to 
PRRSV infection, providing valuable information on the immunobiology behind this viral 
disease. 
Porcine Reproductive and Respiratory Syndrome  
Maintenance of herd health is a topic of great importance in the swine industry, and 
includes the implementation of many continuously updated protocols, including strict biosecurity 
measures, vaccination, and constant vigilance. All of this is done to prevent introduction or 
spread of communicable diseases, such as Porcine Reproductive and Respiratory Syndrome 
(PRRS). PRRS virus (PRRSV) outbreaks are estimated to cause a $664 million loss to the United 
States swine industry annually (Holtkamp et al., 2013). Vaccines have been developed to combat 
PRRSV outbreaks but their success is limited due to the lack of protection against heterologous 
infections (Park et al., 2014) and the hesitation of farmers to implement a PRRS vaccination 
protocol because the vaccine is a modified live virus and can cause clinical symptoms (Hu and 
Zhang, 2014; Renukaradhya et al., 2015). Genetic selection of pigs with improved response to 
PRRSV infection is a valuable tool that can be added to the current PRRSV fight toolbox. 
Studies have shown that there is genetic variation in response to PRRSV (Lewis et al., 2007; 
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Boddicker et al., 2012), indicating that it is possible to select animals with improved genetics for 
PRRSV response traits such as reproductive performance (Lewis et al., 2009; Serão et al., 2014), 
survivability (Vukasinovic and Clutter, 2010), antibody levels (Serão et al., 2014), viremia in 
blood (Biffani et al., 2010; Boddicker et al., 2012; Boddicker et al., 2014a; Hess et al., 2014; 
Boddicker et al., 2014b), and weight gain under infection (Boddicker et al., 2012; Boddicker et 
al., 2014a; Hess et al., 2014; Boddicker et al., 2014b). A major quantitative trait locus (QTL) on 
Sus scrofa chromosome (SSC) 4 was identified to be associated with both the amount of virus in 
the blood (VL) of PRRSV infected pigs up to 21 days post infection (dpi) and weight gain of 
piglets from 0 to 42 dpi (WG; Boddicker et al. 2012; Boddicker, Bjorkquist, et al. 2014; 
Boddicker, Garrick, et al. 2014). These studies focused on the effects of the SSC 4 QTL and 
included data from infection of pigs with only one PRRSV isolate. The work presented in 
Chapter 4 of this thesis examined the genomic regions that account for over 80% of the genetic 
variation of each trait that was not explained by the SSC 4 QTL. Furthermore, our data included 
the response of piglets infected with both the NVSL PRRSV isolate that was used in the 
Boddicker et al. (2012; 2014a; 2014b) studies and a more recent PRRSV isolate, KS06.  
Genome wide association studies 
The second and third objectives of this thesis were to identify genomic regions associated 
with experimental infection with one of two isolates of the PRRSV and to assess enrichment of 
gene ontology (GO) annotation terms of genes in these identified SNP-associated regions. In 
Chapter 4 of this thesis, we identified several previously unidentified genomic regions that were 
associated with response to PRRSV; but there were no regions that were consistently associated 
with VL or WG in both PRRSV isolate datasets. We utilized two GWAS methods in our 
analyses, single SNP and Bayesian variable selection GWAS (Bayes-B). Several regions were 
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shown to be associated with WG or VL by both single SNP and Bayes-B GWAS analyses, 
although single SNP analysis identified a larger number of associated regions than Bayes-B. 
Single SNP analysis performed tests on each SNP individually, with no constraints on the 
number of SNP associated with the phenotype of interest, while our Bayes-B analyses assumed 
that only 1% of the SNPs in the genotype data had an effect on the phenotype. To determine 
whether Bayes-B would be able to identify additional regions with a relaxed assumption of SNP 
association, we lowered π values to those obtained by the Bayes-Cπ method (Chapter 5). Using 
these lower values of π (ranging from 0.42 to 0.77) did, however, not reveal additional genomic 
regions to be associated with either trait. Single SNP GWAS was better able to identify genomic 
regions with smaller effects on each phenotype than Bayes-B, as evidenced by the functional 
results described in the following. In an effort to determine if these SNPs with small effects 
(those with less than genome-wide statistical significance) were true associations rather than 
spurious statistical associations, we performed gene ontology (GO) annotation enrichment tests 
to assess the biological relevance of the genes located near SNPs associated with the phenotype. 
Quantitative traits, such as response to viral infection, are controlled by the action of many 
genes, and each of them may have small effects on the trait. When genes with small effects 
interact in pathways or biological processes, their cumulative effects may result in larger effects 
on the overall phenotype, assuming additive gene action without complementation. SNPs with 
moderate associations may be in LD with these minor QTL. Relaxation of the significance 
threshold in the single SNP results will increase the number of regions identified, but functional 
annotation or GO term enrichment analyses can be used to increase confidence of true 
association. 
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Functional analysis of GWAS results 
As functional analysis of SNP-based GWAS results has not been implemented in our 
traits of interest, we first assessed two criteria for gene list creation - 1) statistical significance 
threshold for identification of associated SNPs and 2) the chromosomal distance (in kilo base 
pairs; kb) from the associated SNPs for identification of positional candidate genes. We used 
BioMart (www.biomart.org) to create lists of genes within window sizes of 1,000, 500, and 200 
kb (500, 250, and 100 kb 5’ and 3’) surrounding SNPs associated with the trait of interest in the 
data from one of two PRRSV isolates at p-value thresholds of 0.01, 0.003, and 0.001, and 
investigated the enrichment of GO terms in the biological process slim category from the Panther 
software (Mi et al., 2013). The number of genes in the lists increased with an increase in the 
significance threshold and with larger window size. Across traits and PRRSV isolates, lists of 
genes within 250 kb of SNPs with p-value<0.003 were most enriched for biologically relevant 
GO terms. Thus, we performed more in depth GO term enrichment analyses on these lists. 
We found that several GO terms were enriched in the genes that were located near SNPs 
associated with each trait. Furthermore, although genomic regions were not consistently 
associated across the two PRRSV isolates used in this study, we found several of the same GO 
terms to be enriched for genes in the associated regions across isolates. Genes near SNPs 
associated with VL were enriched for natural killer cell activation, B cell activation, and immune 
response GO terms. Genes near SNPs associated with WG were enriched for an antigen 
processing and presentation GO term. Genes near SNPs associated with WG in the NVSL data 
were enriched for several metabolically-related GO terms, although enrichment for these 
metabolic GO terms was not statistically significant for WG in the KS06 data. Our GO term  
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enrichment analysis also aided in the identification of functionally relevant candidate genes, as 
shown in the following table 6.1.  
Table 6.1. Candidate genes identified in genomic regions with only the most significant 
statistical associations (GWAS identified) or those identified through GO term enrichment 
analyses (Annotation identified). 
 
 
We found that GO term enrichment analyses of the single SNP GWAS results identified 
more candidate genes compared to looking at genes located near only the most significantly 
associated SNPs (Chapter 4). One value of GO term enrichment analysis is in the ease with 
which these additional candidate genes with relevant function in viral immune response were 
identified. To identify candidate genes from GWAS results, we could search for genes located in 
each SNP-associated region at a time, using a genome browser, such as Ensembl 
(http://www.ensembl.org/Sus_scrofa/Info/Index?db=core). In addition to decreasing the time 
required for detailed analysis of GWAS results, GO term enrichment of genes near SNP 
associated with the phenotype of interest adds valuable biological information to the statistical 
association of SNPs. Functional annotation of genes near SNPs that have moderate associations 
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with the phenotype of interest increase the confidence of true association. Furthermore, 
functional analysis identifies possible pathways involved in the phenotype of interest, which in 
turn aids in the discovery of candidate genes. 
Genomic prediction 
GWAS results help to identify genomic regions associated with traits of interest; another 
use of the associations between genetic markers and phenotypes is genomic prediction. Genomic 
prediction involves the use of statistical methods to predict the genetic merit, or genomic 
estimated breeding value (GEBV), of a selection candidate for a phenotype that has not been 
observed on that individual (Meuwissen et al., 2001). Prediction of GEBVs require a training 
population of individuals that have both phenotypic observations for the trait being selected upon 
and genotypic observations for the same markers for which the selection candidates in the 
validation population have been genotyped. The effects of alleles at each genetic marker are 
estimated using the data from the training population and then used to predict the GEBVs of the 
validation population using only genotypes for those markers (Meuwissen et al., 2001). These 
GEBVs can then be used by animal breeders for genomic selection, or selecting animals with the 
highest genetic merit for the trait or traits of interest using genotypic information (Dekkers, 
2010). Marker assisted selection (MAS) was one of the first eras of genomic selection and 
involved the use of relatively few genetic markers to predict genetic merit of the selection 
candidate (Smith and Simpson, 1986; Lande and Thompson, 1990). One of the major drawbacks 
of MAS was that many associations between markers and phenotypes were unable to be 
replicated, possibly due to the fact that the associations were detected using specific breed 
crosses and were not applicable in commercial crosses (Andersson, 2001; Dekkers, 2012). 
Genetic based prediction of GEBVs for complex polygenic traits, those controlled by many 
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genes, benefitted from the advent of dense genome-wide SNP chips, which provide genotypes 
for thousands to hundreds of thousands of genetic markers (Ramos et al., 2009).  
Genomic selection is particularly useful for traits that are difficult or expensive to 
measure, expressed only in one sex or later in life, or highly polygenic traits controlled by many 
QTL with small effects. Response to PRRSV infection is a good example of a highly polygenic 
trait that is very hard and expensive to measure, even impossible on selection candidates or their 
close relatives; this is because breeding animals are housed on nucleus farms with extremely 
strict biosecurity protocols to maintain high herd health. The aim of Chapter 5 of this thesis was 
to assess the accuracy of genomic prediction of PRRSV response traits across breeding 
companies and PRRSV isolates.  
Even with inconsistency of associated regions across PRRSV isolates (Chapter 4), we 
showed that using data from one PRRSV isolate to estimate SNP effects (training) and using 
these estimates to predict the phenotype of the other isolate using only genotypes (validation) 
was moderately accurate (Chapter 5). We also found that genomic prediction was moderately 
accurate across breeding companies, which disagrees with previous reports of very low to no 
genomic prediction accuracy for different traits across breeds (Hayes et al., 2009; Ibánẽz-
Escriche et al., 2009; de Roos et al., 2009; Toosi et al., 2009; Daetwyler et al., 2012). Although 
the training and validation populations used in this study were from different breeding 
companies, the commercial crossbred pigs were likely more genetically similar across breeding 
companies than the purebred Holstein and Jersey populations used by Hayes et al. (2009). 
Ibánẽz-Escriche et al. (2009), de Roos et al. (2009), and Toosi et al. (2009) examines the 
accuracy of genomic prediction across breeds using simulations, which requires many 
assumptions that are often violated in real data, such as that used in this study. For instance, 
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population simulation often assumes random mating of animals, and the pigs used in this study 
were commercial animals which have been selected on many economically important traits and 
matings are made to capitalize on the genetic merit of the parents without large increases in 
inbreeding (Silió et al., 2013). 
 When we increased the genetic relationship between the training and validation 
populations, by including the validation breeding company in training for across PRRSV isolate 
genomic prediction, on average, genomic prediction accuracy increased, which agrees with 
previous studies that find increased accuracy of genomic predictions with increased relationships 
between training and validation populations (Habier et al., 2007; Goddard, 2008; Hayes et al., 
2009; Daetwyler et al., 2013).  
SNP subsets used in genomic prediction 
We also used different subsets of SNPs for genomic prediction, specifically excluding the 
SNPs near the SSC 4 QTL from prediction and fitting WUR genotype as a fixed effect in the 
model (Genome-WUR) and only the SNPs in the 1 Mb window that includes the WUR SNP 
(WUR only). Our results showed that genomic prediction was most accurate when using the 
effects of all SNPs in the whole genome. In most scenarios, the contribution of the WUR region 
to the accuracy of genomic prediction was large, as evidenced by the marked decrease in 
genomic prediction accuracy using the Genome-WUR SNPs from the whole genome (Chapter 
5), which agreed with previous results by Boddicker et al. (2014a). Boddicker et al. (2014a) 
found that genomic prediction based on only the SSC 4 QTL SNPs was generally more accurate 
than using all SNPs in the genome; however, we found that using all SNPs in the genome was 
the most accurate. We also hypothesized that using only the SNPs associated with the trait of 
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interest in single SNP analyses or associated SNPs near genes whose function is likely involved 
in the trait increases genomic prediction accuracy compared to using all SNPs in the genome by 
removing some noisy SNPs. However, we found that genomic prediction using the whole 
genome was generally more accurate than either subset of SNPs (Chapter 5). Overall, these 
results show that genomic prediction for the scenarios used in this study is most accurate when 
using the estimates of all SNPs in the genome.  
Alternative strategies that could be used to incorporate GO term enrichment information 
into genomic prediction would be to use all SNPs in the genome, but weight different subsets of 
SNPs based on the annotation of genes close to the SNPs. In this way, genomic prediction takes 
advantage of the information from all genotyped SNPs with the additional information provided 
by the annotation of genes near these SNPs. For example, we could assume that SNPs near genes 
involved in natural killer cell activation would be more likely to have an effect on VL than SNPs 
near genes annotated with the mammary gland development GO term. In this example, we would 
allow SNPs in the natural killer cell activation subset to have a higher likelihoood of association 
with VL than SNPs in the mammary gland development subset by setting a higher pi value for 
the latter than the former. Several issues may complicate the implementation of this strategy 
including the following: 1) Genes may be annotated with multiple GO terms, and determining 
one specific subset for neighboring SNPs may not be clear. 2) The porcine genome annotation is 
imperfect, and the locations of over 5% of the SNPs on the current Illumina Porcine SNP60 chip 
are unknown. 3) The values at which to set pi for each SNP subset are unknown and depend on 
many factors, such as the number of SNPs in each subset and the underlying genetic architecture 
of the trait. 
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Application of this research  
The research presented in Chapters 4 and 5 of this thesis provide valuable information 
about the genomics of piglet’s response to experimental infection with one of two isolates of the 
PRRSV. We used GO term enrichment of GWAS results to identify several biological pathways 
that were overrepresented in genes near SNP associated with response to PRRSV infection. This 
time efficient method could be used to provide information about the biological roles of genes 
near SNPs associated with any trait and in any species with an annotated genome. Functional 
analysis of GWAS results is useful in reducing the time required to identify functionally relevant 
genes near SNPs with moderate or smaller sized effects and also provides biological information 
to the statistical association of SNPs. Chapter 5 of this thesis showed that genomic prediction of 
response to the PRRSV was moderately accurate when predicting across PRRSV isolate datasets 
and when predicting across genetic backgrounds. These results would be useful for selection of 
pigs in high health nucleus herds, since these animals are unlikely to be exposed to the PRRSV, 
while it is possible that their progeny or grand-progeny may be on commercial swine farms 
during a PRRSV outbreak. Therefore, the increased genetic value of response to PRRSV 
infection may not benefit the nucleus animal, but favorable alleles may be passed to future 
generations and prove valuable. The moderate accuracies of genomic prediction across breeding 
companies are a valuable result, as this shows that the training population does not need to 
contain close relatives of selection candidates. We also showed that the PRRSV isolate of 
infection of pigs in the training does not need to be the same isolate of infection of pigs in the 
validation, which is important to the swine industry because the PRRSV rapidly mutates and 
infection with the exact same PRRSV strain is unlikely to occur in multiple PRRSV outbreaks 
(Fang et al., 2007; Kimman et al., 2009).  
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Unanswered questions 
There remain several questions to be addressed with regards to the work presented in 
Chapters 4 and 5 of this thesis. First, the data used in these studies were from piglets that were 
experimentally challenged with the PRRSV in a clean and controlled biosecure environment 
(Lunney et al., 2011). It is not clear whether the same genomic regions would be identified to be 
associated with response to natural PRRSV infection in field conditions, where pigs would likely 
be coinfected with multiple pathogens during a PRRSV outbreak (Murtaugh et al., 2002). 
Furthermore, although our data includes responses to two PRRSV isolates, there are many more 
PRRSV strains in the swine industry (Fang et al., 2007; Kimman et al., 2009). Other than the 
SSC 4 QTL, no regions were identified across the two isolates of infection in this study, but there 
may be some consistency of SNP-region associations in future studies with other PRRSV 
isolates. When performing genomic selection, it is wise to ensure that SNPs with larger effects 
on the trait of interest do not have negative effects on other economically important traits in the 
swine industry; for example, if the favorable genotype at a SNP associated with WG during 
PRRSV infection has unfavorable association with WG in healthy conditions, it would not be 
profitable to select on this SNP unless piglets will always be infected with the PRRSV. 
Furthermore, selecting for favorable alleles for response to PRRSV infection that have 
unfavorable effects on response to other diseases would not be profitable. Care should always be 
taken when selecting on immune response traits, even without unfavorable associations as 
mentioned previously. The immune system should be reactive enough to protect the host from 
the infecting pathogen without overreacting to the pathogen, as this can cause damage to the 
host, also. In addition to efficient, the immune response should also be effective; if antibodies do  
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not aid in eliminating a specific pathogen from the host, then production of antibodies will only 
result in wasting of energy by the host without positive effects on pathogen clearance. 
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APPENDIX A. RESULTS FROM PHASING OF SNP GENOTYPES FROM 
COMMERCIAL ANIMALS TO PREDICT SCID CARRIER STATUS. 
Table A.1. Number of animals carrying SCID haplotype 16 (h16) and h12 from 14,974 
commercial pigs or pigs from the RFI selection line at ISU, which were sourced from 
commercial Yorkshire pigs. The breeds of pigs from the breeding company were unknown, with 
non-descript line identifiers (1, 2, and 3) provided. Haplotypes were based on 55 SNPs in the 2 
Mb surrounding the Artemis gene. 
Dataset Breed n h16 
carriers 
n h12 
carriers 
n 
h16/h16 
n 
h12/h12 
n 
h12/h16 
n animals 
total 
National 
Swine 
Registry 
Yorkshire 38 34 1 1 4 985 
Breeding 
Company 
1 0 0 0 0 0 5,665 
2 0 209 0 0 0 5,492 
3 0 78 0 0 0 2,832 
Total  38 321 1 1 4 14,974 
RFI - ISU Yorkshire 111 201 0 5 3 2,350 
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APPENDIX B. MOLECULAR GENETIC TESTS USED TO DETERMINE SCID 
STATUS IN THE IOWA STATE UNIVERSITY RFI POPULATION.  
Haplotype tests  
In order to identify affected, carrier, and homozygous normal pigs in the ISU population 
that do not have genotype data, allele-specific primer sets were designed for seven SNPs in the 
region surrounding the Artemis gene, using Web-based Allele-Specific PCR (WASP; 
Wangkumhang et al, 2007).  PCR cycling conditions for each test included denaturation at 94°C 
for 30 seconds (30s), annealing at temperatures indicated for each primer pair in table A.1 for 30 
seconds, and elongation at 72°C for the time indicated in Table B.1 (E-Time). Each PCR was 
begun with an initial hot start of 95°C for 2 minutes (2m), 40 cycles of amplification, and ended 
with a final elongation step at 72°C for 5m. Table B.1 gives the primer sequences, PCR 
condition information, location, and genotypes for the seven SNPs for which allele specific 
primers were designed.  The bottom portion of the table indicates genotypes, locations of the 
SNPs, and the number of the SNP in the 1 Mb haplotype from Figure B.1 in parentheses.  Three 
of these SNPs are part of the 21 SNPs in the 1 Mb used for haplotype analysis, as indicated in 
Table B.1. The remaining allele-specific primer sets were designed for SNPs in the 1 Mb 
upstream of Artemis. These SNPs were chosen as they segregated with the phenotype and the 
primer design software was able to produce primers sets that were very specific for each allele.  
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Table B.1.  Primer and PCR conditions, genotypes, location and number of the SNPs. 
For reference, the Artemis gene (DCLRE1C ENSSSCG00000011049) is located at Chromosome 
10: 51,553,277-51,597,276:  
 
SNP 
Name  Allele  
Product 
Size  FWD Primer Sequence  REV Primer Sequence  
Anneal 
Temp  
E-
Time  
ASGA-
0048074 
A  177  TCCTCTGACCAAGCCTCTG
T (SEQ ID NO:11)  
TCGTCCATGTACCAGAGC
CT (SEQ ID NO:12) 
56  30s  
C 177  TCCTCTGACCAAGCCTCTG
T (SEQ ID NO:13) 
CGTCCATGTACCAGAGCC
G (SEQ ID NO:14) 
56  30s  
ASGA-
0048114 
A  659  AACCAGTCCCTGACCAAC
TG (SEQ ID NO:15) 
TCCATATTTGTTAAGGGCA
GTAATCT (SEQ ID NO:16) 
54  30s  
G 131  TGCTCAGAGCTTTACATG
GATTTAG (SEQ ID NO:17) 
GGCCCATGTTGACATAAA
GC (SEQ ID NO:18) 
54  30s  
ALGA-
0059043 
A  643  TCCTCTGCAGGGTTTCAAA
G (SEQ ID NO:19) 
CAGGGTGTGGGACTTTGT
T (SEQ ID NO:20) 
54  30s  
G 127  TCAGCTTGGGCAGCTAGG 
(SEQ ID NO:21) 
CCACAGGCACATTGATCT
TG (SEQ ID NO:22) 
54  30s  
H3GA-
0030245 
A  576  AGTTGAAATCAAAGTATC
CCAA (SEQ ID NO:23) 
AACTGTAACAAGCGTCCC
TTTCT (SEQ ID NO:24) 
55  30s  
C 576  AGTTGAAATCAAAGTATC
CCAA (SEQ ID NO:25) 
AACTGTAACAAGCGTCCC
TTTCG (SEQ ID NO:26) 
55  30s  
ALGA-
059061  
A  593  GGTATTCTCCTCCTCTACC
TCT (SEQ ID NO:27) 
CTGGATTGGCAGAGGCTC
TTTAT (SEQ ID NO:28) 
55  30s  
G 593  GGTATTCTCCTCCTCTACC
TCT (SEQ ID NO:29) 
CTGGATTGGCAGAGGCTC
TTTAC (SEQ ID NO:30) 
55  30s  
ALGA-
0059066  
A  475  GAATGGGAGGTGAGTAAG
TAAA (SEQ ID NO:31) 
CCAGCTGCAAGGGAGACT 
(SEQ ID NO:32) 
55  30s  
C 475  GAATGGGAGGTGAGTAAG
TAAA (SEQ ID NO:33) 
CCAGCTGCAAGGGAGACG 
(SEQ ID NO:34) 
55  30s  
ALGA-
0059080  
A  425  AGCATTAAGACTGTGTGT
GTGT (SEQ ID NO:35) 
GGTCAAAGTCGTGGGTGT
GTTT (SEQ ID NO:36) 
55  30s  
G 425  AGCATTAAGACTGTGTGT
GTGT (SEQ ID NO:37) 
GGTCAAAGTCGTGGGTGT
GTTC (SEQ ID NO:38) 
55  30s  
 ASGA-
0048074 
ASGA-
0048114  
ALGA-
0059043  
H3GA-
0030245  
ALGA-
059061  
ALGA-
0059066  
ALGA-
0059080  
Location  51,153,137 (5)  
51,812,252 
(16)  
51,975,024 
(21)  
52,066,694  52,086,867  52,109,172  52,174,549  
h12  C G G C A C A 
h16  C A G C A C A 
Normal  A G A A G A G 
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Figure	B.1.	The 12 and 16 haplotypes that are associated with the SCID phenotype. Sire 
15801 carries the 12 haplotype and sire 11403 and the 4 dams that produced the initial four SCID 
piglets, carry the 16 haplotype. 
 
DNA and cDNA sequencing to identify the causative mutations  
Total RNA was extracted from two sources: whole tissue from ears of 1-day-old piglets, 
and fibroblasts that were cultured from ear snip tissue.  mRNA was reverse transcribed to cDNA.  
Artemis transcripts were then amplified from the cDNA using the following primers: forward 5’-
GGATCCGTGTTCGCCAACGCT-3’ (SEQ ID NO:39 in Patent No. US-2015-0216147) and 
reverse 5’-GCGGCCGCAGAGCTGCCTTTTAGGTTAT-3’ (SEQ ID NO:40 in Patent No. US-
2015-0216147), using an annealing temperature of 60°C and an extension time of 2m 30s.  The 
full Artemis cDNA was amplified using PCR technique, cloned into a TOPO vector, then 
plasmids transferred into E. coli bacteria which were then grown on LB plates with Ampicillin.  
Individual colonies were then picked into LB-Ampicillin media and PCR amplified to ensure 
that each colony contained a vector with Artemis cDNA.  Positive PCR products were cleaned 
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using Exo-Sap and sent to the Iowa State University DNA Facility for sequencing.  
Supplemental Figure 3.1 shows the different transcripts observed in cells from affected pigs.  
While many types of transcripts were observed, specific parts of the gene are missing for 
transcripts from the 12 and the 16 haplotypes.    
For haplotype 16, all transcripts were found to lack exon 8, which results in a transcript 
that is 141 bases shorter than the expected full transcript.  The sequence and translation of the 
longest cDNA clone from haplotype 16 is shown in Sequence and Translation 1 (SEQ ID NOS:1 
and 2, respectively, in Patent No. US-2015-0216147).  Exon 8 and the surrounding region were 
amplified from genomic DNA extracted from ear snip tissue to investigate the presence or 
absence of signal sequences required for normal splicing.  Exons 7 and 8 and portions of the 
surrounding introns were amplified using the following primers: forward 5’- 
CTCAGTGGGTTAGGGACCTG-3’ (SEQ ID NO:41 in Patent No. US-2015-0216147) and 
reverse 5’- GCCATCTGATAGGGTTTCCA-3’ (SEQ ID NO:42 in Patent No. US-2015-
0216147), with annealing temperature of 54°C and elongation time of 1m.  Animals homozygous 
for the 16 haplotype were found to have a point mutation of GàA at the 615th base of the PCR 
product (Sequence 4; SEQ ID NO:7 in Patent No. US-2015-0216147).  This base is part of the 
signal sequence for a splice donor site for exon 8, and is required for proper splicing.  The A 
mutation was seen only in homozygous 16 haplotype animals (Sequence 4; SEQ ID NO:7 in 
Patent No. US-2015-0216147), but a G at this position was seen in the 12 haplotype and all 
normal haplotypes (Sequence 5; SEQ ID NO:8 in Patent No. US-2015-0216147) that were 
sequenced. 
Transcripts from the 12 haplotype were found to lack a 137 base pair long exon 10, 
which would cause a frameshift mutation, resulting in a stop codon shortly after the missing 
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exon.  Sequence and translation of the longest cDNA clone from haplotype 12 are shown in 
Sequence and Translation 2 (SEQ ID NOS:3 and 4 in Patent No. US-2015-0216147).  Exons 10 
and 11 and portions of the surrounding introns were amplified from genomic DNA of 
homozygous haplotype 12 animals using the following primers: forward 5’- 
GCTAAAGTCCAGGCCAGTTG-3’ (SEQ ID NO:43 in Patent No. US-2015-0216147) and 
reverse 5’- CAAGAGTCCCCACCAGTCTT-3’ (SEQ ID NO:44 in Patent No. US-2015-
0216147), with annealing temperature of 56°C and elongation time of 1m.  The signal sequence 
required for splicing of exon 10 was the same as that seen for normal and reference sequences.  
However, sequencing of the genomic region around exon 10 identified a nonsense point mutation 
in the 12 haplotype exon 10 sequence at base 116 of the PCR product (Sequence 6; SEQ ID 
NO:9 in Patent No. US-2015-0216147), with a mutation from GàA.  Under normal 
transcription, splicing and translation, this mutation from GàA would change a Tryptophan 
amino acid codon to a stop codon, resulting in a protein that ends with 266 of the total 712 amino 
acids of the normal Artemis protein.  We have not observed such a transcript in 12/12 animal 
cells thus far.  For the 12 haplotype transcript we do observe, the predicted protein translation 
would be 277 amino acids long (Translation 2; SEQ ID NO:2 in Patent No. US-2015-0216147). 
The genomic sequences for exons 10 and 11 are shown in sequence 7 (SEQ ID NO:10 in Patent 
No. US-2015-0216147). 
These results for the 12 and 16 haplotype sequencing did not show any transcripts 
containing all exons expressed in pig cells that were homozygous for 12 or the 16 through rt-
PCR amplification using primers at the beginning and end of the normal transcript.  Thus a 
normal Artemis protein cannot be produced from any of the RNAs observed.  For the 16 
haplotype, a normal amount of RNA should be present in these cells, which will make a protein 
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that missing 47 amino acids.  For the 12 haplotype, the protein produced would be severely 
truncated if a transcript containing exon 10 was produced; however, no evidence that such a 
transcript is stably produced in 12/12 homozygous animals was found. Translation of the 
transcript observed would also result in a truncated protein. 
While >150 different mutated alleles of Artemis have been found through 2010 (Pannicke 
et al. 2010), none of the reported mutant alleles are exactly the same as the two mutants we have 
identified or as their predicted RNAs/proteins.  Thus, it is difficult to be sure of the actual 
resulting residual level of activity expressed by these mutations. We anticipate that the protein 
predicted to be expressed from the 16 mutation may have some residual activity, while the 
protein predicted to be expressed from the 12 mutation would be completely non-functional. 
Genotyping Methods Used for Crossbred Animals 
Known carrier pigs were mated to Duroc, Landrace, or crossbred animals in order to 
introduce a more diverse genetic background into the SCID carrier population. Offspring that 
resulted from these matings were tested for carrier status (50% of each litter produced expected 
to be SCID carriers) using the seven sets of allele-specific primers described above.  The genetic 
tests performed were not able to accurately distinguish carriers from homozygous normal piglets. 
To genotype these crossbred animals, genomic regions containing exons with causative 
mutations (exon 8 for suspected haplotype 16 carriers and exon 10 for suspected haplotype 12 
carriers) were amplified, cleaned using Exo-Sap, then sequenced. This method of genotyping is 
most accurate in animals outside of the ISU Yorkshire population, such as animals of other 
breeds or commercial animals. 
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Direct Genetic Tests for the SCID mutations 
Figure 3.5 shows the orientation to the two different mutations, their relationship to each 
other along the chromosome, and the new genetics tests for SCID in pigs.  
Specific tests were developed for the mutant sequence at each of the two variants in the 
Artemis/DCLRE1C gene. For the causative mutation in haplotype 16, found at position 615 of 
Sequence 4 (SEQ ID NO:7), the test was established for all animals in which it was assessed.  
For the causative mutation in haplotype 12, found at position 116 of Sequence 6 (SEQ ID NO:9 
in Patent No. US-2015-0216147), the test was able to genotype most animals but not all (see 
information below). 
The ABI PRISM® SNaPshot™ Multiplex Kit (Lifetechnologies, P/N 4323151) 
technology was used for the tests. SNaPshot can be used to distinguish four nucleotides at a 
specific position in a sequence by color. First, a PCR is performed to amplify the region 
surrounding the SNP of interest, i.e. one PCR for the region surrounding haplotype 12 (h12) SNP 
and one for the region surrounding haplotype 16 (h16) SNP. The primers used are called the 
outside primers for the h12 SNP and for the h16 SNP in Table B.2. The melting temperature for 
both PCRs is Tm=54°C. Next, the PCR products are cleaned from remaining primers and dNTPs 
through adding 5 units of Shrimp Alkaline Phosphatase (SAP, USB Corporation, P/N 70092) and 
2 units of Exonuclease I (ExoI, New England BioLabs, P/N M0293) to every 15ul of PCR 
product. To get to the right concentration, ExoI is diluted in a buffer containing 80mM Tris-HCl 
and 2mM MgCl2. The mixture of PCR product, SAP and ExoI is incubated at 37°C for 1 hour 
and deactivated at 75°C for 15 minutes. The cleaned PCR products (one for each SNP) of one 
animal can thereafter be pooled and analyzed together with the SNaPshot™ Multiplex Kit. This 
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kit encloses a SNaPshot Multiplex Ready Reaction Mix that contains fluorescently labeled 
ddNTPs and AmpliTaq®  DNA polymerase in a reaction buffer. In a reaction volume of 10ul, 
we have 5ul of the SNaPshot Multiplex Ready Reaction Mix, 3ul of pooled PCR products and 
0.2uM of each extension primer (for sequence see Table B.1). The extension reaction goes as 
followed: 25 cycles of 10 minutes at 96°C, 5 minutes at 50°C and 30 minutes at 60°C. 1 unit of 
SAP is added after this reaction to remove unincorporated fluorescent ddNTPs from the reaction. 
This SAP incubation is done at 37°C for 1 hour and deactivated at 75°C for 15 minutes. To read 
the fluorescent signal, this product needs to run on an ABI Prism 3700 DNA Analyzer (or 310 or 
3100 Genetic Analyzer), using the GeneScan 120 LIZ size standard, with dye set E5.  
Table B.2.  PCR Primers and Oligonucleotides used in SNaPshot Direct Genetic Tests for the 
Causative Mutations 
Haplotype	 Primer	
Use	
Primer	
Directio
n	
Primer	Sequence	
5’	–	3’	
SCID	
allele	
Normal	
allele	
h16	 PCR		 Forward	 CTCAGTGGGTTAGGGACCTG	(SEQ	ID	NO:46)	 	 	Reverse	 GCCATCTGATAGGGTTTCCA	(SEQ	ID	NO:47)	 	 	SNaPshot	 Forward	 GAGGAGTTCGGAGTCCAG	(SEQ	ID	NO:48)	 A	 G	Reverse	 TCTCTGGGAGAAAGAGCCCTCAGGTA	 (SEQ	 ID	NO:49)	 T	 C	
h12	 PCR		 Forward	 GCATTCACTCAGGCTGCTTT	(SEQ	ID	NO:50)	 	 	Reverse	 CCCAGGAAATACTGGCTCAT	(SEQ	ID	NO:51)	 	 	SNaPshot	 Forward	 CCCCATCTTTTTTAGGCAGAGGAATATTTTCATT	(SEQ	ID	NO:52)	 A	 G	Reverse	 CTCTCTCTCTCTCCGGATGTTATTCCACAGGGTAATTTATTC	(SEQ	ID	NO:53)	 T	 C	
Both tests are performed in matings in which the parents contain both the h16 and h12 
alleles, in order to correctly determine the combined genotype at both positions. In matings 
where only one SCID haplotype is segregating, only one of the two tests needs to be performed. 
We have not observed an animal that carries both mutations on the same chromosome, the two 
mutations appear to always be on separate chromosomes. 
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H16 test (position 615 of Sequence 4; SEQ ID NO:7 in Patent No. US-2015-0216147) 
The h16 test correctly determines the allele at the h16 position (either G/C or A/T) for all 
possible genotypes. These include a GG result for normal animals at both the h12 and h16 
positions, as well as h12/h12 animals, a GA result for h12/h16 and normal/h16 animals, and a 
AA result for h16/h16 animals.  
H12 test (position 116 of Sequence 6; SEQ ID NO:9 in Patent No. US-2015-0216147) 
The h12 test detects the h12 mutant sequence at position 116 of SEQ ID NO:9 (in Patent 
No. US-2015-0216147) but will not always detect the normal sequence on the other chromosome 
in a h12/h16 or a h12/normal animal. Recent results from SNaPshot genotyping of h12 mutation 
carriers have shown that the primers given above may preferentially amplify the h12 mutated 
allele when present. In the absence of the h12 mutated allele, SNaPshot results show the 
expected GG (normal/normal at this position) genotype. In certain cases, SNaPshot genotyping 
of animals with the known genotype of h12/h16 or h12/normal have shown only the h12 mutant 
allele (AA).  
Combining technologies to obtain exact genotype at the Artemis locus 
Correct identification of genotypes for animals that have resulted in these SNaPshot 
genotyping errors have been found through the use of the primers discussed in Table B.1 in 
addition to SNaPshot results from h16 allele genotyping. The primers of Table B.1 of are capable 
of determining whether an animal is SCID affected, carrier, or normal. This information, 
combined with the genotype from h16 SNaPshot will show the exact genotype of that animal. 
